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ABSTRACT
ErbB transmembrane receptors are a family of 4 receptor tyrosine kinases that interact
with one another through homo and heterodimer interactions. When these dimers form,
the kinase domains on the receptor tails interact with one another, transphosphorylating
one another, initiating a signal cascade. The signaling pathways these receptors
participate in are responsible for many different cell functions including apoptosis,
growth, and proliferation. The overexpression of these receptors has been linked to
various forms of cancer, emphasizing the importance of understanding how these
receptors interact with one another to trigger these cascades. Single Particle Tracking
experiments have provided more precise and detailed measures of dimer lifetimes and
diffusion. A major observation from the experiments is the anomalous diffusion of the
receptors. One suggested contributor to this anomalous diffusion is confinement zones on
the membrane. In this work, we develop, validate, and implement a spatial stochastic
model to study these receptors and uncover how their kinetics and dynamics as well as
the membrane landscape come together to impact erbB activation.
We start by focusing on erbB1. Single particle tracking experiments show that
receptor pairs interact repeatedly over a period of time. One possible explanation for
v

these

repeated

interactions

is

to

facilitate

phosphorylation.

An

asymmetric

phosphorylation model is proposed, where one receptor in the dimer pair is responsible
for activating the other receptor, the receiver, which then in turn phosphorylates the
original activator. The model shows that the confinement zones on the membrane play a
critical role in causing repeated receptor interactions and reveals that receptors
dynamically switch between different activation states over time. Our work continues by
delving deeper into the membrane landscape. Single particle tracking data is analyzed to
investigate the characteristics of the observed anomalous diffusion. The analysis gives an
estimate for the size range of the confinement zones and shows that they are a series of
domains, not corrals. Taking the single particle tracking analysis one step further, we
develop a Domain Reconstruction Algorithm that reconstructs confinement zone shapes
and sizes from single particle tracking trajectories. In the final study, we move on to
erbB2 and erbB3 interactions. ErbB3, which is traditionally believed to be kinase dead,
has recently been shown to have weak kinase activity. Through kinase assay experiments,
we show in the presence of erbB2 and heregulin, erbB3 has measurable kinase activity.
Using the reconstructed domains from erbB2 and erbB3 data to create a simulation space,
and experimental data from the kinase assay and single particle tracking, we extend the
erbB1 spatial stochastic model for this study. We show that erbB2 and erbB3 have
significantly different interactions with the cellular membrane confinement zones, erbB3
is dependent on erbB2 activation, and erbB3 homodimer stability inhibits erbB3
activation. Extension of the model to investigate mutation behaviors in erbB3 receptors
reveals insights into how a gain of function mutation in the erbB3 kinase domain impacts
erbB2 and erbB3 interactions. Finally, discovery of a gain of function mutation in the

vi

kinase domain of erbB3 is connected to an uptick in erbB3 kinase activity. As a path
forward from this work, we suggest using the spatial stochastic model to investigate more
possible mutations in erbB3 receptors to give better insight into which mutations would
be promising to explore.
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CHAPTER 1: INTRODUCTION
1.1 OVERVIEW
Cellular signaling is mediated through a host of protein interactions. Proteins on the
cellular membrane interact, become activated, and initiate signal cascades, consisting of
intracellular proteins, in the cytoplasm. These interactions have long been studied for
various cellular proteins. Popular protein systems include the ErbB family implicated in
various forms of cancer (Citri & Yarden, 2006; Yarden & Sliwkowski, 2001), the IgE
receptor known for its role in allergies, and Toll-like receptors (TLR) that trigger immune
responses (Akira & Takeda, 2004). A range of experimental procedures is used to study
these systems, including immunoprecipitation and western blotting. More recently, highresolution experiments have been developed that allow for greater molecular resolution.
These experiments include single particle tracking (SPT) (Low-Nam et al, 2011),
fluorescence resonance energy transfer (FRET), and transmission electron microscopy
(TEM) (Radhakrishnan et al, 2012), to name a few.
Experiments give important insight into how different proteins interact with one
another. These insights can be extended beyond current experimental capabilities by
deriving a relevant mathematical model. Building off of the biological model pieced
together using experiments and incorporating experimental data for model validation, the
mathematical model can be used to visualize and investigate how multiple processes
come together. A quick search of PubMed reveals the recent uptick in interest in
integrating mathematics and biology in the last decade. Figure 1.1 shows the fraction of
papers published on specific search topics from 1980–2013. Figure 1.1 (left) shows the
trends for publications with topics based around mathematical modeling and biology,
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Figure 1.1: Papers published focusing on mathematics and biology. Fraction of papers published on
specific search topics from 1980-2013.

2

mathematical biology, and quantitative biology. Figure 1.1 (right) shows the trends for
publications with topics focused on different types of mathematical model methods also
focused on biology. Based on the conclusions of the mathematical model, novel
experimental methods can be developed to examine the mathematical model outcomes to
further validate or modify the model. This methodology allows for an efficient cycle of
experimentation, modeling, and novel experiment development.
1.2 MOTIVATION
In this work, we focus on the ErbB family of tyrosine receptor kinases (RTKs). ErbB
receptors are a group of four tyrosine kinases (ErbB1/2/3/4) that are activated via ligand
binding and subsequent formation of homo and heterodimers. The main function of the
ErbB family is to mediate important cellular processes such as homeostasis, pathology,
and development (Linggi & Carpenter, 2006) as well as the interactions between cells
(Yarden & Sliwkowski, 2001). Specifically, ErbB receptors play an important part in the
regulation of cell growth, proliferation, differentiation, and apoptosis (Baselga & Swain,
2009; Costa et al, 2009b). Given these important roles in normal cell development, it is
not surprising that in the early 1980’s ErbB1, ErbB2, and ErbB3 were implicated in the
progression of cancers (Baselga & Swain, 2009; Yarden & Sliwkowski, 2001) including
breast, lung, and bladder (Britten, 2004). ErbB4’s role in cancer development is currently
not well understood (Baselga & Swain, 2009). ErbB1, which can form dimers with all of
the other receptors, typically forms mitogenic homodimers and is overexpressed in nonsmall-cell lung cancer (Yarden & Sliwkowski, 2001). ErbB3, which has classically been
believed to be kinase dead (Berger et al, 2004; Linggi & Carpenter, 2006), dimerizes with
ErbB2 to form an oncogenic heterodimer (Baselga & Swain, 2009). Both ErbB2 and
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ErbB3 are prevalent in breast cancer (Baselga & Swain, 2009; Yarden & Sliwkowski,
2001). Due to the strong link between these receptors and various forms of cancers, it is
crucial to gain a better understanding of how the receptors interact and their signaling
mechanisms.
Traditionally, experimental methods are used to understand ErbB signaling.
Immunoelectron microscopy (EM) has been used to study ErbB receptor distributions on
the cellular membrane, as well as the adapter protein recruitment (Yang et al, 2007).
More recently, Single particle tracking (SPT) experiments have been used to visualize
ErbB behavior within the live cell context. This SPT data has provided improved
dynamic measures of dimer lifetimes, receptor diffusion, and insight into different
receptor pair combinations. Low-Nam et al. (2011) published ErbB1 SPT data showing
strong evidence that transient receptor co-confinement promotes repeated interactions
between ErbB1 monomers. Steinkamp et al. (2014) recently published new SPT that
indicates ErbB3 does in fact form a homodimer, as well as other experiments showing
that the kinase domain of ErbB3 is active. To investigate the observation made from the
experiments on ErbB1 and ErbB2/3, the parameters from the SPT experiments must be
used to develop a spatial stochastic model. This model will be able to resolve dynamics
of receptors that cannot yet be investigated through experimental methods. In a step
towards making the connection between experiments and modeling stronger, the overall
goal of this work is to develop and implement a spatial stochastic model using
parameters from live cell imaging to investigate the kinetics and dynamics of ErbB
receptors as influenced by the membrane landscape and other ErbB receptors.
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1.3 MATHEMATICAL

SIMULATION

OF

MEMBRANE

PROTEIN

CLUSTERING FOR EFFICIENT SIGNAL TRANSDUCTION
1.3.1 Notes
The work shown in this section, 1.3, was published in Annals of Biomedical
Engineering in November 2012, Volume 40, Pages 2307-2318. DOI 10.1007/s10439012-0599-z.
Krishnan Radhakrishnan1, Ádám Halász5, Meghan M. McCabe3, Jeremy S. Edwards2,3,4
and Bridget S. Wilson1,4*
1

Dept. of Pathology, 2Dept. of Molecular Genetics and Microbiology, 3Dept. of Chemical

Engineering and 4Cancer Center, University of New Mexico, Albuquerque, NM 5Dept. of
Mathematics, West Virginia University, Morgantown, WV
*Address correspondence to bwilson@salud.unm.edu
1.3.2 Abstract
Initiation and propagation of cell signaling depends on productive interactions
between signaling proteins at the plasma membrane. These diffusion-limited interactions
can be influenced by features of the membrane that introduce barriers, such as
cytoskeletal corrals, or microdomains that transiently confine both transmembrane
receptors and membrane-tethered peripheral proteins. Membrane topographical features
can lead to clustering of receptors and other membrane components, even under very
dynamic conditions. This review considers the experimental and mathematical evidence
that protein clustering impacts cell signaling in complex ways. Simulation approaches
used to consider these stochastic processes are discussed.
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1.3.3 Key Terms
Clustering; Spatial Stochastic Simulations; Cell Signaling
1.3.4 Introduction
Cell signaling, used for both intracellular and intercellular communication, is
essential for the healthy physiological functioning of multi-cellular organisms. Ligand
binding to a transmembrane receptor triggers an intracellular signaling cascade that
results in altered cell behavior. The proper integration of different environmental signals
is critically important to many biological processes, including cell survival,
differentiation, proliferation and migration (Bublil & Yarden, 2007; Keating et al, 2008;
Kitaura et al, 2003; Lo, 2010; Wennerberg et al, 2005; Yang et al, 2007). Aberrations in
signal transduction have been implicated in numerous pathologies, from allergy and
asthma to many different cancers (Bublil & Yarden, 2007; Colicelli, 2004; Govindan,
2010; Hynes & MacDonald, 2009; Keating et al, 2008; Lo, 2010; ten Klooster & Hordijk,
2007; Vigil et al, 2010; Yang et al, 2007). Signal transduction pathways have therefore
been studied extensively, and many drugs developed to target them (Bublil & Yarden,
2007; Friday & Adjei, 2008; Govindan, 2010; Lo, 2010; ten Klooster & Hordijk, 2007;
Vigil et al, 2010).
Knowledge of the structure of the plasma membrane and of signaling processes
continues to improve, due to advances in experimental techniques and imaging
technologies (Lidke & Wilson, 2009; Wells et al, 2010; Wilson et al, 2010). There is
considerable evidence for the concept that the cell membrane is compartmentalized into
microdomains, such as protein islands (Wilson et al, 2007) and lipid rafts (Nagy, 2002).
Receptor clustering in small or large aggregates (illustrated schematically in Figure 1.2)
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at discrete locations has been noted in many cell types (Abulrob et al, 2010; Bader et al,
2009; Hartman & Groves, 2011; Keating et al, 2008; Saffarian et al, 2007; Szabo et al,
2008; Yang et al, 2007), prompting intense interest in roles for membrane microdomains
in signal propagation and preliminary mathematical studies to understand both formation
of clusters and their role in cell signaling (Brinkerhoff et al, 2004; Costa et al, 2009a;
Costa et al, 2009b; Fallahi-Sichani & Linderman, 2009; Hsieh et al, 2010; Hsieh et al,
2008; Linderman, 2009; Reddy et al, 2010; Tian et al, 2007; Tian et al, 2010). There is
general agreement that the composition of these microdomains is quite heterogeneous
and, further, that their stability is influenced by the dynamic interactions of the cortical
cytoskeleton with membrane proteins and lipids. The cytoskeleton also limits diffusion of
membrane constituents by forming “picket fences” and “corrals” (Kusumi et al, 2005b;
Suzuki et al, 2005). The role of these membrane features in promoting or limiting
protein-protein interactions remains controversial, since there is strong potential to both
enhance and inhibit signaling (Allen et al, 2007; Costa et al, 2009a; Miura et al, 2001;
Pike, 2003). To help resolve these issues, several groups are developing spatially realistic
mathematical simulations of receptor motion, aggregation/clustering and activation in the
cell membrane.
It is important to note that parameters for these mathematical models rely on powerful
new experimental techniques. High resolution microscopy techniques, such as
Transmission Electron Microscopy (TEM) and photoactivation Light Microcrosopy
(PALM), have been applied to map the spatial distribution of signaling molecules in fixed
cells (Lillemeier et al, 2010; Wilson et al, 2007). These snapshot images of protein
distributions can be supplemented with powerful new live cell imaging approaches,
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Figure 1.2: Schematic representation of microdomains and receptor clustering. Left: Cartoon
representation of features that can subcompartmentalize the plasma membrane, including rafts or
islands, and the cortical cytoskeletal network. These features are highly dynamic, permitting rapid
exchange by diffusion. Right: Representation of the distribution of receptors (yellow, blue symbols)
in and out of domains (pink regions) formed by these features. Arrows point to various states,
including monomers, dimers, and aggregates. Receptors that are transiently trapped in domains are
locally crowded (arrow, top right) and appear as clusters by imaging technologies. This molecular
crowding can be more pronounced upon ligand stimulation, due in part to formation of dimers and
larger aggregates with decreased diffusive mobility. This review considers the experimental and
computational evidence that molecular crowding influences receptor dimerization/aggregation and
recruitment of signaling proteins.
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including fluorescence resonance energy transfer (FRET), fluorescence lifetime
correlation spectroscopy (FLCS), and single particle tracking (SPT) experiments (Lidke
& Wilson, 2009). These techniques can generate key information regarding the kinetics
of protein-protein interactions, including rates of dimerization, size of receptor aggregates
and changes in diffusion properties (Low-Nam et al, 2011). These rich data sets support
the development of more accurate and detailed mathematical models that in turn improve
understanding of biological results.
1.3.4.1 Key concepts and definitions relevant to the consideration of protein
clustering in the plasma membrane
In this brief review, we focus attention on the mathematical simulation of protein
clustering in the plasma membrane, an initial step in many signaling pathways. The
protein species considered may be a surface receptor, that is triggered by binding to an
extracellular ligand, or could be an intracellular signaling partner, such as an adaptor
protein or enzyme that propagates signaling through the cell interior. We define
clustering as the non-random spatial distribution of a membrane species, which can be
observed and experimentally validated through modern technologies. “Snap-shot” images
of membrane proteins often capture some level of clustering even before the onset of
ligand binding to receptors or active signaling (Bader et al, 2009). We hypothesize that
these basal levels of clustering arise from brief, non-productive interactions among
proteins as they encounter one another while diffusing in the plasma membrane or when
proteins are transiently co-confined in a raft, island, or corral (Figure 1.2). Thus
clustering in this sense is not synonymous with oligomerization, which reflects the direct
and measurable interaction between membrane components. It is important to point out
that stable oligomers cannot be distinguished from unstable clusters in imaging
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techniques using fixed cells, such as TEM and PALM. However, new imaging protocols
can now accurately measure the dynamics of protein-protein interactions at the molecular
scale (Lidke & Wilson, 2009). A recent example from our Center is the simultaneous
single particle tracking (SPT) of pairs of EGFR molecules, each labeled by virtue of
binding to EGF conjugated to different colors of quantum dot probes; only when two
EGF-QD-bound receptors were both coincident and exhibited correlated motion, could
they pass the stringent criteria for oligomerization (Low-Nam et al, 2011). The concept of
clustering becomes particularly important as we consider the data suggesting that the
spatial proximity of proteins can promote protein-protein interactions, including
oligomerization, by increasing the likelihood of productive collisions.
1.3.4.2 Choosing the right modeling approach
Mathematical models constructed to date to study signal transduction pathways are of
varied complexity. They can be classified conveniently as deterministic methods, in
which inherent temporal and spatial fluctuations in diffusion and reaction rates are
ignored, and stochastic methods, which attempt to capture these fluctuations (Figure 1.3).
The simplest modeling approach is to assume that the system of interest is well mixed,
without any spatial concentration gradients, and describe the reactions by a system of
ordinary differential equations (ODEs). The utility of ODE modeling is enhanced by
systematic sensitivity analysis, which examines automatically changes in model behavior
due to parameter variation (Radhakrishnan, 1991; Radhakrishnan et al, 2009). Such a
deterministic, well-mixed approach continues to be widely used (Tian et al, 2010), and
has produced useful results (Brightman & Fell, 2000; Radhakrishnan et al, 2009).
However, these approaches do not take into account either spatial inhomogeneities or
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stochastic fluctuations, which can be significant when the number of molecules in the
region of interest is small. At a slightly higher level of complexity, some spatial
description is provided by dividing the region of interest into separate well-mixed
compartments. Additional ODEs are needed to describe inter-compartmental species
translocation reactions, thus mimicking spatial movement.
These well-mixed, ODE-based continuum pathway models (Kholodenko et al, 1999)
were expanded to include spatial inhomogeneity (Brown & Kholodenko, 1999;
Slepchenko et al, 2003) by solving partial differential equations (PDEs) that include
molecular diffusion effects. Stochastic methods that assume spatially well mixed systems
have also been developed to account for temporal fluctuations (Gillespie, 2007; Li et al,
2008). Stochastic PDEs include both spatial information and temporal fluctuations. The
most detailed, and thus most complex, models are fully spatial, stochastic methods that
track the movement of individual molecules (Andrews & Bray, 2004; Burrage et al,
2007; Costa et al, 2009a; Costa et al, 2009b; Grima & Schnell, 2008; Hsieh et al, 2010;
Hsieh et al, 2008; Reddy et al, 2010; Tolle & Le Novere, 2010b). However, the
computational burden increases rapidly with increasing complexity of the modeling
approach. Figure 1.3 summarizes the various modeling approaches and their range of
applicability.
Mathematical simulation of events in the plasma membrane faces unique challenges.
Membrane proteins are constantly undergoing random motion in the plane of the
membrane, where the diffusion rate is influenced by the environment, such as hindrance
by microdomains, and thus varies both spatially and temporally. Optimally, the spatial
location of every protein needs to be predicted, in order to capture clustering imposed by
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Figure 1.3: Classes of mathematical models for molecular processes in cells and the scales at which
they are applicable to signaling processes. A possible quantitative guide is the size of the largest
element that can be treated as spatially homogeneous (horizontal axis) and the typical number of
molecules of one species in the element (vertical axis). The suggested spatial resolution is determined
by the size of the biological element of interest and current computational capabilities. Spatially
resolved models are resource-intensive, and are therefore generally applied to small subsystems.
Cell-level models of large signaling networks are typically well mixed; spatial Monte Carlo studies
rarely scale beyond a few hundred nanometers. A promising approach for multiscale applications is
a combination of compartment-based models at the large scales and fully spatial simulations focused
on a few important processes within small structural elements of the membrane. Temporal
fluctuations arise largely from the discrete and stochastic nature of the underlying molecular
processes. The relative magnitude of temporal fluctuations (DN) decreases as the number of particles
increases. The discrete nature of the particle number can thus be ignored when N is significantly
greater than 1. That is, deviations from the expected average behavior can be neglected when the
expected magnitude of the fluctuations is small compared to N.
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membrane topography and to predict the outcomes of both transient and prolonged
protein-protein binding events. Fully spatial, stochastic methods offer capabilities that
can capture accurately the dynamics of these events, but can be associated with
prohibitively high computation cost. Novel hybrid approaches show promise for solving
some of these computational challenges.
Finally, this section would not be complete without introducing the unique power of
rules-based approaches (Faeder et al, 2009; Hlavacek et al, 2006). Here, molecular
interactions in signaling networks are treated as systems of encoded rules. Molecules are
represented as structural objects that have modular domains and associated states
representing conformations or covalent modifications of these domains. Importantly the
input files and model specification blocks are compatible with multiple types of
computational approaches, including coupled ODEs that result in deterministic solutions
of reaction kinetics as well as stochastic methods.
1.3.5 Applications in specific signaling pathways
Sections below briefly summarize mathematical models that have been developed to
study signal transduction pathways, with emphasis on methods developed by our group
and others to capture the influence of clustering and other spatial aspects. We focus on
three representative signal transduction pathways (EGFR, Ras/MAPK and GPCR) where
protein clustering has been implicated, and on the modeling approaches used to approach
this unique set of challenges.

13

1.3.5.1 Our group’s focus: spatial aspects of signaling through the epidermal
growth factor receptor
A member of the ErbB family of plasma membrane receptors, EGFR is critically
important to many biological processes, including embryonic development and
carcinogenesis (Bublil & Yarden, 2007; Keating et al, 2008; Yang et al, 2007). Upon
binding any one of several ligands, including EGF, the ErbB receptors homo- or heterodimerize. Dimerization is followed by transphosphorylation of tyrosine residues in
receptor cytoplasmic tails, which enables recruitment of cytosolic signaling proteins. The
reader is referred to Figures 2,3 in the article by Telasco & Radhakrishnan, for diagrams
of EGFR/ErbB1 dimerization, phosphorylation and adaptor protein recruitment (Telesco
& Radhakrishnan, 2012). Subsequently, these complexes activate many different
signaling cascades, including the Ras-MAPK pathway discussed in the next section.
There exists considerable experimental evidence for preexisting clusters of resting
EGFR (Figure 1.4) and for dynamical changes after addition of ligand (Abulrob et al,
2010; Bader et al, 2009; Keating et al, 2008; Saffarian et al, 2007; Szabo et al, 2008;
Yang et al, 2007). We have built simulation platforms at different levels of complexity, in
order to evaluate the impact of EGFR clustering in the plasma membrane.
1.3.5.1.1 Approaches and methodology
Our first attempt to develop a spatial model of the EGFR pathway was a simple
compartmental model that accounted for receptor density differences observed in the
plasma membrane, with some regions having high-receptor density and others displaying
low-receptor density (Mayawala et al, 2005b). The focus of this study was to explore
whether the added computational complexity associated with spatial modeling was
justified. Our initial goal was to determine if the non-uniform receptor distribution in the
14

cell membrane could account for the experimentally observed, concave-up Scatchard plot
for binding of EGF ligand to its receptor. We simply optimized the distribution of
receptors into high- and low-density regions, and were able to determine the parameter
space that allowed for a concave-up Scatchard plot. This first attempt at
compartmentalized spatial modeling showed that accounting for the spatial organization
of receptors was highly valuable, and should be pursued, to enable both qualitative and
quantitative understanding of cell signaling involving (at least) the EGFR.
This study convinced us of the utility of spatial modeling of membrane-bound receptors
and of its importance in understanding cell signaling. We have now accumulated
extensive experience in developing spatially realistic simulations of the cell membrane
and also addressed the initiation of signaling (Chatterjee et al, 2005; Costa et al, 2009a;
Costa et al, 2009b; Hsieh et al, 2010; Hsieh et al, 2008; Mayawala et al, 2004; Mayawala
et al, 2005a; Mayawala et al, 2005b; Mayawala et al, 2006). Next, we summarize our
development of lattice-based and lattice-free (or off-lattice) methods, as well as our use
of hybrid approaches.
1.3.5.1.2 Lattice-based Monte Carlo (MC) approaches.
In lattice-based models, molecules are located at discrete grid points in the spatial
domain and diffusion is restricted to movement to an unoccupied neighboring point.
Lattice-based MC simulations have become very popular in the physics, chemistry,
materials and engineering communities, as they provide spatio-temporal information at
significantly reduced computational cost, compared to off-lattice simulations

15

Figure 1.4: Experimental results and mathematical model predictions of EGFR clustering. (a)
Experimental evidence for EGFR clustering in absence of ligand. Electron micrograph of gold
particle-labeled EGF receptors in resting A341 cells (~2 million EGFR/cell), reveals a non-random
distribution and provides evidence for receptor co-confinement. (b) Spatial domain used in latticefree Monte Carlo simulation. The spatial domain simulated by the off-lattice Monte Carlo procedure
was a square of area 2 lm2, representative of a small region in the plasma membrane. This region was
modified to include many islands or preferred domains (the gray rectangles within the membrane
patch), to simulate the receptor-trapping microdomains seen in (a). Movement of receptors into and
out of the simulated microdomains over a time period of 30 s is indicated by the thin colored tracings.
Receptor trapping in the microdomains was reproduced mathematically by stipulating that receptors
had a greater probability of entering these regions than of leaving them. (c) Simulation predictions of
receptor clustering in absence of ligand. The predicted particle positions after 30 s of simulation time
are indicated by the black dots. The Hopkins statistical test (inset) was used to test the randomness of
receptor distribution. The right shift of the distribution (compared to the random or normal
distribution shown in red) confirms the clustered nature of the receptors. The predicted receptor
distribution compares well with the experimental observation in (a). (d) Simulations using a coupled
spatial/nonspatial stochastic algorithm (CSNSA) support the conclusion that EGFR clustering
promotes activation of the adaptor SOS. ODE models confirm this conclusion, using a fast diffusion
coefficient to override contributions from membrane spatial organization (from Hsieh et al. and
Costa et al.).
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(Auerbach, 2000; Chuan Kang & Weinberg, 1995; Coppens et al, 1999; Gilmer, 1980;
Zhdanov & Kasemo, 1994). The MC method is a coarse graining of molecular dynamics
(MD) simulations (Auerbach, 2000), because MD is impractical for rare event dynamics,
such as hopping between deep minima of a potential energy surface. The MC method
stochastically solves an underlying master equation using pseudo-random numbers by
constructing the probability with which the various states of the system have to be
weighted according to a Markov process. MC simulations can provide continuous time
information. Gillespie established the foundations of time-dependency for chemical
reactions in a spatially homogeneous system (Gillespie, 1977; Gillespie, 2007). His
approach is easily applicable to arbitrary complex computational systems, and is often
referred to as the kinetic or dynamic MC method. Despite important algorithmic
implementations (e.g., dependency graphs (Gibson & Bruck, 2000), lists of neighbors,
binary-tree search, etc.), MC simulations are seriously plagued by (1) the presence of fast
reactions that occur in large biochemical networks seen in biology and (2) the execution
of one event at a time.
Our Spatial Kinetic Monte Carlo (SKMC) method (Mayawala et al, 2005a; Mayawala
et al, 2005b) utilizes a modified null-event, lattice-based MC algorithm (Costa et al,
2009a; Mayawala et al, 2006). The spatial domain, representing a small region of the
plasma membrane, is a two-dimensional square lattice of side ℓ, divided into a large
number of much smaller square bins of side a (<< ℓ). The SKMC algorithm consists of
first randomly selecting an occupied lattice site, and then choosing either a successful
(reaction or diffusion) or unsuccessful (null) event, based on calculated probabilities. If a

17

d
successful event is chosen, it is executed. The transition rate Γi→
j for diffusion of species

from any site i (i.e., lattice point i) to a nearest-neighboring site j as defined as
d
Γi→
j =

€
1 D
Γ σi 1 − σ j , j ∈ Bi
4

(

)

where ΓD = 4D /a 2 and D is the diffusion coefficient of the species located at site i.
€
The term Bi denotes €
the set of four possible nearest-neighboring sites to which diffusion
€
can occur in two dimensions from site i. Because species are allowed to diffuse only to an

unoccupied site, we define an occupancy function σj for each of the four nearestneighboring sites, in order to simplify the procedure for computing the transition rate for
diffusion. For any site k (= i or j), σk is set equal to 1 if the site is occupied, or to 0 if the
site is unoccupied. The transition rate for a chemical reaction at site i, Γir depends on the
reaction type and is directly related to the standard reaction rate.

€ at site	
  𝑖 is computed by
The probability pix of an event	
  𝑥 (=𝑟 reaction or	
  𝑑 diffusion)
using the relation
€

pix =

Γix
Γmax

where Γmax is a normalization constant, defined as

€

⎛ ΓD
⎛
⎞⎞
r
⎟⎟⎟⎟
Γmax = 4⎜⎜ + max⎜⎜
Γ
∑
4
⎝
allforwardreactionevents
⎠⎠
⎝

€

⎛
⎞'
r
+max⎜
∑ Γ ⎟
⎝ allbackwardreactionevents⎠
where the multiplicative factor of 4 accounts for events occurring in the four directions of

€
the two-dimensional
square lattice. Finally, the time step	
   Δ𝑡 used to advance the
simulation time is computed as Δt = 1/Γmax .
18
€

1.3.5.1.3 Rule-based, non-lattice simulator
Our non-lattice, stochastic simulator is an alternative approach (Hsieh et al, 2010;
Hsieh et al, 2008). In the lattice-free method, particles are not confined to discrete points
in space but are randomly repositioned upon undergoing a diffusion event. Receptors and
other proteins in the 2D membrane and 3D cytosolic space are represented by sphere-like
particles with radii determined from experimental data and their coarse-grained molecular
models. At each time step, species diffusion is simulated as Brownian motion (Figure
1.4). In addition, species have the potential to react with spatially nearby species. This
simulator was designed for flexible model development and deployment by a
modularized and rule-based approach. It tracks the individual reactions of multistate
molecules and accommodates complex situations.
1.3.5.1.4 Hybrid approaches
We continue to improve our basic SKMC algorithm, leading to increased efficiency
and speed of the simulations. One significant advance was the coupling of our latticebased SKMC simulations on the cell membrane to well-mixed stochastic simulations
within the cytosol (Costa et al, 2009a). In Costa et al (2009a) we describe the
development of an algorithm that couples a spatial stochastic model of membrane
receptors with a nonspatial stochastic model of cytosolic reactions. Our novel hybrid
algorithm provided a computationally efficient method to evaluate the effects of spatial
heterogeneity on the coupling of receptors to cytosolic signaling partners. Results
obtained using a compartmental ODE method compared well with those generated with
our hybrid model. Thus, for sufficiently high receptor copy number, the far simpler ODE
model may be adequate. However, for spatially inhomogenous systems where the
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receptors numbers are low, the hybrid method was significantly superior to the ODE
model.
1.3.5.1.5 EGFR density, through clustering or overexpression, influences signaling
output
We have applied these methods to study the early molecular mechanisms involved in
EGFR signaling. For example, we applied the lattice-based spatial stochastic model of the
plasma membrane to examine the influence of cytoskeletal corral openings on EGFR
clustering (Costa et al, 2009b). Clustering was shown to depend on both receptor
concentration and picket fence density. For high picket fence densities, clustering
increased with increasing receptor concentration in the range examined. Conversely, low
receptor concentrations combined with small corral sizes inhibited clustering; at normal
to high receptor concentration, maximal clustering occurred at an intermediate corral size
(~100 nm). These results indicate that both the number of clusters and the average cluster
size are likely to be complex functions of receptor density and microdomain size. It
follows that compartmentalization of the plasma membrane could either inhibit or
enhance signaling, concepts that require further exploration.
The non-lattice, rules-based simulator allowed us to explore the effect of EGFR
overexpression and its relation to carcinogenesis (Hsieh et al, 2008). We postulated that
increased receptor density in membrane microdomains or protein islands might lead to
more frequent interactions between non-ligand bound receptors, and further, that large
numbers of these short-lived interactions might explain EGFR signaling known to occur
even in the absence of ligand (Bader et al, 2009). One important aspect was consideration
of EGFR extracellular domain conformation, based upon structural studies showing that
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the resting EGFR is predominantly in a “closed” conformation. Binding of ligand is
proposed to stabilize the extended conformation and expose the dimerization arm. In our
simulations, we assumed that the resting EGFR “fluxes” between the open and closed
states, but spends 99% of its time in the closed state. This property translates to a low
probability that two diffusing monomers will collide under conditions where both expose
their dimerization arms and are therefore competent to form a complex. The 2D
simulation space included membrane microdomains that transiently trapped receptors (as
in Figure 1.4), setting up clusters undergoing dynamic exchange. Remarkably, at levels of
receptors typical of most normal cells, co-confinement in membrane microdomains
lowered the threshold for ligand-independent receptor dimerization but resulted in very
modest signaling output. When the simulation space was populated with densities
typically seen in tumors with EGFR gene amplification, which can express millions of
EGFR per cell, the percent of activated receptors could exceed 10% with our parameter
values. Clustering had little effect in these cases, since the overall density on the
membrane was already very high.
We have used both lattice and non-lattice models to consider how spatial aspects
might affect the recruitment of signaling molecules to the phosphorylated EGFR tail
(Costa et al, 2009b; Hsieh et al, 2010). In Hsieh et al (2010), we also considered the
combinatorial complexities associated with the fact that EGFR has multiple
phosphorylation sites, and further, the fact that each phosphotyrosine site is capable of
binding multiple partners. We used coarse-grained molecular docking simulations to
show that steric hinderance can impose important constraints on the composition of
adaptor proteins capable of docking simultaneously on the EGFR tail. Modeling
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predictions in Hsieh et al (2010) were quantitatively consistent with experimental data for
the kinetics of both EGFR phosphorylation and recruitment of adaptor proteins.
Importantly, both papers provide mathematical support for the conclusion that clustering
of receptors can amplify signaling by promoting sequential binding of adaptor proteins.
These results provide confidence in our models, and have led to ongoing studies of other
growth factor receptors that initiate signaling through dimerization, particularly VEGFR,
as well the heterodimerizing members of the ErbB family. This field continues to
advance, as demonstrated by the hybrid approaches of Radhakishnan and colleagues
(Telesco & Radhakrishnan, 2012) that consider ErbB structural and diffusion properties
using increasingly complex models. Additional aspects of cell surface topography, such
as the induction of membrane curvature by endocytic adaptor proteins, are new concepts
that will provide important insight into the control of signal transduction through the
biophysical principals of membranes.
1.3.5.2 Work by others: the case of signaling via Ras/MAPK pathways.
The Ras superfamily consists of over 100 small GTP-binding proteins (or GTPases),
which respond to various extracellular stimuli to regulate important signal transduction
pathways (Vigil et al, 2010; Wennerberg et al, 2005). These proteins, which have low
intrinsic GTPase activity, “switch” between active GTP-bound and inactive GDP-bound
conformations. The processes mediated by GTPases include cell division, differentiation,
apoptosis and migration, cytoskeletal reorganization, and intracellular protein trafficking
(ten Klooster & Hordijk, 2007). Abnormalities in these pathways are seen in various
pathologies, including obesity, diabetes, inflammatory diseases, cardiovascular disease,
neurological disease, and cancer (Colicelli, 2004; ten Klooster & Hordijk, 2007; Vigil et
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al, 2010). Therefore the pharmacological targeting of GTPases and/or their signaling
pathways is an active field (Vigil et al, 2010).
The Ras/Raf/MEK/ERK mitogen-activated protein kinase (MAPK) pathway has been
investigated extensively, both in the clinic and the laboratory, and by mathematical
modeling (Brightman & Fell, 2000; Friday & Adjei, 2008; Fujioka et al, 2006;
Hatakeyama et al, 2003; Hornberg et al, 2005; Kholodenko et al, 1999; Kholodenko et al,
2010; Orton et al, 2005; Radhakrishnan et al, 2009; Sasagawa et al, 2005; Schoeberl et al,
2002; Tian et al, 2007; Tian et al, 2010; Wiley et al, 2003). Activation of a number of
receptors, including EGFR, leads to guanine nucleotide exchange (dissociation of GDP,
gain of GTP) by membrane-tethered Ras, thereby activating it. The activated Ras in turn
activates Raf (Ras-associated factor), the first kinase in the cascade. Subsequently, Raf
activates MEK (MAPK/extracellular signal-regulated kinase kinase), which then
activates

ERK

(extracellular

signal-regulated

kinase).

The

translocation

of

phosphorylated ERK to the nucleus and activation of transcription factors mediates many
cellular activities.
Numerous mathematical models have been developed to study this pathway
(Brightman & Fell, 2000; Fujioka et al, 2006; Hatakeyama et al, 2003; Hornberg et al,
2005; Kholodenko et al, 1999; Kholodenko et al, 2010; Orton et al, 2005; Radhakrishnan
et al, 2009; Sasagawa et al, 2005; Schoeberl et al, 2002; Tian et al, 2007; Tian et al, 2010;
Wiley et al, 2003). Much of this work uses compartmental models and ODEs to follow
the temporal evolution of activated ERK, and does not consider clustering in the plasma
membrane. However, Tian et al (2007; 2010) have mathematically evaluated various
spatial aspects of Ras signaling, including clustering in the plasma membrane. This group
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utilized a hybrid approach to simulate reactions in the cell membrane and those in the
cytosol, enabling them to separate the contribution of the plasma membrane structure to
the signal. They combined the well-mixed stochastic model of Gillespie (Gillespie, 1977;
Gillespie, 2007) to simulate reactions in the membrane with an ODE model for the
cytosolic reactions. They assumed that the number of RasGTP clusters was proportional
to the EGF concentration, and these clusters served as platforms for recruiting Raf to the
plasma membrane for activation. The lifetime of RasGTP clusters was assumed to be
normally distributed over a measured value. Plasma membrane reactions, in addition to
binding and activation of Raf by RasGTP clusters, included recruitment by activated Raf
of the KSR-MEK-ERK complex from the cytosol and activation of MEK by activated
Raf and of ERK (MAPK) by activated MEK. KSR (kinase suppressor of Ras) is a
scaffold protein that facilitates MAPK activation by providing binding sites for assembly
of the signaling complex. The recruitment of both Raf and the KSR-MEK-ERK complex
was modeled as occurring through random collisions with the plasma membrane. With
dissolution of a nanocluster, all recruited proteins diffused back to the cytosol, where the
activated MEK and ERK continued their roles. Using this model in conjunction with
biological experiments, Tian et al. (2007) concluded that RasGTP clustering is essential
for signal transduction. Moreover, the RasGTP clusters operate as sensitive switches in
that they produce approximately the same levels of normalized activated ERK over a
wide range of ligand concentration. One possible explanation for this behavior is the
establishment of locally high concentrations of recruited proteins and thus the spatial
restriction of active ERK production to RasGTP nanoclusters, whose generation and
lifetime are themselves strictly regulated (Tian et al, 2007). Tian et al. (2007) also
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concluded that the production of RasGTP nanoclusters in direct proportion to ligand
concentration can ensure high fidelity of signal transduction.
Subsequently, Tian et al. (2010) incorporated models for following the temporal
evolution of RasGTP clusters in the cell membrane. In particular, they studied K-Ras
clustering and how it is influenced by the protein Galectin-3 (Gal3). Previous
experimental work had shown that Gal3 is a scaffolding protein recruited to the plasma
membrane, where it is necessary for the formation of Ras nanoclusters (ShalomFeuerstein et al, 2008). Their mathematical model considered the two species, membranebound RasGTP and Gal3, initially in the cytosol. Once Gal3 is recruited by RasGTP, the
RasGTP-Gal3 complexes are assumed to diffuse randomly in the plasma membrane and
react with one another to form complexes of various sizes.
To simplify the calculation procedure, Tian et al. (2010) allowed for a maximum
cluster size of ten. The various combinations of possible complexes resulted in a total of
27 species and 136 reactions in the plasma membrane. In agreement with our earlier
observation, they concluded that spatial stochastic modeling of such a large system poses
a considerable computational burden. Therefore they developed an ODE system to follow
the temporal evolution of complexes of size 1-10, using a spatial stochastic model to only
deduce collision rates among the complexes (Hsieh et al, 2010; Hsieh et al, 2008). This
deterministic system was solved with a Runge-Kutta method suitable for stiff ODEs
(Radhakrishnan, 1991). The collision rates were obtained by initially placing RasGTP
randomly in a square-shaped representation of the plasma membrane. Recruitment of
Gal3 produces the RasGal complex. These molecules were allowed to diffuse randomly,
and a collision was said to occur when the distance between two molecules was less than
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the sum of their radii. The collisions produced various combinations of Ras-Gal
complexes. When a nanocluster, defined as a cluster consisting of 5 or more RasGTP
molecules, formed it was assumed to become immobile in the plasma membrane. During
the calculation procedure the total numbers of collisions giving rise to all cluster types
were tracked. At the end of the computational time period, the collision rate constants
were computed from the total numbers of collisions. Kinetic rate constants for the ODE
model were then derived from the collision rate constants, by using a genetic algorithm in
conjunction with experimental data. The validity of this deterministic ODE model was
checked with results generated with a stochastic simulation algorithm (Gillespie, 1977).
Presumably due to the large numbers of proteins, the stochastic simulations predicted
only small fluctuations. This observation supports use of deterministic models when the
protein copy number is high, in agreement with our observations.
Using this modeling approach, Tian et al. (2010) studied clustering of K-Ras-GTP in
the plasma membrane arising from interactions with Gal3 for various KRas and Gal3
copy numbers. The simulation time period was sufficiently long for the system to
equilibrate. The time to equilibrate was approximately two minutes, an important result
because it is in good agreement with the time period required for RasGTP loading in
response to stimulation (Tian et al, 2007). Their results also successfully reproduced the
experimental results of Plowman et al. (2005) that approximately 42% of the RasGTP
were in clusters and the average cluster size was approximately 7. Tian et al. (2010) also
generated the equilibrium nanocluster number versus size histogram. Their results
showed that nanoclusters with two to four molecules accounted for only 2.1% of the
RasGTP, whereas a cluster size of 5 was the most prevalent. Nanoclusters larger than 5 in
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size were progressively smaller in number, approximately inversely proportional to the
size. The authors speculate that one possible reason for the lowered incorporation of
RasGTPGal3 complexes into clusters of size 5 or larger is the remodeling of the lipid
environment of the cluster by the stable pentamer. Their results also suggest that cluster
formation is only weakly dependent on RasGTP concentration, and is determined by the
Gal3 cytosolic concentration. Tian et al. (2010) concluded that on the basis of their
simulations neglecting the formation of clusters with more than 10 RasGTP molecules is
reasonable. Notably, this work illustrates the difficulty of spatial modeling of systems
with large reaction networks.
1.3.5.3 Work by others: G-protein coupled receptors
The GPCRs constitute the largest family of transmembrane receptors, consisting of 5
subfamilies (Alberts, 2008; Rosenbaum et al, 2009). These proteins, whose structure and
function were reviewed recently by Rosenbaum et al. (2009), are characterized by seven
transmembrane spanning α-helical segments (Alberts, 2008; Fuxe & Kenakin, 2010).
They regulate many physiological functions such as vision, gustation and olfaction
(Rosenbaum et al, 2009; Vilardaga et al, 2010). Neurotransmitters, hormones and
environmental stimuli activate these pathways. GPCRs are also implicated in many
human diseases, such as inflammation, retinitis pigmentosa, nephrogenic diabetes
insipdus, and Kaposi’s sarcoma (Fuxe & Kenakin, 2010; Insel et al, 2007; Vilardaga et al,
2010; Waller et al, 2004). At present, most pharmaceutical drugs used by humans target
GPCRs by serving as agonists or antagonists (Fallahi-Sichani & Linderman, 2009;
Vilardaga et al, 2010).
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Many aspects of GPCR signaling are well established. In the classical view, binding of
ligand to a GPCR induces a conformational change in the receptor. The activated receptor
initiates guanine nucleotide exchange (GDP→GTP) in its principal signaling partner, a
heterotrimeric (αβγ) G-protein complex. Like ras, heterotrimeric G proteins are tethered
to the cytosolic leaflet of the plasma membrane through covalently attached lipids, and
assume an active state once bound to GTP. An additional step is required for
heterotrimeric G proteins: the separation of the GTP-bound Gα subunit from the
Gβγ subunit, which diffuses into the cytosol. The subsequent activation of downstream
effector proteins results in various distinct biological reactions.
Recent work has focused on new aspects of GPCR signaling, such as the evidence that
at least some GPCRs can form homo- or hetero-dimers (Brinkerhoff et al, 2004; Fuxe &
Kenakin, 2010; Waller et al, 2004). These dimers can interact further to form oligomers
(Fallahi-Sichani & Linderman, 2009). Although believed essential for signaling to occur,
the dimerization mechanism is well characterized for only a few GPCRs (Lambert, 2010).
Due to the importance of GPCR signaling in healthy and diseased states, GPCR
interactions, along with membrane organization, and their impact on signaling must be
well characterized. Mathematical modeling is therefore being used increasingly to help
unravel the intricacies of this pathway. A useful review of mathematical models that have
been developed to study GPCR signaling is given by Linderman (2009).
Brinkerhoff et al. (2004) used triangular lattice-based Monte Carlo (MC) models to
simulate receptor dimerization and activation in a two-dimensional plane, examining how
dimerization creates clusters of receptors. Their model demonstrates the applicability of
MC methods to systems with discrete reactions that are diffusion limited (Brinkerhoff et
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al, 2004). Randomly selected particles undergo either one of two possibilities at each
time step: displacement in a random direction by a distance governed by the diffusion
coefficient or a chemical reaction. Reaction possibilities considered were receptor
dimerization, binding of ligand by receptor, receptor activation of G protein, and receptor
phosphorylation. This group’s simulations suggest that clustering arises through both
dimerization and cross talk between receptors as they approach one another closely and
are able to share an effector. They also concluded that the resulting clustering enhances
signaling.
Fallahi-Sichani et al. (2009) investigated lipid raft impact on GPCR signaling with a
combination of MC (stochastic) and deterministic models. A lattice-based, kinetic MC
model was used to establish the effects of low-diffusivity rafts on receptor dimerization
and cluster dynamics. The stochasticity of the model allowed for receptor distributions to
be examined, leading to parameter estimations for exploring the effects on downstream
signaling using an ODE model. The fraction of plasma membrane covered by
microdomains (rafts), which was varied from 2-30%, had a significant impact on output.
At 2% coverage, microdomains amplified the overall response, but at higher coverage the
signal was attenuated. They concluded that dimerization and lipid raft trapping
cooperatively control the extent and dynamics of GPCR signaling.
Tolle et al. (2010b) developed an off-lattice, Brownian diffusion-based stochastic
model, which they used to determine how AMPAR (alpha-amino-3-hydroxyl-5-methyl4-isoxazolepropionic acid receptor) diffusion in the dendritic spine affects synaptic
signaling, specifically Long-Term Potentiation (LTP).(Tolle & Le Novere, 2010a) LTP,
an increase in synaptic strength, is a well-studied form of synaptic plasticity, the ability to
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change the strength of a signal (Santamaria et al, 2010; Tolle & Le Novere, 2010a). Tolle
et al.’s model accounts for the dendritic spine membrane, membrane receptors and
scaffolding proteins known to bind to membrane receptors (Tolle & Le Novere, 2010a).
The spatial domain representing the plasma membrane of the synaptic spine was modeled
as a square of surface area corresponding to the measured volume of the spine. This
square was separated into two different compartments or domains, in order to account for
the two physiologically different portions of the plasma membrane: the post-synaptic
density (PSD) and the extra-synaptic membrane (ESM). The PSD is a protein-rich region
where AMPARs are concentrated (Santamaria et al, 2010; Tolle & Le Novere, 2010a),
while the rest of the membrane is classified as the ESM (Tolle & Le Novere, 2010a), The
transmembrane receptor movement within the ESM was modeled with Brownian-type
diffusion, while confined motion was used to model the restricted diffusion within the
PSD. Simulation results indicate that randomly placed receptors quickly localize to the
PSD, which Tolle et al. (2010a) suggest explains the quick onset of LTP.
1.3.6 Concluding remarks.
This review specifically considers the mathematical modeling of protein clustering on
the plasma membrane and the evidence that signal transduction can be enhanced by
locally high concentrations of proteins that increase the probability of protein-protein
interactions. This feature is especially important when the numbers of particles are small.
When proteins are overexpressed, as in EGFR amplication in certain cancers, clustering
may not be as significant (Hsieh et al, 2008). The role of membrane microdomains in
signaling may be quite complex, since both inhibitory and stimulatory effects have been
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observed experimentally and theoretically (Allen et al, 2007; Costa et al, 2009a; Miura et
al, 2001; Pike, 2003).
Mathematical modeling, in conjunction with biological experiments, is providing new
insights into the mechanisms that govern protein clustering in membranes and the
resulting impact on signaling. Increasing experimental detail is being matched by
increasingly complex models that account for previously ignored biological subtleties
(Chakraborty et al, 2003; Erban & Chapman, 2009; Grima & Schnell, 2008; Li et al,
2008; Radhakrishnan et al, 2010; Resat et al, 2009; Turner et al, 2004). An important
goal is to predict the functional responses of whole cells and cell-tissue systems, based
upon integration of spatial and temporally encoded signals from surface receptors.
Achieving this goal will necessitate the development of efficient and accurate multi-scale
simulation capabilities. A daunting challenge to mathematical modeling of cell signaling
continues to be the scaling up of computationally intense methods developed for studying
molecular behavior to enable predictive modeling at progressively more complex levels,
from the cellular to the systemic.
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1.4 RECEPTOR TYROSINE KINASES: THE ERBB FAMILY
1.4.1 ErbB1
ErbB1 is part of the ErbB family of receptor tyrosine kinases (RTK) (Citri & Yarden,
2006). ErbB1 is not only critical for normal growth and development, but has also been
implicated in various forms of cancer (Yarden & Sliwkowski, 2001). The ErbB1 receptor
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fluctuates between a closed and open conformation (Baselga & Swain, 2009), with the
open conformation being stabilized through ligand binding. When the receptor is in the
open conformation, the dimerization arm is exposed, allowing the receptor to form
homodimers with other ErbB1 receptors and hetero-dimers with the other three members
of the family, ErbB2, ErbB3, and ErbB4 (Yarden & Sliwkowski, 2001). Due to the
fluctuation of receptor conformation, dimerization between receptors is possible in the
absence of ligand, forming pre-formed dimers (Schlessinger, 2002). The ability of nonligand bound ErbB1 monomers to partner with one another, as well as with ligand-bound
monomers, leads to multiple ligand:receptor dimer configurations.
When the receptors form a dimer, the kinase tails form an asymmetric configuration
connecting the C-lobe of one kinase tail to the N-lobe of the opposite kinase tail. This
conformation is often referred to as an asymmetric dimer (Zhang et al, 2006). When the
kinase tails interact, the tails are phosphorylated through transphosphorylation. This
phosphorylation, sometimes referred to as dimer activation, triggers a signal cascade,
recruiting different effector and adaptor proteins to the tail (Linggi & Carpenter, 2006;
Yarden & Sliwkowski, 2001). Macdonald-Obermann et al.’s (2009) study showed an
alternate view of transphosphorylation in light of the asymmetric dimer configuration. In
their phosphorylation mechanism, the C-lobe of one receptor, deemed the “activator”,
activates the N-lobe of the opposite tail, deemed the “receiver”, which then
phosphorylates the tail of the activator.
Recent SPT studies published by Low-Nam et al. (2011) give even greater insight
into the kinetics and dynamics of ErbB1. Using a Hidden Markov Model to analyze the
SPT data, they were able to separate receptor diffusion in to three distinct states, free,
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confined, and dimer. This type of resolution allows for more accurate diffusion
coefficients to be derived from the data. Low-Nam et al. (2011) found that ErbB1 dimers
diffuse much slower than ErbB1 monomers. Further analysis of the SPT data revealed the
interaction dynamics between receptor pairs. They were able to calculate dimer off rates
by studying the characteristics of the distance between two receptors over time. This
analysis gave insight into the kinetics of the different dimers (preformed, 2 ligand:2
receptor, and 1 ligand :2 receptor), showing that ligand does in fact stabilize the dimer,
leading to lower off rates. Finally, studying the distance between receptor pairs lead to
the observation that a pair of receptors will interact multiple times throughout the course
of a minute, forming dimers and falling apart again.
1.4.2 ErbB2 and ErbB3
ErbB2 is different from the other 3 members of the ErbB family due to its structure.
While ErbB1/3/4 all are typically in a closed conformation when no ligand is bound,
ErbB2 is always in the open conformation without the presence of ligand. There is no
known ligand associated with the ErbB2 receptor (Baselga & Swain, 2009; Linggi &
Carpenter, 2006). Overexpression of ErbB2 is rampant in breast cancer, making ErbB2 a
typical target for therapeutics (Baselga & Swain, 2009). ErbB3 has recently become a
major focus of study for the ErbB family (Baselga & Swain, 2009). Studies show that
overexpression of ErbB3 is also linked to breast cancer (Yarden & Sliwkowski, 2001),
and ErbB3 is now being studied as a target for possible therapies (Baselga & Swain,
2009). Together, ErbB2 and ErbB3 are known to form oncogenic dimers, with extremely
potent signal cascades (Zhang et al, 2012).
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Published works by top ErbB researchers have suggested that the ErbB3 receptor
cannot form a homodimer (Baselga & Swain, 2009; Berger et al, 2004). However, recent
SPT experiments published by Steinkamp et al (2014) have suggested that ErbB3 does in
fact form homodimers, extremely stable homodimers. SPT experiments have shown that
ErbB2 and ErbB3 form dimers, though they are shorter lived than the ErbB3
homodimers. Kinase assay experiments by Steinkamp et al. (2014) have also given
insight into the activation state of ErbB3, showing that there is measurable kinase activity
in ErbB3 in the presence of heregulin. The current accepted signaling unit is ErbB2ErbB3 (Baselga & Swain, 2009; Linggi & Carpenter, 2006; Warren & Landgraf, 2006;
Yarden & Sliwkowski, 2001), however, the results seen from the SPT experiments, as
well as kinase assays by Steinkamp et al. (2014), suggest that the main signaling unit may
in fact be the ErbB3 homodimers. A possible activation mechanism would be that ErbB2
must first activate ErbB3’s kinase domain through dimerization, then the active ErbB3
receptor would be able to form a dimer with, as well as activate, another ErbB3 receptor
and cause the mitogenic signal cascade.
1.5 RESEARCH FOCUS
The focus of this dissertation work is the ErbB family of receptor tyrosine kinases.
Specifically, we look at the kinetics and dynamics of these receptors on the cellular
membrane through a spatial stochastic model. Recent advancements in experiments,
mainly in single particle tracking, have been a strong motivation for this work. Many
exciting and interesting observations have been made through SPT, and we knew
integrating those results and observations with a spatial stochastic model would enable us
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to look even deeper into the meaning and implications of those results. The methods used
to create our spatial stochastic model are discussed in Chapter 2.
We started out by focusing on the homo-interactions of ErbB1 to build our model,
validate it, and then predict how the observed dynamics are impacted by different factors.
We proposed that the repeated interactions between ErbB1 receptors, as observed through
SPT, are a product of the membrane landscape and receptor density. We further
suggested that the repeated interactions are a mechanism to facilitate phosphorylation
through an asymmetric phosphorylation mechanism. Finally, we were able to investigate
how these factors come together and impact the receptor’s activation state over time. This
work is discussed in detail in Chapter 3.
We then spent time analyzing the diffusion data from SPT experiments to get insight
into the membrane landscape and it’s role in receptor diffusion. From our previous work
and the SPT experiments, we knew that confinement zones on the membrane impacted
receptor diffusion. We sought to quantitatively understand the observed anomalous
diffusion by studying the diffusion properties of proteins in the cellular membrane, and
how different structures on the membrane contribute to these properties. This work is
discussed in Chapter 4. We then took the diffusion analysis one step further to
reconstruct the confinement zones encountered on the membrane during SPT
experiments. We proposed we could estimate the size and shape of the confinement zones
by converting the dynamic trajectory data into static spatial data and applying a clustering
algorithm. The “Domain Reconstruction” Algorithm (DRA) is discussed in Chapter 2
and implemented in Chapter 5.
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Finally, we extended our spatial stochastic model to a heterogeneous population to
investigate the dynamics between ErbB2 and ErbB3, and used the DRA to create our
simulation space. Our focus was to investigate the interactions and phosphorylation
kinetics between ErbB2 and ErbB3. In this work, we truly integrated experimental work
and modeling. We set out to investigate the impact of ErbB3 activation on the currently
accepted ErbB2-ErbB3 interaction model and how the membrane landscape impacts
those interactions. Our final goal was to then use our ErbB2-ErbB3 spatial stochastic
model to study possible mutations in ErbB3 and see impact the activation states of ErbB2
and ErbB3. This work is discussed in Chapter 5. In Chapter 6, we bring all the studies
together and discuss their significance and impact in the fields of membrane biology and
ErbB receptors.
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CHAPTER 2: MODELING METHODS
2.1

OVERVIEW
The use of mathematical models to describe and investigate various biological

systems has been increasing exponentially over the past decade. In response to this, many
modeling methods have either been applied from other scientific areas or been developed
out of necessity to describe new behaviors (Andrews et al, 2010). These models range
from population style deterministic models all the way to intricate single particle
stochastic models. The system being studied, as well as the questions to be answered,
dictate the necessary type of model and the level of resolution that model will need
(Andrews et al, 2010). As experimental methods have been developed over time, the
resolution of these experiments has also increased. The uptick in single molecule
experiments and the resulting detailed data call for modeling methods to be further
developed.
Here we describe methods for generating a model with spatial resolution and single
molecule precision utilizing single molecule experimental data. Our approach takes a
logical progression from initial biological system design through simulation. Important
spatial aspects must first be determined along with the reaction network of the system.
Once the model system is well defined, the dynamics and kinetics can be derived and the
necessary parameters obtained. After the model is completely developed, the relevant
outputs of the model needed to test the motivating hypothesis can be defined and the
model can then be implemented.
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2.2

SIMULATION SPACE CHARACTERIZATION

2.2.1

Summary

Introduction of a two dimensional space into a model requires a few extra
specifications above and beyond those in non-spatial models. The minimum requirements
to define this surface are the spatial limits and the initial distribution of proteins on the
surface. Additional details may also be specified, such as membrane obstacles, keeping in
mind as more and more detail is added to the 2D surface, the expense (time) of the
simulation increases.
Generation of the simulation space is based on available physiological information
about the model system, as well as restrictions of the simulation. Images obtained
through experiments providing single particle information, such as an electron
micrograph, can be used to import an initial distribution of the protein of interest.
Similarly, single particle tracking data can be used to reconstruct confinement zones
receptors encounter on the membrane. Combining this data with information about the
receptor population allows for a good estimate for a simulation space and initial
conditions. Here we discuss in detail the two methods we have developed, an Image
Importer and Domain Reconstruction Algorithm (DRA), to import and analyze this data
to recreate physiologically relevant simulation spaces.
2.2.2

Image Importer

2.2.2.1 Motivation
One method used to visualize ErbB receptors on the cellular membrane is electron
micrography (EM). The receptors are fixed on the cellular membrane, labeled with
immuno-gold particles, and then imaged (Yang et al, 2007). The resulting EM images
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give insight into receptor distribution on the membrane. ErbB1 receptors tend to cluster
on the membrane. These pockets are often referred to as confinement zones or domains.
This view of receptor distribution on the membrane is one of the observations that lead to
the addition of spatial resolution to our model. In a first step towards integrating
experimentally observed receptor distributions for initial spatial conditions, we developed
a method to import the receptor positions from EM images and estimate domain sizes
based on the receptor clusters.
2.2.2.2 Particle Import and Domain Estimation
The EM image importer uses the Image Processing Toolbox in Matlab. The program
has been setup to walk the user through importing data through various popup instruction
boxes. The programs algorithm depicted as a flowchart is shown in Figure 2.1. An
example screenshot of using the importer is shown Figure 2.2. This algorithm is
implemented in Chapter 3.
EM Image Importer Function
1. Specified image is read in to Matlab.
2. User specifies if domains will be included, and if so, how many.
3. Scale bar length is read in. This will give a unit conversion between pixels and the
physical units the image is in. The units are specified within the .m file.
4.

x and y limits are read in. These are the absolute boundaries for the simulation
space.

5. If domains are to be included, they are read in one at a time until the number of
specified domains in Step 2 is met.
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Figure 2.1: EM Image Importer Algorithm Flowchart.
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Figure 2.2: EM Image Importer Screen Shot. The EM Image Importer walks the user through
importing receptor and domain positions through a series of prompts.
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a. Domain x and y limits are read in. These limits are defined by the cluster
size of receptors in the image. The domain is a rectangle defined by the x
and y limits.
b. Receptor x,y positions within the specified domain are read in.
6. Receptor x,y positions not in domains are read in.
7. The total number of receptors is calculated and all the data collected is saved to a
.mat file for later use.
2.2.3

Domain Reconstruction Algorithm

2.2.3.1 Motivation
While the necessity of spatial resolution has been shown and modeling methods have
been developed to address it, characterization of the simulation space using single
particle data has not yet been explored. Here we take the addition of spatial resolution
one step further by directly incorporating single particle tracking data to describe and
represent the simulation space features and particle distributions. Many studies involving
single particle tracking have observed a particle diffusion pattern that suggests the
particles are in a confined area (Kusumi et al, 1993; Low-Nam et al, 2011; Saxton, 1993).
Taking into account this observation, we have created an algorithm that analyzes single
particle tracking data to reconstruct the size and shape of these confining areas. A flow
diagram of the algorithm is shown in Figure 2.3. The algorithm first picks out the points
in the trajectories determined to be in a confined space, and then performs a cluster
analysis on the points. The clusters are then converted into contours, which are then
“inflated” to reconstruct the shape of the confining space. This algorithm is implemented
in Chapter 5.
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SPT Data
Static Data
Dynamic Data
Cluster Analysis
Trajectory Point
Ranking
Contour Drawing
Confined Point
Compilation
Contour Inflation

Final Domains
Figure 2.3: Domain Reconstruction Algorithm Flowchart. The DRA starts from dynamics single
particle tracking data. The algorithm ranks the data and compiles the points. The data is then
converted to static spatial data and used to determine domain size and distribution. The domains are
reconstructed via a clustering algorithm, contour drawing, and contour inflation.
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2.2.3.2 Trajectory Analysis
One of the major undertakings of this algorithm is the need to transform dynamic
trajectory data into static spatial data. To accomplish this task, we devised a ranking
system that sorts every point in an individual trajectory into two groups: confined or free.
The confined points are what would be considered to be in a confinement zone, while the
free points are considered to be “free” on the membrane.
To rank these points, we first calculate the jump size (displacement) for a selected
number of time steps (1, 2, 5, 10, 20, 50, 100, 200). The time step is applied moving
forward through the trajectory as well as backwards through the trajectory. Covering this
range of step sizes accounts for “holes” that may be in the trajectory data due to
experimental conditions such as blinking of the quantum dots or quantum dots
temporarily moving out of the focal plane. These jump sizes are calculated for each
trajectory in a set of comparable SPT files, then aggregated by step size.
Once the jump sizes have been compiled, the individual points from each trajectory
are ranked. For every point, the relative rank is calculated by comparing the point’s jump
size to all the other points’ jump sizes for a specific step size. The jump sizes for a
specific step size are sorted in order from smallest to largest. The rank of a specific point
is where it falls in that order. This is repeated across all points for each step size.
Some points may not have a score for all 16 step sizes due to the aforementioned
holes in the trajectories. To account for this, a weighted average is used to determine the
overall rank for each point. First, for each point, the forward and backward ranks for a
step size are combined. The combined ranks for each step for that point are then averaged
together; this is the final rank for that point.
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2.2.3.3 Cluster Analysis
We rely on distance based hierarchic clustering. This approach had been widely used
in the literature, ranging from ecology and genomics to receptors on the cell membrane
(Espinoza et al, 2012). Our method is a modified version of that developed by Espinoza
and coworkers for TEM images of receptors labeled with gold nano-particles.
Given N points {P1,P2,…,PN} in a plane, with coordinates {(x1,y1),…(xN,yN)}, we
want to partition them into mutually exclusive groups or clusters in a way that reflects
their proximity or similarity to each other. This is not a clearly defined notion and the
appropriate clustering method should be ultimately determined by the experimental
context. Here, we use the “slow points” identified from jump size distributions as
indicators of an underlying physical structure (such as lipid rafts); therefore the notion of
proximity defined by physical distance to the closest members of the cluster is more
appropriate considering, for instance, an average distance to the entire cluster (this is the
idea underlying K-means clustering).
We construct clusters by comparing the distance d ( P1,P2 ) =

2

( x1 − x 2 ) + ( y1 − y 2 )

2

between points to a reference length L, sometimes called a “scale”. Two points A, B are
in the same cluster if their distance d ( A,B) ≤€L ; we denote this relationship by A ~L B.
We extend the relationship by transitivity: if A ~L B and A ~L C, then B ~L C. It is easy to
€

see that the procedure will induce a partition of the set of points. (The ~L relation is
symmetric and transitive, therefore it is an equivalence relation in the mathematical
sense; the clusters are the corresponding equivalence classes.)
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The partition into clusters is unique for a given set of points and length scale L. Any
two points in a cluster can be linked by a connected path consisting of line segments of
length ≤ L connecting points from the same cluster (Figure 2.4A).
2.2.3.4 Contour Drawing
In order to build a geometric area (shape or footprint) around a given cluster, we start
with the union of the circles of radius L/2 centered on all members of the cluster. We
assume the cluster resulted from hierarchic clustering with distance parameter L, so any
member of the cluster must be reached from any other member through a sequence of
segments connecting cluster points, such that no individual segment is long than L. The
connection graph in Figure 2.4 constructed by putting an edge between all pairs of points
whose distance is ≤ L must be connected, and therefore, the union of the circles (Figure
2.4B) must form a contiguous area.
To straighten the boundary of the region defined this way, we extend the area by
adding rectangles of height L along the contour of the connection graph (double lines
Figure 2.4C). The reconstructed region is the reunion of the inside of the contour graph,
and the circles and rectangles around the vertices and edges of the contour (shaded,
respectively grey areas on Figure 2.4D).
The contour graph or “tight contour” for a cluster of points is defined by the sequence
of boundary points and the segments that connect them. The list is constructed by adding
new points to the contour, based on the existing points and a reference direction. As the
contour is built, it circles around the points in a counter-clockwise direction, so that all
the interior points are to the left hand side. When the process is finished, the last point in
the contour is identical to the first one.
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Figure 2.4: Clustering Algorithm Walkthrough. (a) The points in a cluster form a connected graph,
where edges connect points whose distance is less than the length scale L. Circles of diameter L
centered on two points intersect if and only if the points are connected in the sense described above.
(b) We want to define the footprint based on the reunion of all the circles of diameter L, centered on
the points in the cluster. (c) We first identify the outer contour (sometimes a skeleton, with no
interior) of the cluster graph (double blue shaded lines). We ‘pad’ the area defined by the circles by
adding rectangles along the edges of the contour graph. (d) The reconstructed region is the reunion
of the inside of the contour graph (if any), and the circles and padding rectangles around the vertices
and edges of the contour graph.
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Contour Building Algorithm
1. Start with the rightmost point of the group; set the reference direction pointing to
the right. (Any point on the convex hull is acceptable; the reference direction
needs to be pointing toward the outside of the hull.)
2. Add new points:
a. Identify all the points in a circle of radius L centered on the last point
added (the current point); these are the candidate points.
b. Draw line segments from the current point to each candidate point. If this
intersects a segment in the already identified part of the contour, discard
respective candidate point.
c. Order the remaining candidates by the clockwise angle from the reference
direction to the segment connecting the current point to the candidate;
choose the candidate with the smallest angle and add it to the list.
d. Set reference direction to point from the newly added point back to the
previously added point
3. The process terminates when the same segment is added to the contour. The same
point may be visited twice, in opposite directions. Upon successful termination,
the last point in the list is the same as the first one.
NOTE: The contour defined this way is not unique, but the algorithm always returns a
contour that is a refinement of the convex hull of the points, is not self-intersecting, and
contains no edges longer than L.
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2.2.3.5 Contour Inflation
The tight contour or contour graph defines the reconstructed region. This contour is
often lacking an “inside”, and can have sections that are just a single chain of points. The
rationale of padding is to represent the area “of influence” of each point in the cluster –
roughly, the set of geometric locations that are closer to this cluster than to any points
that are not part of the cluster.
The padding adds two types of elements to the core contour and its interior:
1. A rectangle of height L/2 on the outer side of each edge of the tight contour graph
2. A sector of a circle of radius L/2 at each vertex with a positive (convex) angle
The contour inflation algorithm constructs a second contour (the outer or padded
contour) that encloses the first one. Similarly to the tight contour, the padded contour
defined as a polygonal line; the vertices of the polyline are all auxiliary points, and are
not elements of the cluster.
The contour inflation algorithm proceeds along the inner contour, and builds the outer
contour parallel to it, adding one or more points to account for each vertex of the inner
contour. If the angle at the respective vertex is positive (convex), we add the corners of
the padding rectangles and points on the arc of the padding circle centered on the vertex;
if the angle is negative (concave), then we only add one point, namely the intersection of
the two padding rectangles.
Below we describe the algorithm we employed. This algorithm also relies on a
reference direction, which corresponds to the segment preceding the current vertex (with
the direction defined by that of the algorithm – counterclockwise in our case).
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Contour Inflation Algorithm
1. Start at a point on the tight contour. Moving counter-clockwise along the contour,
set the reference direction to that of the incoming edge in the counter-clockwise
direction, and the current direction to the outgoing edge.
2. The elements of the new contour that are added to represent the current vertex are
set based on the angle between the incoming and outgoing directions.
a. If the angle is positive (left turn, convex vertex), then add a sector of a
circle of radius L/2, centered on the current vertex, and delimited by the
radii perpendicular to the incoming and the outgoing edges. The sector is
discretized as a sequence of points starting with the end the radius
orthogonal to the incoming edge and ending at the other one. At least one
intermediate point is added at the end of the radius that is the symmetry
axis of the sector.
b. If the angle is negative (right turn, concave vertex), we only add the point
where the two adjacent rectangles intersect. This point is also on the
symmetry axis (bisector) of the angle on the inner contour.
3. The algorithm proceeds along the vertices of the inner contour, adding points to
the outer contour for each of them. The process terminates when the starting
vertex is reached, and is about to be passed in the same direction as in the first
iteration.
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2.3

SPATIAL STOCHASTIC MODEL

2.3.1

Motivation

Any of the stochastic modeling methods mentioned previously may be implemented
with the simulation space derived above. For our work, we chose Smoluchowski
dynamics with modifications proposed by Andrews and Bray (2004). We felt that this
model most accurately represented physiological processes of the known available
models. We opted to develop our own version of Andrews and Bray’s (2004) model,
instead of directly using their simulator SMOLDYN, for two distinct reasons:
1. Inclusion of our reconstructed simulation spaces, mentioned above.
2. Unique Receptors. We needed to be able to keep detailed records about each
receptor over the simulation time.
While SMOLDYN is a very effective and efficient simulator, both of the above
mentioned capabilities were not available in SMOLDYN at the time we started this work.
We developed the code in FORTRAN 90 for ease of use and the ability to be compiled.
Here we will go through the steps necessary to define the model as well as how to
implement the experimental data.
2.3.2

Biological Reaction Network Definition

Deriving the reaction network for a system of interest is a very important step.
Leaving out a reaction or over specifying the system can lead to incorrect conclusions.
We suggest a bottom up approach, starting as simple as possible and building on to the
network, as necessary. Our reaction network includes a series of first order reactions and
second order reactions.
1. First Order Reactions
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a. Dimer Dissociation
b. Phosphorylation
c. Dephosphorylation
d. Domain Escape (Confined Receptor ! Free Receptor)
2. Second Order Reactions
a. Receptor dimerization
2.3.3

Particle Diffusion

Once the simulation space and reaction network have been specified, the diffusion of
the proteins and the reaction kinetics must be accounted for. Receptor diffusion is based
on Brownian motion. Brownian motion is represented in a simulation by picking a
random number from a normal distribution and applying that value to the root mean
square (RMS) step length, recreating the stochastic nature of diffusion (Andrews & Bray,
2004; Kusumi et al, 1993; Popov & Agmon, 2001).

x(t + Δt) = x(t) + RMSξx
y(t + Δt) = y(t) + RMSξy
RMS = 2DΔt
where x and y are the receptor’s Cartesian coordinates, RMS is the root mean square

€
step, Δt is the time step, and ξx and ξy are the normally distributed random numbers.
Periodic boundary conditions are used as a receptor approaches the edge of the
simulation space.
Membrane obstacles create a hurdle for the diffusing receptors during the simulation.
The diffusion depends on the type of membrane obstacle encountered. If the obstacle is
simply a boundary, the receptor may either “jump” the obstacle or be reflected off the
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boundary in the opposite direction. If the obstacle is a confining area, sometimes referred
to as a sticky box or domain, the receptor typically has an easier time entering the
confinement zone, however needs to pay a higher “toll” to escape. The toll is applied
using a probability calculation using the transition rate, or escape rate, from one zone to
the next:
P (Transition) = 1 − exp( −rTransition Δt )

However, this probability has been simplified further to:
€

P (Transition) = rTransition Δt
due to the small time step.

If a confined receptor is set to diffuse out of a

€

confinement zone, and this escape probability is not met, the confinement zone assumes a
reflective boundary condition, trapping the receptor inside.
2.3.3.1 Boundary Conditions
There are two sets of boundary conditions encountered during receptor diffusion,
periodic and reflective. A periodic boundary is used when a receptor reaches the edge of
the simulation space. As the receptor approaches the edge of the simulation space, the
jump that takes the receptor across the boundary is split between the remaining distance
before the boundary and the rest of the jump distance. The jump distance beyond the
boundary is then transposed to the opposite boundary edge and continued back into the
simulation space. Conditions and equations for implementing the periodic boundary
condition are in Table 1.
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Minimum Bound

Maximum Bound

x Final = x Initial + Δx + LSimSpace
x

x Final = x Initial + Δx − LSimSpace
x

y Final = y Initial + Δy + LSimSpace
y
€

y Final = y Initial + Δy − LSimSpace
y

Cross y
Boundary
Cross

x

Boundary

€

Table 1: Periodic Boundary Conditions. Equations for calculating a receptor’s new position when a
simulation space boundary is crossed.

€Reflective

boundary conditions are used
€ for simulation space confinement zones.

When a receptor encounters a confinement zone that it cannot cross, the receptor is
directly reflected away from the obstacle. The receptor jump is split again between the
distance to the obstacle and the distance the receptor would move beyond the obstacle.
This second distance is the distance the receptor is moved away from the obstacle.
Conditions and equations for implementing the reflective boundary condition are in Table
2.

Cross

y

Boundary
Cross

x

Boundary
€

Minimum Bound

Maximum Bound

x Final = 2x Obstacle
− Δx − x Initial
Min

x Final = 2x Obstacle
− Δx − x Initial
Max

y Final = 2y Obstacle
− Δy − y Initial
Min

y Final = 2y Obstacle
− Δy − y Initial
Max

€

Table 2: Reflective Boundary Conditions. Equations for calculating a receptor’s new position when it
encounters an obstacle in the simulation space.

€

2.3.4

Receptor Kinetics

€

Modified Smoluchowski dynamics are used to simulate receptor kinetics (Andrews &
Bray, 2004). The simulator focuses on one receptor at a time, picking every receptor
once, on average, over a fixed time step. Receptors are picked randomly using a uniform
distribution, allowing the order the receptors are moved or reacted to be different for each
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time step. Once a receptor is picked, the possible reactions for that receptor are examined
and applied as appropriate. There are two types of reactions possible, 1st order and 2nd
order.
First-order reactions are implemented through a probability calculated using the
reaction rate and simulation time step:
P ( reaction) = 1 − exp( −rreaction Δt )

This probability has been simplified further, as in Hsieh et al. (2008) and Andrews
and Bray(2004):

€

P ( reaction) = rreaction Δt

Second-order reactions require more detail to account for two receptors interacting
€

with one another. A receptor’s likelihood to react with another receptor is based on a
distance termed the binding radius. The binding radius takes into account the dimer on
rate, diffusion coefficient of the receptors that will comprise the dimer, and the
simulation time step (Andrews & Bray, 2004). While the binding radius is not a physical
radius relative to the size of the receptor, the use of this radius allows the simulation to be
closer to the physical situation than previous methods using probabilities (Andrews &
Bray, 2004; Erban & Chapman, 2009; Gillespie, 1977; Hsieh et al, 2008; Popov &
Agmon, 2001). When the chosen receptor is moved, the final position is scanned for
other receptors within the binding radius. If a receptor is within this distance, the
receptors will react. Calculation of the binding radius is done through an iterative process
where the experimentally determined reaction on rate is compared to the simulation’s on
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rate of reaction. This causes the binding radius to be a function of diffusion coefficients,
the reaction on rates, and the simulation time step (Andrews & Bray, 2004).
When a reversible reaction occurs, an unbinding radius is used to set the dissociating
receptors apart. The unbinding radius is calculated such that the occurrence of an
unrealistic amount of repeated interactions is minimized:

where σb is the binding radius and σu is the unbinding radius. The default ratio of binding
radius to unbinding radius is 0.2 (Andrews & Bray, 2004).
2.3.5

Parameters

The necessary parameters become apparent once the diffusion and reaction equations
have been defined. Ideally, the parameters would come from relevant experimental data
with single particle precision. This is currently not possible for many systems; therefore
the next best source would be ensemble data from a relevant experimental system. If
experimental data is not available for a specific parameter, either through experiments or
literature, a last resort method would be to fit the parameter. Zhang et al. (2009) showed
the importance of where parameters come from, and show that mixing parameters from
different cell lines can cause incorrect conclusions to be drawn from simulations. For this
reason, we have tried our best to obtain parameters that have all originated from the same
cell lines relevant to the receptors focused on in each of our models. Our parameters
mainly come from SPT experiments, however kinase assays were used for the
phosphorylation/dephosphorylation rates. The specific parameter sets and where they
came from are discussed in each chapter that implements this modeling scheme.
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2.4

NOTES
Matlab scripts for the Simulation Space sections are available in Appendix A.

Fortran code for the spatial stochastic model is available in Appendix B.
2.5
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3.1 ABSTRACT
ErbB1 overexpression is strongly linked to carcinogenesis, motivating better
understanding of erbB1 dimerization and activation. Recent single particle tracking data
have provided improved measures of dimer lifetimes and strong evidence that transient
receptor co-confinement promotes repeated interactions between erbB1 monomers. Here,
spatial stochastic simulations explore the potential impact of these parameters on erbB1
phosphorylation kinetics. This rule-based mathematical model incorporates structural
evidence for conformational flux of the erbB1 extracellular domains, as well as
asymmetrical orientation of erbB1 cytoplasmic kinase domains during dimerization. The
asymmetric dimer model considers the theoretical consequences of restricted
transactivation of erbB1 receptors within a dimer, where the N-lobe of one monomer
docks with the C-lobe of the second monomer and triggers its catalytic activity. The
dynamic nature of erbB1 phosphorylation state is shown by monitoring activation states
of individual monomers as they diffuse, bind and rebind after ligand addition. The model
reveals the complex interplay between interacting liganded and non-liganded species and
the influence of their distribution and abundance within features of the membrane
landscape.
3.2 INTRODUCTION
ErbB1 (EGFR, Epidermal Growth Factor Receptor) is the canonical member of the
erbB receptor family (Citri & Yarden, 2006) and a critical player in normal growth and
development, as well as carcinogenesis (Citri & Yarden, 2006).

ErbB1 signaling is

initiated by ligand-induced homo- and hetero-dimerization that is mediated primarily by
engagement of extracellular dimerization arms (Baselga & Swain, 2009). Structural

59

evidence also suggests that the erbB1 extracellular domain fluctuates between the closed
and open conformation in the absence of ligand (Baselga & Swain, 2009), transiently
exposing the erbB1 dimerization arm and permitting transient “pre-formed” dimers to
occur (Schlessinger, 2002). We previously used spatial stochastic modeling to predict the
impact of receptor density, through local receptor trapping in membrane domains or
receptor overexpression, on the rate of pre-formed dimers (Hsieh et al, 2008). The ability
of non-ligand bound erbB1 monomers to partner with each other and with ligand-bound
monomers leads to a complex mix of dimer configurations. Once dimers form, the signal
is propagated by activation of integral tyrosine kinase activity in the receptor cytoplasmic
tail, trans-phosphorylation of tyrosine residues in receptor tails and recruitment of
cytosolic signaling partners (Citri & Yarden, 2006). Both deterministic and stochastic
mathematical models have been developed to consider the complexity of erbB1 signaling,
with successive generations of erbB1 models building on ever richer data sets for binding
kinetics, phosphorylation/dephosphorylation dynamics and adaptor recruitment (Blinov et
al, 2006; Costa et al, 2009b; Hendriks et al, 2003; Hsieh et al, 2008; Kholodenko et al,
1999; Kleiman et al, 2011; Radhakrishnan, 2010; Sasagawa et al, 2005; Schoeberl et al,
2002).
Not yet considered in mathematical models is the asymmetrical docking and
activation of erbB1 cytoplasmic kinase domains, which accompanies extracellular
domain dimer formation (Lu et al, 2012; Macdonald-Obermann & Pike, 2009; Mi et al,
2011; Zhang et al, 2006). In an asymmetric dimer, the N-terminal lobe of one kinase
domain in the dimer pair interacts with the C-lobe of the other (Zhang et al, 2006).
Mutagenesis and biochemical studies support an unusual transactivation model, where
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activation of catalytic activity is restricted to the monomer whose C-lobe has been
engaged. Thus, one monomer in the dimer pair is considered to be the “receiver” and the
monomer contributing the N-lobe is considered to be the “activator”. A novel aspect of
the present study is the consideration of restrictions that asymmetrical docking
theoretically imposes upon ErbB trans-phosphorylation into the spatial stochastic model,
taking advantage of the flexibility of the model’s rule-based framework.
Our model also builds on improved measures of erbB1 diffusive behavior and
dimerization kinetics, made possible through remarkable advances in single particle
tracking (SPT) methodology (Low-Nam et al, 2011). This recent study by Low-Nam et
al. (Low-Nam et al, 2011) provided important new parameters for the spatial stochastic
model. Among these values are the differential lifetimes of dimer pairs, based upon the
occupancy of the ligand-binding site in each monomer. For example, the authors showed
that dimer pairs comprised of two ligand-bound monomers have the longest lifetimes,
compared to lifetimes of pairs comprised of one ligand-bound and one unliganded
monomer or 2 unliganded monomers (Low-Nam et al, 2011). In addition, data from SPT
experiments provided strong evidence for repeated interactions between two receptors
while co-confined in specialized features of the plasma membrane, referred to as
membrane domains or corrals. Since SPT relies on sparse labeling and captures only a
minute fraction of receptor dimer events, an important aspect of the spatial model
presented here is the explicit consideration of the impact of these new measurements on
population dynamics. The spatial model also yields new insight into the activation states
of individual monomers after ligand addition, as they cycle through rounds of
dimerization, asymmetrical kinase activation and phosphorylation/dephosphorylation.
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3.3 MATERIALS AND METHODS
3.3.1 Mathematical Modeling
This ErbB1 model was used as the flagship example while developing the Spatial
Stochastic Model, as described in Chapter 2. In this instance, an electron micrograph of
immuno-gold labeled ErbB1 receptors was used to define domains and receptor density
for the simulation space. This implementation of the SSM includes receptor diffusion,
domain escape, and four different reactions. Diffusion: At each time step, individual
monomers can diffuse or react. If unrestricted by domains, receptors freely diffuse.
Receptors also freely enter domains, with defined values for restriction from exit from
domain boundaries (Table 3). Escape probabilities are determined through fitting, to
arrive at similar receptor cluster distributions at any point during the simulation process;
this parameter was validated by the Hopkins spatial statistic (Hsieh et al, 2008; Zhang et
al, 2008) and by comparison of jump size distributions with experimental values from
single particle tracking (Low-Nam et al, 2011). Reactions: Four possible reactions are
possible: dimerization (2nd order), dissociation (1st order), phosphorylation (1st order), or
dephosphorylation (1st order). After moving, each monomer’s position is scanned for
other receptors within the binding radius; dimerization likelihood within this radius is
based upon a modification of the Smoluchowski approach (Andrews & Bray, 2004) and
calculated from dimer estimates in Martin-Fernandez et al. (2002). Dimer dissociation is
implemented through a probability calculated using the dimer off rate and the simulation
time step. When dimers dissociate, the monomers are assigned an unbinding radius to
minimize the occurrence of an unrealistic amount of repeated interactions. These binding
and unbinding radii take into account the kinetics and diffusion of the receptors. Using
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Species
LR
LRP
R
RP
LRLR
LRR
RR
LRPLR
LRPR
RPR
LRPLRP
LRPRP
RPRP

Dimer On
Dimer
Domain
Dephos
Rate
Phos Rate
Off Rate Exit Rate
Rate
[1/s]b
[mm3/s]
[1/s]a
[1/frames]a
[1/s]b
c
[*1E-04]
0.0512
----0.0121
----0.0512
----0.0121
--0.13
0.0512
----0.0183
----0.0512
----0.0183
--0.13
0.0191
0.9138
0.273
0.00874
0.0733
--0.0191
0.9138
0.738
0.00874
0.0733
--0.0191
0.9138
1.24
0.00874
0.0733
--0.0191
0.9138
0.273
0.00874
0.0733
0.13
0.0191
0.9138
0.738
0.00874
0.0733
0.13
0.0191
0.9138
1.24
0.00874
0.0733
0.13
0.00563
0.9138
0.273
0.00874
0.0733
0.13
0.00563
0.9138
0.738
0.00874
0.0733
0.13
0.00563
0.9138
1.24
0.00874
0.0733
0.13

Diffusion
Coeff
[µm2/s]a

Table 3: ErbB1 Model parameters. Set of experimental parameters used for each of the species
during simulations. a – Low-Nam et al (Low-Nam et al, 2011), b – Kleiman et al (Kleiman et al,
2011), c – Back-calculated using SMOLDYN (Andrews & Bray, 2004)

the binding and unbinding radius as the inner and outer bound of this region, respectively,
minimizes instantaneous rebinding (Andrews & Bray, 2004). Phosphorylation occurs
only during dimerization intervals and is based upon a rule where one monomer in the
dimer is assigned at random as the activator and the other monomer in the dimer is the
receiver. Phosphorylation is estimated as a 1st order reaction based on the assumption of
excess phosphate. Dephosphorylation occurs at the same rate irrespective of monomer or
dimer state (Table 3). Supporting equations and mathematical methodologies are
available in the Supporting Material.
3.3.2 Single Particle Tracking
Detailed methods for tracking and analyzing erbB1 motion are described in LowNam et al. (Low-Nam et al, 2011). In brief, erbB1 were tracked with two-color quantum
dots (585 and 685 QDs, Molecular Probes) conjugated with either VHH monomeric
antibody fragments (non-competing with ligand) or with EGF-conjugated QDs. A431
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breast cancer cells were serum starved for a minimum of 2 hrs and observed on an
Olympus IX71 inverted microscope equipped with a 60 x 1.3 N.A. water objective and an
electron multiplying CCD camera (Andor iXon 887). Samples were maintained at 3436oC by an objective heater (Bioscience Tools, San Diego CA). QD probes were applied
at picomolar concentrations to achieve sparse labeling required for single particle
tracking. A 3-state Hidden Markov model was used to identify transition rates between 2
distant monomers (free), co-confined pairs and dimerized receptors. From these rates, the
states of receptor pairs in the raw data could be extracted.
3.4 RESULTS AND DISCUSSION
In this work, we began with modifications to our existing spatial stochastic model
(Hsieh et al, 2010). Receptors are represented as discrete particles and move through a 2D simulation space with Brownian motion and under periodic boundary conditions. An
improvement in the model is the use of modified Smoluchowski dynamics to govern
reactions, as described in Methods. Similarly to Hsieh et al (Hsieh et al, 2010; Hsieh et al,
2008), this simulation approach follows the molecular transformations and Brownian
motion of individual particles; however, each dimerization and dissociation reaction type
is implemented using a single, pre-calculated geometric parameter, yielding both faster
execution and increased physical accuracy.
Dimerization reactions in this simulation environment are diffusion-limited.
Individual particles move independently and randomly at each time step, with normally
distributed jump sizes. At the end of each move, a scan of the surrounding area within a
defined radius of the particle determines where a binding event will occur. This “binding
radius” was based upon simulations that reproduce results of Martin-Fernandez et al

64

(Martin-Fernandez et al, 2002) and takes into account measured reaction rates and
diffusion coefficients (Low-Nam et al, 2011), with 1 µsec simulation time steps. The
model tracks all particles in the simulation at every step. Rather than monitor binding of
ligand, these simulations are initiated with a predetermined percent of ligated receptors as
a simplification strategy. Table 3 summarizes the experimental values for dimer off-rates,
phosphorylation and dephosphorylation, used to calculate probabilities for events to
occur at each time step in the simulation.
The conformational states of erbB1 are specifically represented by dimerization rules
in the model, as illustrated schematically in Figure 3.1A. In the absence of bound ligand,
receptors (R) are presumed to predominantly assume the bent state, with a 1% probability
at each time step of fluxing to the open state that exposes the dimerization arm (Hsieh et
al, 2008; Schlessinger, 2002). Ligand-bound receptors (LR) are assumed to be in the
extended conformation as long as ligand is bound. Thus, there are three possible types of
erbB1 homodimers: two ligand-bound receptors (LRLR), one ligand bound receptor and
one non-liganded receptor (LRR), and two non-liganded receptors (RR, the “preformed”
dimer state).
An important feature of the model is the introduction of membrane domains that
transiently confine receptors. Figure 3.1B-C illustrates how the area and distribution of
domains are initialized based upon immunogold-labeling of erbB1 decorating the
membrane of A431 breast cancer cells. As described in Methods, both domain location
and receptor density are imported directly from EM images through a graphical user
interface. By limiting the probability of exit from domains, receptors are confined within
them for discrete periods but explore much of the membrane landscape over a period of
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Figure 3.1: ErbB1 species, simulation space, diffusion and off-rate validation (A) Monomer and
dimer species accounted for in the spatial stochastic model. R is a resting monomer with no ligand
bound. Resting receptors spend 99% of simulation time in a tethered conformation, with 1%
probability to flux to the extended conformation. LR is a ligand bound monomer and stabilized in
the open conformation. RR is a preformed dimer, formed by encounters between two monomers in
the open conformation. LRR is comprised of one unliganded monomer and one liganded monomer.
The LRLR dimer is comprised of two ligand bound monomers. (B) TEM image used to initialize the
starting positions of ErbB1 receptors and estimate size and density of confinement zones. (C)
Simulation interpretation of the TEM image, including static confinement zones in black boxes. (D)
Sample trajectory of three different receptors over a 4-minute simulation. (E) Monomer diffusion
coefficient calculated from simulation data. Simulation diffusion coefficients match the diffusion
coefficients from SPT experiments. (F) Histograms of dimer lifetimes for 2:2 dimers. Each
histogram is fit to determine the specific dimer off rate. The red line is the simulation data fit and
the blue line is the experimental data fit (Low-Nam et al, 2011).
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seconds to minutes (Figure 3.1D). Diffusion coefficients used in the model are based
upon SPT measurements (Low-Nam et al, 2011). ErbB1 monomers are assigned the fast
diffusion rate of 0.0512 µm2/s for unconfined receptors, slowing to 0.0191 µm2/s upon
dimerization. Fully phosphorylated dimers further slow to 0.00563 µm2/s, approximating
the slowdown attributed to assembly of docking partners and remodeling of the local
environment (Low-Nam et al, 2011). The diffusion rates for unphosphorylated dimers
were based upon tracking of erbB1 dimers in the presence of the kinase inhibitor
PDI53035 (Low-Nam et al). It is noteworthy that we did not assign the slowest diffusion
rate to partially phosphorylated dimers that could also slow further when recruiting
docking partners, based on comparisons indicating that implementation of further
slowdown had no significant impact on the results.
Figure 3.1E summarizes the spread of jump sizes for receptors diffusing and
dimerizing within the domain-studded simulation landscape, reported as a CPA
(cumulative probability analysis) plot. This analysis compares favorably with CPA plots
generated from single particle tracking data for erbB1 bound to QD-probes (Low-Nam et
al, 2011). Figure 3.1F shows that the distribution of lifetimes for simulated dimers also
closely matches experimental data. The model thus captures the essential features of
anomalous diffusion, as well as the stochastic nature of dimer dissociation, observed for
erbB1 receptors in living membranes.
3.4.1 Membrane domains promote repeated interactions between monomer pairs
Figure 3.2A illustrates the reproducible observation that pairs of erbB1 monomers,
tracked with 2 colors of QD-EGF, can bind and rebind multiple times during live cell
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Figure 3.2: Membrane domains influence repeat interactions between receptors. (A) Separation
distance over time between two QD-labeled receptors during a single particle tracking experiment.
The receptors are initially in a dimer state, dissociate and redimerize several times, as indicated by
the state line overlay. (B) Separation distance over time between two ligand bound receptors during
a simulation demonstrating the same pattern of repeat interactions. (C) Summary of repeated
interactions over an entire simulation for all possible receptor pairs. A few individual receptors
interact with one another more than 100 times during a single 4-minute simulation. (D) Time
between rebinding interactions of two receptors are shown for LRLR dimers. Many rebinding
interactions occur below the frame rate, 20 frames/second, used in SPT experiments (Low-Nam et al,
2011) as indicated by the arrow. While most rebinding incidents occur within 50 seconds, time to
rebinding can occur more than 150 seconds later.
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imaging. This characteristic behavior has been attributed to co-confinement, based upon
the unlikely probability of repeat encounters if dissociated monomers diffuse rapidly
away from their original contact site (Low-Nam et al).

We tested this notion by

examining the trajectories and binding events between receptors in the spatial stochastic
model, using a simulation space with membrane domains and 50% ligand-bound
receptors. Representative results are shown in Figure 3.2B, where two receptors interact
multiple times during a 50 second simulation.
Figure 3.2C reports results of this analysis applied to the entire population of
receptors in the simulation space over a 4 minute time course. The number of repeat
interactions between each pair of receptors varies broadly, with a high value of 141
binding interactions between a given pair.
Another prediction arising from these simulations is the average time to rebinding. A
large number of rebinding reactions (28%) occur within 0.05 seconds (Figure 3.2D,
arrow), which is equivalent to the frame rate of the data collection in (Low-Nam et al).
Since simulation results are analyzed with millisecond resolution, it suggests that the
number of repeated encounters may be underrepresented during image acquisition.
3.4.2 Implications of the asymmetric model for receptor transphosphorylation
We next consider the implications of asymmetric kinase orientation within erbB1
dimers. The cartoon in Figure 3.3A illustrates the basic scheme used to create rules for
trans-phosphorylation when kinase activation is restricted to only one monomer in a
given pair. Here, the N-lobe of the “activator” monomer is in contact with the C-lobe of
the “receiver” monomer. We make the theoretical assumption that the now active
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Figure 3.3: Impact of asymmetric receptor phosphorylation (A) A model for receptor
phosphorylation shuffle. When a dimer forms, due to the configuration of the N and C lobes, only
one tail of the dimer may be phosphorylated. In order for a dually phosphorylated dimer to occur, a
phosphorylated receptor and an unphosphorylated receptor must dimerize in the correct
configuration such that the unphosphorylated receptor is phosphorylated. (B) Example of a ligand
bound receptor state over a 4 minute simulation (top) and the average percent of time spent in each
state for all of the ligand bound receptors during the simulation (second row). Ligand bound
receptors spend the majority of time in the dimer state. (C) Sample receptor state of a non-ligand
bound receptor (top) and the average percent of time spent in each state for all of the non-ligand
bound receptors during the simulation (second row). Non-ligand bound receptors also spend a large
fraction of time in the dimer state, however they are also found to be in the monomer state much
more often than ligand bound receptors. (D) Phosphorylation state of non-liganded and liganded
species, independent of receptor state. Less than 40 percent of non-liganded species are
phosphorylated, on average, compared to the almost 60 percent of phosphoylated liganded species.
(E) Percent of LRLR dimers in different phosphorylation states. LRLR is an unphosphorylated
dimer (blue), LRPLR is a singly phosphorylated dimer (green), and LRPLRP is a dually
phosphorylated dimer (red). A quasi-steady state is reached in the first minute of the simulation.
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“receiver” then trans-phosphorylates its partner; the probability of this enzymatic
modification is a function of the dimer lifetime for the pair.
This fundamental premise leads to an interesting prediction: As dimers dissociate and
rebind in a stochastic process, it improves the likelihood that each erbB1 monomer has
the opportunity to be both receiver and activator. The predicted outcome of this receptor
“shuffle” process is illustrated in Figure 3.3B, in the context of a simulation with 50% of
receptors bound to ligand at the onset. The graph traces the transition states of a single
ligand-bound erbB1 receptor in the simulation space over 250 seconds. Collectively, the
ligand-bound receptors in this simulation achieved the dimer state approximately 90% of
the time. The predominant dimer type is LRR, due to an equilibrium shift from equal
amounts of available LR and R monomers to an equilibrium that favors R monomers (See
Figure A.2). Receptors cycle rapidly through all possible dimerization and
phosphorylation states, spending 58% of the time as a phosphorylated species (Figure
3.3D).
In contrast, Figure 3.3C tracks the transition states of an unliganded receptor in the
same simulation. The unliganded receptors in this simulation participated in dimer events
frequently, spending only 9% of the simulation period as free monomers. However, due
to the short dimer lifetimes for RR and LRR, only 35% of unliganded receptors are
phosphorylated on average (Figure 3.3D).
In order to reconcile transient interactions with sustained signaling, we next analyzed
the potential for accumulation of phosphorylated dimers over the same stochastic
simulation time course (Figure 3.3E). At early times, the asymmetric model predicts that
the predominant dimer state is LRPLR, where only one erbB1 monomer is
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phosphorylated. Dimers achieving phosphorylation of both liganded monomers
(LRPLRP) reach similar levels with a short delay (red traces in Figure 3.3E). We
conclude that rapid receptor re-encounters permit the system to quickly reach
equilibrium, providing a significant pool of phosphorylated receptors for recruitment of
signaling partners.
In Figure 3.4, we compare steady state phosphorylation for liganded (LRP) and
unliganded (LP) receptors over a range of ligand doses and for two different receptor
densities. Results for the high density situation are shown in Figure 3.4A, again for A431
cells where the erbB1 gene is amplified and there are an estimated 4 million receptors per
cell. At low ligand doses (10-20% occupancy), between 30-40% of the phosphorylated
species are unliganded receptors (RP) that interacted with liganded receptors (LRP). As
the ligand dose increases, the ratio drops dramatically without raising the overall levels of
phosphorylation. The failure to achieve 100% phosphorylation is due to the combined
effects of phosphatase activity and the lower availability of free monomers. Plots in
Figure 3.4B report ratios of phosphorylated species where erbB1 expression levels were
more normal at 30,000 receptors per cell. In this case, the simulation landscape was
initialized with erbB1 receptor distributions acquired from immuno-gold labeled Hec50
cells (see Figure 3.5C). At the lowest doses of ligand (10-30%) occupancy, almost 50%
of the phosphorylated species are unliganded receptors. We attribute this to the lower
availability of liganded monomers in the sparsely populated membrane. These results
offer insight into the lateral propagation hypothesis of Bastiaens and colleagues (Verveer
et al, 2000) and the observations that 1:2 dimers are signaling competent (Liu et al,
2012). They suggest that initiation of a global response by low doses of ligand is unlikely
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A

B

Figure 3.4: Ratio of Phosphorylated receptors, LRP to RP. (A) Percent of phosphorylated LR and R
for increasing amounts of receptor ligand occupancy for A431 cells. Initially, at low levels of ligand
bound receptor, the percentage of phosphorylated non-ligand bound receptors increases. As
liganded receptor percentage increase, unliganded receptor phosphorylation decreases. (B) Percent
of phosphorylated LR and R for increasing amounts of receptor ligand occupancy for HEC50 cells.
A similar trend of LRP and RP are seen for HEC50, however the sparseness of the receptors on the
membrane creates a larger deviation between simulations.
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Figure 3.5: Membrane landscape impacts receptor state. (A)-(D) Receptor density and distribution
for simulations. (A) Initial simulation space imported from an immuno-gold labeled EM image of an
A431 cell. Static confinement zones based on receptor cluster size are included. (B) Randomized
distribution of the same number of receptors in (A), after diffusion simulations in the absence of
confinement zones. (C) Initial simulation space imported from an immuno-gold labeled EM image of
an HEC50 cell. Static confinement zones based on receptor cluster size are included. (D)
Randomized distribution of the same number of receptors in (C), after diffusion simulations in the
absence of confinement zones. (E) Receptor state for simulation conditions represented in the
matching simulation space and 0% ligand bound receptors. The presence of domains impacts how
often receptors will encounter one another. The simulations with domains present have a higher rate
of dimer occurrence, as well as a large number of phosphorylated receptor species. (F) Receptor state
for simulation conditions of 10% ligand bound receptors and corresponding simulation space.
Similarly to the 0% ligand bound simulations, the occurrence of dimers and phosphorylated species
is increased in the presence of domains. The presence of ligand also allows for the formation of
species not present in 0% ligand bound receptor simulations. (G)-(H) Number of phosphorylated
species, on average during a simulation, present and scaled to whole cell values for A431 cells (G) and
HEC50 cells (H). The presence of domains has a clear impact on the number of phosphorylated
species. (I) Repeated interactions of receptors on HEC50 cells with 10% ligand bound receptors
present. Simulations with domains and without domains were performed.
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when the fast dephosphorylation rates measured by Kleiman et al. (2011) are coupled
with fast off-rates for LRR (Low-Nam et al, 2011).
3.4.3

The membrane landscape impacts receptor state

Our next goal was to evaluate the impact of membrane domains and receptor density
upon phosphorylation efficiency, integrating both the improved dimer life-time
measurements and the asymmetric model. Results are shown in Figure 3.5, where the
panels in A-D illustrate the four different conditions initialized into the simulation
landscape. We first compared the impact of domains upon the rate of so-called “preformed” dimers that occur in the absence of ligand. These events rely on encounters
between monomers that have both randomly fluxed up to the extended conformation;
since each monomer is assumed to flux at a rate of 1%, there is a 0.01% probability for
dimerization at each encounter. Results are compared for ligand-less erbB1 diffusing and
transiently getting trapped in domains, versus the same number of receptors diffusing
with unrestricted Brownian motion. Results show that domains are particularly influential
on the predicted levels of “pre-formed” dimers. As described above, the binding radius
was parameterized based upon the observations of Martin-Fernando et al. (2002), who
estimated steady state levels of pre-formed dimers on A431 cells at 14%. Thus, as
expected, simulations are consistent with this value in the corresponding domain
landscape, Figure 3.5E. When domains are removed, dimerization reaches levels of only
2%. At normal receptor density represented by Hec50 cells, up to 10% percent of
receptors achieve dimerization in the domain-studded landscape.

Remarkably,

dimerization of unliganded receptors at this lower density is a very rare event in the
absence of domains, with estimates below 0.2%.
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Figure 3.5F next compares the dimerization frequencies where 10% of the receptors
are ligand bound and subject to the same four initial conditions (high density +/domains; normal density +/- domains). Results again demonstrate the potential influence
of domains, which is particularly impactful on the rate of dimer formation at normal
receptor expression levels.
Results in Figure 3.5G-H illustrate the relative impact of domains and receptor
density on signaling output, represented by the number of receptors predicted to be
phosphorylated at steady state. In the case of high receptor density (Figure 3.5G), up to
3% (~150,000) of receptors are phosphorylated in the absence of ligand on A431
membranes with domains. At 10% ligand occupancy, this value rises dramatically to an
estimated 1 million phosphorylated receptors. In the absence of domains, these estimates
drop to 18,000 and 587,000 phosphorylated receptors respectively.
For the case of Hec50 cells with normal erbB1 receptor density (Figure 3.5H),
predicted values of phosphorylation attributed to pre-formed dimers is modest even in the
presence of domains, at only 1400 phosphorylated receptors. Without domains, receptor
phosphorylation of ligand-less receptors is exquisitely low (17 total). Values in the case
of 10% ligand occupancy are also reported in Figure 3.5H, with 8,500 phosphorylated
receptors in the domain landscape and only 1,200 in the absence of domains.
As a final demonstration of the impact of domains, Figure 3.5I compares the
predicted frequencies of repeated interactions in Hec50 membranes, with and without
domains and 10% ligand occupancy. Repeated interactions occur often when receptors
are co-confined, even at this low density of receptors. In the absence of domains,
repeated interactions between the same pair of receptors are much more rare events.
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3.5 CONCLUDING REMARKS
Dimerization is a key event for many growth factor receptors, including erbB1 and its
closely related family members (Lemmon & Schlessinger, 2010). Previous work by us
and others have established that erbB1 dimerization is rapidly reversible (Chung et al,
2010; Kawashima et al, 2010; Low-Nam et al, 2011), leaving open important questions
regarding the sustainability of signaling. Here we specifically consider receptor
dimerization as a diffusion-limited process, with an emphasis on the impact of receptor
co-confinement in plasma membrane domains or “rafts”. Our approach is based upon
mathematical modeling, using a spatial stochastic framework that incorporates the
concepts of membrane domains. This approach was validated by its close approximation
of receptor diffusion characteristics, including the range of jump distributions measured
by single particle tracking. In addition to experimentally determined diffusion behavior,
model parameters for dimer dissociation and phosphorylation/dephosphorylation are
estimated from quantitative measurements in live cells (Hsieh et al, 2010; Kleiman et al,
2011; Low-Nam et al, 2011). As suggested in our earlier work (Hsieh et al, 2008;
Radhakrishnan, 2010), simulations confirm that transient receptor domain confinement
can effectively raise local receptor density and enhance the likelihood for productive
receptor encounters.
This work has strong implications for the field of membrane biology, where the
influence of “receptor clustering” remains a matter of considerable debate. ErbB1 and its
family members are among the best studied examples of plasma membrane
nanoclustering, with evidence for erbB1 homoclustering in resting cells from a wide
variety of techniques including electron microscopy (Hsieh et al, 2010; Hsieh et al, 2008;
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Yang et al, 2007), scanning near-field optical microscopy (Nagy et al, 1999), homoFRET (Yeow & Clayton, 2007), cross-correlation (Costantino et al, 2005; Keating et al,
2008), proximity ligation assay (Soderberg et al, 2006), multispectral plasmon coupling
microscopy (Wang et al, 2011), number and brightness (Nagy et al, 2010), and single
molecule techniques (Ariotti et al, 2010; Low-Nam et al, 2011; Orr et al, 2005). The
phenomenon of membrane protein clustering crosses many cell types. A partial list of
examples include MHC molecules (Lavi et al, 2012; Singer & Nicolson, 1972), C-type
lectins and viral proteins (Cambi et al, 2004; Itano et al, 2012), TCR, BCR and Fc
receptors (Lillemeier et al, 2006; Pierce & Liu, 2010; Wilson et al, 2000), CD36
scavenger receptors (Jaqaman et al, 2011), and GPI-anchored proteins (Brameshuber et
al, 2010; Varma & Mayor, 1998).
The observation of nanometer scale proximity of membrane proteins, typically from
microscopy methods, is sometimes interpreted as a reflection of oligomerization state.
Here, we do not make the assumption that “clusters” observed by immunoelectron
microscopy are accurate reporters of the oligomeric state of erbB1. Rather we assume
that these images capture a mix of non-random receptor distributions that principally
result from monomers diffusing in and out of membrane domains. Productive encounters
between monomers can lead to formation of dimers. Since we have yet to experimentally
observe or quantify larger erbB1 oligomers (Clayton et al, 2007) with single particle
tracking, we do not explicitly consider that interesting possibility here.
There is evidence that membrane domains arise through complex mechanisms,
including cytoskeletal barriers (Andrews et al, 2008; Jaqaman et al, 2011; Kusumi et al,
1993; Lavi et al, 2012), the partitioning of saturated lipids and cholesterol (Simons &
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Gerl, 2010), and ionic protein-lipid or protein-lipid interactions (Douglass & Vale, 2005;
Lillemeier et al, 2006; Spira et al, 2012; van den Bogaart et al, 2011). Due to this
complexity, we do not make assumptions here about the primary mechanism underlying
the domains that cause erbB1 clustering. The assignment of membrane domain area
based upon EM images can be considered a “coarse-graining” approach, where clustering
is both maintained throughout the simulation period and satisfies the essential
characteristics observed experimentally for receptor motion. In our current simulation
framework, domains are held to be static in size and location. This strategy lowers
computational costs and follows the observation of Douglass and Vale (2005) that some
slow-diffusing membrane proteins can serve as reporters for relatively stable domains.
However this simplification likely does not reflect the true dynamic nature of protein-rich
domains, that may diffuse as entities in the membrane, themselves encountering
cytoskeletal barriers and cycling between growth and dispersion at the nanometer or
submicron scale (Lavi et al, 2012).
Our model explicitly considers the mounting experimental evidence for erbB
structural rearrangements associated with dimerization. Like the integrins, the
extracellular domains of erbB receptors are now well known to exist in both bent and
extended confirmations (Burgess et al, 2003; Cho & Leahy, 2002; Ferguson et al, 2003;
Ferguson et al, 2000; Garrett et al, 2003; Ogiso et al, 2002), where ligand binding
stabilizes the upright form and exposes the dimerization arm. To integrate this concept
into mathematical models, we assume that unliganded receptors are predominantly in the
bent confirmation and that ligand receptors are fixed in the dimerization competent
conformation (Hsieh et al, 2010; Hsieh et al, 2008). A primary goal of the current study
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was to incorporate the critical discovery that erbB catalytic activation is dependent upon
an asymmetrical orientation of their kinase domains (Jura et al, 2009; MacdonaldObermann & Pike, 2009; Zhang et al, 2006). These landmark papers established that
contact of the N-lobe of the “activator” with the dimer partner’s C-lobe relieves
autoinhibition of the kinase domain solely in the “receiver” (Zhang et al, 2006).
Conclusions of these crystallographic structure studies have supported by electron
microscopy analysis of negatively-stained full length EGFR, in the presence and absence
of ligand and/or kinase inhibitors (Lu et al, 2012; Mi et al, 2011). These studies indicate
that the conformational orientations of dimerized erbB kinase domains are dominated by
the active asymmetrical orientation, as opposed to the inactive symmetrically orientation
(Landau et al, 2004), although kinase inhibitors can shift the class averages for the two
orientations.
We consider the implications of the asymmetric erbB1 activation scheme in its
simplest form, by assuming that during the lifetime of the dimer only one member of the
dimer pair becomes catalytically competent for transphosphorylation of its partner.
Consistent with evidence that dimers composed of 1ligand:2receptors are signaling
competent (Liu et al, 2012), the activation state of erbB1 in our simulations is not
governed by ligand occupancy per se but rather by the lifetime of dimers determined
experimentally (Low-Nam et al, 2011). The probability for productive interactions is
highest for 2:2 receptors, since the off-rate is slowest, followed by 1:2 receptor pairs and
by 0:2 preformed dimers that have very fast off-rates. We do note that the number of
phosphorylated receptors is increased above the total value for ligand-bound receptors,
through repeated interactions and the productivity of 1:2 dimers. This amplification,
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combined with transient dimerization, does allow for phosphorylation of unliganded
receptors in 1:2 dimers that then dissociate and later interact with other unliganded
monomers. However, the shorter lifetimes and reduced interaction probability associated
with unliganded receptors results in very few productive 0:2 dimer events.
Since our simulations are initiated with a fraction of monomers bound to ligand, our
current model does not consider the potential for negative cooperativity (Adak et al,
2011; Macdonald-Obermann & Pike, 2009; Tynan et al, 2011). If ligand binding were to
be considered in the spatial stochastic model, it would lower the probability for an
additional ligand to bind to a 1:2 receptor pair only during its relatively short lifetime (koff
= 0.738s-1)(Low-Nam et al, 2011).
One notable prediction of the simple asymmetric model considered here is that fast
dissociation of dimers effectively promotes signaling, because re-encounters increase the
likelihood that each monomer has repeated, equal opportunities to become
phosphorylated by the “receiver”. We note the recent work of Pike and colleagues, who
used a novel luciferase fragment complementation assay to provide compelling evidence
for asymmetric and sequential activation of kinases in erbB homo- and heterodimers
(Macdonald-Obermann et al, 2012).

These authors also raise the possibility that

reciprocity could occur during the lifetime of the same dimer event, if the kinase domains
can reorient while the monomers remain bound.

This intriguing possibility is not

explored here, due to lack of information about energetic requirements and feasibility of
such a reorientation on the time scale relevant to even the most stable 2:2 dimer (<10
sec).
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This work adds to a growing appreciation that cell signaling is markedly influenced
by the spatial organization of the plasma membrane, where lateral segregation in the 2D
environment influences interactions between signaling proteins and the propagation of
positive signaling or associated negative regulatory networks (Casaletto & McClatchey,
2012; Dehmelt & Bastiaens, 2010; Harding & Hancock, 2008). Our simulations predict
that ligand-bound erbB1 cycle rapidly through all possible receptor states, generating
pulses of signaling competent states. The potential for short-lived components to generate
robust, system-level output has been coined “digital signaling” (Harding & Hancock,
2008). We expect that the impact of membrane spatial organization will vary widely in
disease and normal settings, even for a single species of receptor such as erbB1.

For

example, we show here that cells expressing very high levels of erbB1 (typical of gene
amplification in certain cancers) are less dependent on domain co-confinement for
productive encounters than cells with modest levels of surface receptors. Cell-type
variable factors that could alter the stability of domains and extend receptor capture
events include lipid composition, the extent and dissociation kinetics of cortical
cytoskeletal connections with membrane anchors, and the lipid-protein ratio. Since lipid
remodeling, protein macromolecular assembly, and cytoskeletal rearrangements often
accompany signaling, the organization of the plasma membrane is subject to alterations
over important time and length scales. Highly diffusible products of signaling cascades,
such as reactive oxygen species proposed to inhibit phosphatases acting on erbB1 and
enhance lateral propagation (Reynolds et al, 2003), would not be subject to the same 2D
restrictions. Exploring the impact of the evolving 2D and 3D landscape through creative
imaging and mathematical approaches is a future challenge for the field.
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4.1

SUMMARY
The anomalous diffusion of membrane receptors has been linked to trapping in

transient confinement zones, which may be due to restrictions imposed by the cortical
cytoskeleton or by lipid- and protein-defined nanodomains. Single particle tracking (SPT)
experiments reveal subdiffusion properties, where the apparent diffusion constant
decreases with the observation time and reflects confinement at length scales below 500
nm. High resolution imaging of fixed receptors show a non-random distribution, with
clusters that range from a few to hundreds of receptors. It is unclear if these clusters are
synonymous with lipid rafts or protein islands, which have size estimates in the range of
20-100 nm. Also unknown are the relative exchange rates of receptors diffusing between
these clusters. Herein, we investigate SPT data from FcεRI receptors, performed at a rate
of 20 frames per second. While the time dependence of the mean square displacement
exhibits subdiffusion, the apparent diffusion constant derived from the distribution of
displacements over a fixed time duration increases with the jump distance. We show
through simulations that this feature can be the consequence of a combination of factors.
If the frame interval is comparable to the diffusion time scale through a confining
microdomain, free movement inside the domain is not directly observable. We were able
to closely reproduce the observed fixed duration distributions from Monte Carlo
simulations, performed in a landscape of small, confining domains of ≈100 nm diameter
that cover a few percent of the membrane area. These simulations also exhibit
subdiffusion. Simulations in a landscape of uniformly semi-permeable barriers but no
confining domains produced qualitatively different distributions.
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4.2

INTRODUCTION
In the original fluid mosaic model (Singer & Nicolson, 1972), membrane proteins

were assumed to move more or less freely along the membrane. As experimental methods
improved, it became clear that the plasma membrane has a complex structure with lipid
rafts (Edidin, 2001; Simons & Ikonen, 1997; van Meer & Simons, 1982), aggregations of
receptors and other membrane proteins (Lillemeier et al, 2006), and elements of the
cytoskeleton (Kusumi & Sako, 1996). Studies of the mobility (Axelrod et al, 1976; de
Keijzer et al, 2008; Feder et al, 1996; Low-Nam et al, 2011; Schütz et al, 1997) and
localization (Bobroff, 1986; Gelles et al, 1988; Ober et al, 2004; Schmidt et al, 1995) of
membrane receptors and other transmembrane proteins have been a continued source of
information on the rich structure of the cell membrane.
Studies based on single particle tracking (SPT) techniques have revealed deviations
from normal Brownian motion (Sako & Kusumi, 1994; Sako & Kusumi, 1995; Simson et
al, 1995; Simson et al, 1998), consistent with transient confinement in areas of
characteristic length in the range of 300-600 nm. These results give rise to the model of
hop-diffusion, where particles are embedded in a network of microdomains separated by
actin filaments and other elements of the cortical cytoskeleton; diffusion within a
microdomain is normal, but crossing between domains is partially restricted. This model
was further refined by theoretical and simulation studies of diffusion in the presence of
various types of obstacles, including trapping in corrals, as well as by non-specific
binding sites (Niehaus et al, 2008; Saxton, 1995; Saxton, 2008). In general, the predicted
behavior is subdiffusion, where the effective diffusion constant decreases as the
observation time or distance increase. Complementary to SPT methods that focus on a
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small number of molecules at high temporal resolution, protocols such as superresolution
and immunogold transmission electron microscopy provide “snap-shot” position data of a
large number of molecules of interest. These approaches (Lillemeier et al, 2006; Nagy,
2002; Veatch et al, 2012; Wilson et al, 2000; Wilson et al, 2001; Yang et al, 2007) have
revealed clustering of receptors in areas consistent with a structure of quasi-randomly
distributed microdomains that in total comprise a small fraction of the cell membrane.
Small clusters are observed even in the absence of ligand stimulation, with diameters in
the range of 20-100 nm. The connection between the proposed mechanisms underlying
subdiffusion and these smaller receptor clusters is not well understood.
Recent results using sophisticated imaging techniques indicate that most yeast
membrane proteins tend to segregate, self-organizing into separate domains (Spira et al,
2012). Proposed mechanisms for membrane protein clustering in higher eukaryotes relate
it to lipid rafts and/or a corral structure induced by the cytoskeleton. Cytoskeletoninduced corrals are consistent with larger (≈ 200 nm) domains and can preserve, but not
induce, local concentrations of specific proteins. A plausible mechanism for the
origination of protein clusters relies on vesicle trafficking of proteins newly delivered to
the membrane (Gheber & Edidin, 1999; Lavi et al, 2007; Lavi et al, 2012). On the other
hand, lipid rafts (Parton & Hancock, 2004; Rao & Mayor, 2005) have a complex
chemical structure and may attract specific membrane proteins. Lipid rafts have been
generally associated with “nanodomains” as small as 20 nm, which exhibit high mobility
(Brameshuber et al, 2010). The variety of membrane associated proteins and of the
observed spatial and temporal scales of clustering suggests that there are several, perhaps
overlapping mechanisms at work (Saikh & Edidin, 2006). One such mechanism is the
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transient confinement (Simson et al, 1998) of specific proteins by specialized
microdomains.
Recent SPT results with FcεRI (Andrews et al, 2008) as well as EGFR (Low-Nam et
al, 2011) demonstrate transient co-confinement of pairs of receptors, clearly
distinguishable from correlated motion due to dimerization. The concept of transiently
confining microdomains has been implemented in computer simulations of the movement
of membrane receptors. Simulations of diffusion in a landscape of small confining
microdomains (consistent with the locations of clusters derived from static TEM images)
successfully recapitulate the observed signal initiation kinetics (Hsieh et al, 2010; Hsieh
et al, 2008; Pryor et al, 2013). This prompted us to consider the impact of confining
domains on diffusion properties of receptors, and compare it with mobility statistics from
SPT experiments.
Here we seek a quantitative understanding of anomalous diffusion through
comparative results of simulations incorporating transiently-confining domains with
authentic SPT trajectories of quantum-dot (QD)-labeled FcεRI receptors. SPT data were
taken at intervals of 50 ms, in the absence of ligand stimulation (Figure 4.1). The time
dependence of mean square displacements is consistent with subdiffuson but the
distribution of displacements at fixed duration exhibits limited movement at short
distances and faster diffusion at longer distances, in apparent contradiction with the
confinement hypothesis. We show through numerical simulations that this is qualitatively
consistent with a structure of small, transiently confining domains in the range of 30-250
nm (comparable to the diffusion length corresponding to frame interval τ). The observed
distributions can be closely duplicated by model simulations.
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Non-Brownian displacements and attractive microdomains
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4.3

MATERIALS AND METHODS

4.3.1

Background

Molecules in a homogeneous environment typically execute a random walk, a
succession of discrete steps interspersed with random changes of direction and speed. A
point particle is said to execute Brownian motion in two dimensions (d = 2) if its
displacements (x, y) after time, t, are random and normally distributed, according to the
probability density function (PDF)
f ( x, y;t ) =

⎛ x 2 + y 2 ⎞
1
exp⎜ −
⎟ ,
4 πDt
⎝ 4Dt ⎠

(1)

where D is the (isotropic) diffusion constant. Eq. (1) implies two easily verifiable
€
properties regarding
the displacement r ≡ (x2 + y2)1/2. First, the distribution P(r2) of square

displacements r2 after a fixed time t is exponential:
P(r 2 ) =

⎛ r 2 ⎞
1
⎜⎜ − 2 ⎟⎟ ,
exp
2σxy2
⎝ 2σxy ⎠

(2)

where the standard deviation σxy of the displacement in either the x or y direction
€
satisfies σ2xy = 2Dt.
Second, the mean square displacement (MSD), defined as the

expectation of the square of the displacement vector, <r2> = <x2> + <y2>, is proportional
to the time (duration), t, over which the displacement takes place. The slope is
determined by the diffusion constant,
2
r 2 = 2σxy
(t) = 4Dt .

(3)

Single particle tracking experiments provide estimates of the coordinates (xk, yk) of
individual particles €
in a sequence of frames taken at some time interval τ. These can be
used to construct distributions of step sizes at fixed observation times (durations) Tobs,
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corresponding to integer multiples of the frame interval (Tobs = τ, 2τ, …), as well as to
derive the dependence of MSD values on the observation time.
SPT results often reveal anomalous diffusion that deviates from standard Brownian
motion. The presence of obstacles, either a network of barriers (Sako & Kusumi, 1994;
Saxton, 1995), or a set of trapping locations (Saxton, 2008), typically results in a
behavior that is consistent with unimpeded diffusion at time and spatial scales below that
of the obstacles, and slower diffusion at larger scales.

The classic signature is

subdiffusion, a sub-linear dependence (decreasing slope) of the mean square
displacement as a function of time.
Turning to distributions of step sizes over time intervals of a given length, obstacles
should result in faster movement over short distances, and limited (slower) movement
over long distances. This is to be expected if the characteristic size of the barriers B is
larger than the diffusion length, σ = 2 (DTobs)1/2, associated with the observation interval
Tobs (given by a frame rate). Traditionally, the σ < B condition is considered necessary
for the observation of confinement, requiring high-speed recording capabilities (Saxton,
2009). With moderate frame rates, the effect of confinement is readily identifiable, albeit
more subtle.
When comparing trajectories obtained from single particle tracking with model
simulations, one must take into account the sources of error due to the experimental
techniques used to obtain the trajectories. Step size distributions derived from imaging
are potentially impacted by a localization error (Pezzarossa et al, 2011; Saxton, 2009),
due to the uncertainty affecting the position measurements. The position analysis of
quantum-dot (QD) tracking data relies on fitting a curve to the intensity distribution
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recorded in several pixels, over the observation time. Position uncertainty adds a
normally distributed error to the true position. If this error is independent from the true
position, it will result in a normally distributed apparent displacement added to the true
distributions, and a constant added to the corresponding MSD. Another source of
uncertainty affecting positions is due to time averaging; the signal generated by the light
detected by each pixel is recorded continuously, and the intensities reported for each
frame are derived from the time-integrated signal over the entire frame interval. In our
analysis, we simulated the effect of localization uncertainty and time averaging on the
positions of particles (Figure A.4).
Fluorescent imaging techniques rely on the performance of the fluorescent tag
(fluorophore) used in the experiments. All fluorophores have a finite lifetime due to
photobleaching. Quantum dots provide superior performance in this respect, but are
subject to blinking, short, random intervals when they do not emit their characteristic
light; thus individual QDs cannot be detected in a subset of the images captured during an
experiment. The resulting tracks are fragmented, but can be reliably re-assembled if the
density of fluorophores is appropriately low (Smith et al, 2010). The fragmentation
results in an incomplete record of the positions of the respective particle; this is taken into
account when sampling the displacements at various numbers of multiple steps (Figure
A.3C).
4.3.2

Single Particle Tracking (SPT) Data and Analysis

4.3.2.1 Cell preparation, data acquisition, and tracking.
SPT experiments were performed on RBL-2H3 cells labeled with QD-IgE as
previously described (Andrews et al, 2008). In brief, QD-IgE binds to its high affinity
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receptor (FcεRI) expressed on the mast surface, permitting single molecule tracking. QDIgE is prepared by mixing biotinylated IgE with streptavidin QDs (Invitrogen) at a 1:1
ratio. Cells were primed with 100 pM of each color of QD-IgE (585 and 655 nm) for 10
minutes at 37 °C. QD-IgE primed cells were imaged using an Olympus IX71 with 436
nm excitation (mercury lamp with 436/10 nm band-pass) and emission collected through
a QuadView image splitter (Optical Insights) with 655/40 and 585/20 nm band-pass
filters for simultaneous imaging of 2 channels (Low-Nam et al, 2011). Imaging
temperature was maintained at 34-36 °C by an objective heater (Bioscience Tools). Data
was acquired at 20 fps (50 ms exposure time) for a total of 1000 frames. Singlemolecule localization and trajectory connections were performed as previously described
(Andrews et al, 2008; Low-Nam et al, 2011). Short tracks were elongated (concatenated
after particle identification) using the procedure described in (Low-Nam et al, 2011).
4.3.2.2 Step size distributions.
For each trajectory identified as described above, the X and Y coordinates were
recorded for every frame (time step) when an identification of the respective particle was
made. We collected x and y displacements for every integer multiple Tobs = NT·τ of the
frame interval τ = 50 ms from NT = 1 to at least NT = 200 by selecting pairs of
observations of the same particle separated by the respective number of time steps. To
ensure statistical independence, the pairs were selected so that the corresponding time
intervals for the same NT would never overlap, but could share endpoints, as illustrated in
Figure A.3C.
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4.3.3

Numerical Simulations

4.3.3.1 Brownian motion in the presence of barriers
Basic Brownian motion is simulated in a fixed time step algorithm that replicates the
mathematical definition. Given the position (Xk, Yk) of a particle after k iterations, the
displacements (x, y) are each selected from the distribution defined by Eq. (1) with t set
equal to tsim, the simulation time step. The position vector is then set to: (Xk+1 , Yk+1) =
(Xk + x, Yk + y). In the absence of obstacles or boundaries, this algorithm is exact.
In order to separate the observation and simulation time scales, and to avoid
discretization artifacts in the diffusion process, the simulation time step tsim was set as a
fraction of the lesser of the observation time Tobs and the characteristic time tdiff = B2/D
for diffusion through the barrier spacing length unit B:
t sim

⎛ 2B 2
⎞
τ min
=
;τ min ≡ min⎜
,Tobs ⎟ ,
N steps
⎝ D
⎠

(4)

with Nsteps ≥ 100. The step distributions had a weak dependence on the simulation time
€ step, but stabilized when tsim << τmin. We verified that our results were essentially

unchanged upon decreasing the simulation time step by up to three orders of magnitude
(Figure A.4).
Similarly to (Niehaus et al, 2008; Saxton, 1995; Wieser et al, 2007) and others, semipermeable barriers are implemented as line segments with no thickness. Barriers are
characterized by a dimensionless permeability or crossing probability, pcross ≤ 1. When,
during a simulation update, the next position of a particle would result in crossing a
barrier, the move is accepted with probability pcross and is rejected otherwise (Figure
A.4A). If the move is rejected, the position of the respective particle stays the same. In a
departure from similar work in the literature (Heinemann et al, 2013; Saxton, 2007;
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Wieser et al, 2007), we let the same barrier have different permeabilities for crossing in
one or the other direction. Barriers with 100% permeability are equivalent to free
movement. We use asymmetric barriers to model confining domains; crossing into the
domain is allowed with permeability 1, but exit from the domain has pcross ≈ 1 − 5 %.
4.3.3.2 Corrals and confining domains
In all the simulations presented here, the barriers form a rectangular network, with
sets of barriers parallel to each axis, as illustrated in Figure A.4B. The network is defined
by two sequences of barrier coordinates, {X1B, …, XBNB} and {Y1B, …, YBNB}, each
arranged in increasing order. The simulation area is thus partitioned into rectangles Rjk =
[XjB, Xj+1B] × [YkB, Yk+1B], which represent our domains. The rectangular geometry
allows for an implementation of the Brownian simulation at a moderate computational
cost. The simulation area is subject to periodic boundary conditions.
We used the assignment pattern of barrier permeabilities to emulate two types of
membrane landscapes. In the corral configuration (Figure 4.2A, inset), boundaries are
uniformly semi-permeable and each of the N2B domains represents a corral separated
from its neighbors by such boundary segments. In the confining domain configuration
(Figure 4.2B, inset), only a subset of the rectangles (one in a patch of N2B) has semipermeable boundaries. The boundaries of a confining domain are semi-permeable (pcross =
1−5%) for particles exiting the domain, and are fully permeable (pcross = 100%) for
particles entering; all other boundary segments are turned off (set to full permeability,
thus not interfering with particle motion).
The barrier coordinates are specified in terms of an intrinsic distance unit B. In
simulations with uniform barrier spacing (Figure 4.2AB), the barriers were located at
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multiples of B: XB = YB = {0, B, 2B, 3B, …}. To avoid spurious effects due to
periodicity, we introduced non-uniform barrier spacing selected from a normal
distribution centered on the average spacing.
The geometry of the simulations discussed in Figure 4.4 is depicted in Figure 4.2C.
The basic patch of 10B ×10B is divided into 4 × 4 = 16 domains (thus ∆XB ≈ ∆YB ≈
2.5B) , using the following barrier coordinates: XB ≡ {0, 2.70, 6.56, 7.01, 10.00} × B; YB
≡ {0, 3.16, 4.50, 6.81, 10.00} × B. This primary pattern of barriers was repeated once in
each direction, for a total simulation area of 20B × 20B with 64 domains. In each instance
of the elementary pattern, one the 16 boxes (initially chosen at random but kept the same
throughout the different simulations) was confining. The full 20 × 20 area was subject to
periodic boundary conditions.
All our simulations and analysis were implemented in Matlab. In a typical simulation,
we used 104 particles and a total simulation time to 103 times the characteristic time τmin
defined in Eq. (4). For corral simulations, particles were initially distributed uniformly in
the simulation area. The initial states for confining domain simulations had a
proportionally higher fraction of the particles distributed uniformly inside the confining
domains.
4.3.3.3 Units, scales, conversions
The simulations are performed using intrinsic (or simulation) time and length units,
with a diffusion constant of D(sim) = 100 and barrier spacing length scale B(sim) = 1.
Individual simulation runs are characterized by the configuration type, barrier geometry
(XB, YB), permeability pcross, simulation time step tsim, and the observation time Tobs. The

97

dimensionless ratio between the barrier spacing length scale B and the diffusion length
corresponding to the observation time,
1/ 2

σrel =

€

2( D⋅ Tobs )

(5)

B

is independent of the units, hence it also corresponds to the ratio of the physical
diffusion length and barrier spacing scale (or domain size parameter), B(phys). In
simulation units (where B = 1), σrel coincides with the diffusion length.
Conversion to physical units requires setting the time and length conversion factors,
defined as follows:

t ( phys) = α T ⋅ t ( sim ) ;x ( phys) = α L ⋅ x ( sim )

(6)

The time conversion factor is determined from the requirement that the observation

€ time in the simulation correspond to the physical one:
( sim )
Tobs = α T Tobs
→ αT =

Tobs
( sim )
Tobs

(7)

In principle, the length conversion factor could be determined using a known physical
€ distance, for example by setting the barrier spacing scale B based on the typical linear

size of a microdomain. A more practical option is to use the apparent diffusion constant,
defined by the slope of the mean square displacement versus time plot,
2
1 ⎛ d r
( phys)
Deff ≈ ⎜⎜
4 ⎝ dt

⎞( phys) α 2 ⎛ d r 2
⎟⎟
= L ⋅ ⎜⎜
4 α T ⎝ dt
⎠

( phys)
⎞( sim ) α 2
α T Deff
( sim )
L
⎟⎟
=
⋅D
→α L =
( sim )
α T eff
Deff
⎠

€
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(8)

4.4

RESULTS

4.4.1

SPT tracking confirms FcεRI motion is non-Brownian, with two distinct
anomalous features

We analyzed a dataset of 1685 traces reconstructed from high resolution imaging of
quantum dots conjugated to IgE (QD-IgE), which attach to FcεRI receptors on
unstimulated RBL cells. The data was collected in three experiments that resulted in sets
of 686, 319, and 653 trajectories respectively. Each set contains 7 recordings (or movies)
of 1000 frames each; each movie resulted in a number of trajectories obtained
simultaneously, in the same image field of a biological sample. The images were taken at
an interval of τ = 50 ms, corresponding to a frame rate of 20 fps. While the general
aspects of the trajectories are those of a random walk (Figure A.3A), the step size
distributions (Figure 4.1) deviate from standard Brownian behavior.
We analyzed the displacements of the particles over a range of 1 to 200 consecutive
time steps, corresponding to observation times from Tobs = 50 ms to 10 s. The mean
square displacement (MSD) increases with Tobs (Figure 4.1A); the slope initially
decreases, then stabilizes at Tobs ≥ 1 s. The expected dependence for Brownian motion
(Eq.3) is linear, <r2> = 4D·Tobs. A diminishing slope corresponds to an effective diffusion
coefficient that decreases with the observation time, from an initial value of D’eff = 0.058
µm2/s to an average of D’eff = 0.033 µm2/s. This non-Brownian behavior is generally
associated with reduced mobility or confinement at larger distances.
Distributions of individual displacements corresponding to a fixed duration Tobs do
not immediately support this interpretation. Compared to a normal distribution with the
same variance, individual displacements have an excess of short and very long values
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(Figure 4.1B). The deviation is more clearly illustrated by the distribution of the
individual square displacements (ISD). For Brownian particles, the ISD distribution is
exponential, Eq. (2); therefore plots of log P(r2) should be linear, with slope −1/(4D·Tobs).
Experimentally (Figure 4.1C) the log-ISD distribution displays an upward curvature. This
may be interpreted as an effective diffusion constant that gradually increases with
distance, in apparent contradiction with the MSD time dependence described above.
Sub-linear time dependence of the MSD of membrane bound molecules typically
reflects the presence of obstacles that limit their random movement. Corrals resulting
from elements of the cytoskeleton (Niehaus et al, 2008; Sako & Kusumi, 1994; Saxton,
1995), small confining domains consistent with lipid rafts (Simson et al, 1998), or
localized trapping sites (Saxton, 2007) may all limit movement at larger distances,
resulting in relatively higher mobility at short distances. The reduced short distance
mobility seen in the ISD distributions is puzzling; a possible explanation is that the
observation time Tobs is too large compared to the typical time it takes the particles to
cross an obstacle (Kusumi et al, 2005a); but then subdiffusion should also be missed by
the MSD time dependence.
4.4.2

The anomalous features of experimental ISD distributions are reproduced by
Brownian simulations in a landscape of attractive domains, but not in a
landscape of corrals

In order to understand the observed behavior, we performed simulations of twodimensional Brownian motion in the presence of semi-permeable barriers. Particle
movement was simulated using a fixed time step Brownian motion algorithm with
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periodic boundary conditions; barriers allowed or blocked individual crossing attempts by
particles in a probabilistic fashion, based on a pre-defined permeability, pcross ≤ 1.
We used two types of barrier configurations, corrals and confining domains. Corrals
(Figure 4.2A, inset) represent a cytoskeleton induced partition of the membrane into
domains that have similar physico-chemical properties; in our simulations they are
separated by boundaries of uniform permeability pcross, that does not vary between
domains or with the direction of particles crossing it. Confining domains (Figure 4.2B,
inset) represent lipid rafts that have an affinity for the membrane proteins of interest.
Simulated confining domain cover a few percent of the membrane surface; their
boundaries are fully permeable to particles entering and have permeability pcross ≈ 1 −
5% to particles exiting the domain.
First, we performed simulations in a corral landscape, with barriers evenly spaced at
distance B = 1. Keeping the same permeability, we varied the observation time Tobs so
that the corresponding diffusion length σ = 2(DTobs)1/2 probed a range of values around
B. All resulting log-ISD distributions (Figure 4.2A) exhibit the expected signature of
confinement, in that the apparent diffusion coefficient decreases as r2 increases toward
the barrier spacing B2 = 1. However, the apparent diffusion constant increases again at r2
> B2 and the alternating pattern is repeated around r2 ≈ 4B2. Also as expected, the
confinement signature weakens as Tobs increases. For σ values above B, the slowdown at
r2 ≈ B2 is increasingly overshadowed by the higher mobility regime B2 < r2 < 4B2, and by
the second reduced mobility interval at r2 ≈ 4B2. In summary, the log-ISD distributions
generated in the corral configuration could explain the absence of higher mobility at low

101

distances, but none of them exhibited the upward curvature in Figure 4.1C, consistent
with higher mobility at larger distances.
This prompted us to consider the confining-domain configuration. The log-ISD
distributions in Figure 4.2B were generated using the same algorithm, with permeability
and Tobs values as the set in Figure 4.2A, but with a single, square shaped attractive
domain of size B2 in the simulation area. Distributions with longer Tobs (such that σ > B)
have consistently increased mobility for r2 > B2. The signature of confinement is also
present, with a noticeable but transient decrease in mobility for r2 ≤ B2. For smaller σ
values, both features are less pronounced; still, the large distance mobility (or effective
diffusion coefficient) is higher than for the corresponding distributions for corrals.
The network of barriers constituted a uniform periodic grid in the corral simulations
of Figure 4.2A, and the attractive domain used for Figure 4.2B was a unit square. To
eliminate possible artifacts due to the regular geometry, we repeated the simulations in
landscapes where the barrier spacing were taken from a random distribution, centered on
the same average spacing of B = 1; in the corresponding attractive-domain simulations,
the attractive domain was one of the rectangles from the corral geometry. We used the
same permeability of 1% in the two types of geometries. The resulting ISD distributions
(Figure 4.3A-D) are smoother, without pronounced slope variations at r2 = B2 and 4B2.
They confirm that the corral geometry does not result in consistently increased long
distance mobility, while the attractive-domain geometry always does. In both types of
simulation, the MSD versus observation time curve had a decreasing slope. For small
Tobs, the effective diffusion constant (Figure 4.3F) starts close to the value (D0 = 100
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sim.units) corresponding to pure Brownian motion, decreases, then remains constant for
Tobs > 0.01.
4.4.3

Experimental displacement statistics are closely approximated by
simulations in a landscape of partially confining domains 30-250 nm in
diameter

Next, we wanted to see whether the observed ISD and MSD distributions can be
approximated by Brownian motion in the presence of a system of barriers. To avoid the
artifacts of a periodic barrier structure, we defined a network of unevenly spaced,
rectangular barriers (Figure 4.2C).
Compared to the SPT data, simulations in this geometry using the corral
configuration (uniformly semi-permeable barriers) exhibited weaker deviations from the
ideal Brownian behavior. We obtained a consistently better match to the data with
simulations using the attractive-domain configuration, where only a subset of the
rectangular compartments were surrounded by barriers, which only impeded exit from the
respective domains. We performed simulations with a range of permeability and diffusion
length values, in order to match as closely as possible the experimental distributions from
one of the three data sets. Direct comparison with the experimental results for the fixed
time step distributions reveals a strong qualitative similarity, as illustrated in Figure 4.4A
and C. The simulations shown in Figure 4.4 were obtained using a permeability of pcross =
5% and σ = 2B . The barrier coordinates are XB ≡ {0, 2.70, 6.56, 7.01, 10.00} × B and
YB ≡ {0, 3.16, 4.50, 6.81, 10.00} × B, resulting in ratios of σ/∆X and σ/∆Y in the range

€of (0.44 … 3.14).
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The simulation results were converted to physical units by identifying the observation
time with 50 ms and setting the length scale so that the long-term slope of the MSD
versus time curve (Figure 4.4B) matched the experimental slope of 0.132 µm2/s (effective
diffusion constant of Deff = 0.033 µm2/s). This corresponds to B = 77.2 nm, giving barrier
sizes of ∆X = {208, 298, 35, 231} nm, ∆Y = {244, 103, 178, 246} nm. The highlighted
values correspond to attractive domains (Figure 4.2C), whose diameters thus ranged from
35 to 246 nm.
There are discrepancies between the simulated and experimental statistics. Simulated
ISD distributions at longer observation time over-estimate the number of small steps.
While the simulated MSD distribution (Figure 4.4B) does exhibit sub-diffusion, the
initial slope of the experimental curve (D’eff = 0.058 µm2/s) is not matched by the
simulation. It is interesting to note that the microscopic diffusion constant used in the
simulation (D0 = 0.059 µm2/s) is very close to this value, but results in a smaller vertical
offset.
4.5

DISCUSSION
The particle tracking data discussed here exhibits two types of deviations from

Brownian diffusion, sublinear dependence of the mean square displacement (MSD) on
the observation time, and slow apparent diffusion at short distances exhibited by
individual square displacements (ISD) at fixed time. Subdiffusion has long been
recognized as a likely consequence of obstacles to free movement, such as a network of
domains separated by semi-permeable barriers (Kusumi et al, 2005b; Saxton, 1995), or
transient trapping (Saxton, 2008). The peculiar features of ISD distributions have been
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noted previously, most recently in a careful statistical analysis of FcεRI mobility data
(Espinoza et al, 2012).
The present analysis provides a plausible explanation of both features, based on the
hypothesis of a collection of small, partially confining domains that occupy a fraction of
the membrane area. We propose a model of anomalous diffusion that reconciles the
original hop-diffusion model (Kusumi et al, 2005b) with the inhomogeneous, frequently
clustered distribution of receptors (Lillemeier et al, 2006).
In the original hop-diffusion model, the membrane is divided (partitioned) into
microdomains, mostly by elements of the cytoskeleton that act as semi-permeable
barriers to the movement of receptors. Receptors perform Brownian motion with
diffusion coefficient D0 within microdomains, but their movement between domains is
limited, except for rare “hop” events. As a result, free diffusion is limited by the typical
domain size B. It should be observable in SPT experiments with a high enough frame rate
(so that Tobs << B2/4D0). Displacements over distances r > B are unlikely, and the mean
displacements over time scales that exceed B2/4D0 are bounded or increase consistently
with a smaller, effective diffusion constant Deff < D0. By the same logic, individual
square displacement (ISD) distributions should exhibit decreasing mobility for distances
exceeding the diffusion length σ = (4D0Tobs)1/2. We found that this picture was consistent
with the experimentally derived MSD curves (Figure 4.1A), but not with the individual
square displacement (ISD) distributions, which exhibited increased mobility at higher
distances.
The experimental ISD distributions (Figure 4.1C and Figure 4.4C) are likely affected
by the relatively long observation time (50 ms), which corresponds to a diffusion length
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of ≈ 100 nm. To better understand the implications of the hop-diffusion model, we
performed simulations of diffusion in a network of domains (corrals) separated by semipermeable barriers. The resulting ISD distributions exhibited decreasing mobility only for
shorter observation times, indicating a more complex behavior than described above.
However, they did not reproduce the monotonically increasing mobility observed
experimentally. By contrast, this feature was clearly matched by simulations where all
boundaries were fully permeable, except for only one of the domains, which had semipermeable boundaries in the outgoing direction (Figure 4.2). This led us to formulate a
modified version of hop diffusion.
In our proposed model, the microdomains of interest are small, and occupy in
aggregate only a fraction of the membrane area; they are partially confining, in that their
boundaries are more easily crossed inbound than outbound. By contrast, the rest of the
membrane is non-confining and allows high[er] mobility. This model has been implicitly
used in (Hsieh et al, 2010; Hsieh et al, 2008; Pryor et al, 2013), in Monte Carlo
simulations of signal initiation; however, to our knowledge, it has not been rigorously
evaluated for faithful reproduction of receptor mobility characteristics.
The confining domain hypothesis can explain both of the non-Brownian features
observed experimentally. Receptors will spend most of their time in a confining domain;
rare “hop” events will place a receptor in the open area where it can diffuse quickly until
it is trapped by another confining domain. The distribution of individual square
displacements (at fixed observation time) results from the overlap of two populations,
confined particles with limited movement and escaped particles that diffuse quickly. The
former dominate short displacements and the latter dominate long displacements, hence
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the steep slope (low mobility) at short distances and lower slope (high mobility) at large
distances. Simulations also reproduce the sublinear dependence of the mean square
displacement. We performed simulations in a landscape of rectangular shaped domains as
described above, in a variety of geometries and mobilities, and were able to obtain a good
match to the experimental distributions (Figure 4.4) over a range of observation times.
Similarly to the original hop-diffusion model, unimpeded Brownian behavior is
recovered in our model at short observation times (equivalent to a high frame rate). The
upward curved shape of the logarithmic individual squared displacement (ISD)
distributions and the decreasing slope in the MSD time dependence are robust features of
the model; however, the precise shape of both sets of curves is sensitive to the geometry
of the barriers, especially to the size and diameter of the attractive domains. Thus, it is
very likely that closer matching simulations can be obtained by using varying sizes for
the domain barriers, a combination of permeabilities, and irregular shaped domains. This
effort should be guided by a theoretically motivated procedure to extract the
characteristic parameters from the experimental results.
4.6

NOTES
This work was submitted to Biophysical Journal to be reviewed for publication on

March 25th, 2014.
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5.1

ABSTRACT
Members of the erbB family of receptor tyrosine kinases are capable of both homo-

and hetero-interactions. Because each receptor has a unique set of binding sites for
downstream signaling partners and differential catalytic activity, subtle shifts in their
combinatorial interplay may have a large impact on signaling outcomes. Overexpression
and mutation of erbB family members are common in numerous human cancers and alter
the balance of activation within the signaling network. Here we report the development of
a spatial stochastic model that addresses the impact of varying ligand concentrations and
erbB2-erbB3 ratios on erbB3 homo and hetero-interaction dynamics and phosphorylation
state. We also report experimental and computational analysis of an erbB3 gain-offunction mutant, located in the C-lobe asymmetric dimerization interface, which shows
enhanced phosphorylation at low ligand dose associated with increased kinase activity.
5.2

INTRODUCTION
The ErbB family of receptor tyrosine kinases consists of four related receptors that

form both homo- and heterodimers (Lemmon & Schlessinger, 2010), as well as
potentially higher-order oligomers (Kozer et al, 2013). This work focuses on the unusual
properties of erbB3, that are markedly dependent upon engagement with a
heterodimerizing partner for its transphosphorylation and upregulation of its inherently
weak catalytic activity (Shi et al, 2010; Steinkamp et al, 2014). Previous studies have
suggested that erbB3 favors erbB2 over other erbB family members for
heterodimerization (Zhang et al, 2009) and erbB2/erbB3 interactions are important in
both normal developmental processes (Yarden & Sliwkowski, 2001), as well as cancer
initiation and progression (Liu et al, 2007; Vaught et al, 2012). Although erbB3 and
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erbB4 share heregulin/neuregulin 1 as a ligand (HRG/NRG1) and can form heterodimers
(Monsey et al, 2010), it is only the erbB3/erbB2 complex that is implicated in melanoma
growth and survival (Zhang et al, 2013). ErbB3 expression has been linked to resistance
of tumors to tyrosine kinase inhibitor therapies (Huang et al, 2012; Lee et al, 2014; Sato
et al, 2013; Sergina et al, 2007), motivating more comprehensive analyses of erbB3
dynamics and signaling capabilities.
Mathematical modeling has emerged as a powerful method to explore the
complexity of erbB family signaling (Andrews & Bray, 2004; Blinov et al, 2006;
Kholodenko et al, 2010; Kleiman et al, 2011; Radhakrishnan, 2010; Zhang et al, 2009),
particularly when supported by high quality, quantitative measurements at different time
and length scales (Pryor et al, 2013; Shankaran et al, 2013). Most prior computational
studies have neglected erbB3 as a significant catalytic entity. A notable exception is the
work of Telesco et al. (2011), who suggested that even the minimal level of basal erbB3
autophosphorylation could alter the dynamics of erbB signaling pathways and contribute
to drug resistance. Recently, we demonstrated that tyrosine kinase activity is significant
in immuno-isolated, intact erbB3 after binding heregulin (HRG), providing that erbB2 is
co-expressed (Steinkamp et al, 2014). High resolution imaging methods, such as single
particle tracking (SPT), captured erbB3-erbB3 and erbB3-erbB2 interactions in real time
and revealed that ligand-bound erbB3 engaged in homointeractions that were 3-4x more
stable than when bound to erbB2 (Steinkamp et al, 2014). These observations raised the
intriguing questions: Under what conditions might erbB3’s catalytic activity be
important? And, further, what is the potential impact of spatial organization and serial
engagements of both homo- and heterodimer configurations upon signaling?
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We approach these questions through a stimulation platform designed to reflect
characteristics of the membrane landscape, that underlie the anomalous diffusion
characteristics of erbB receptors (Low-Nam et al, 2011; Steinkamp et al, 2014) as well as
the random nature of receptor encounters in the 2D fluidic membrane. Recently applied
to the study of erbB1/EGFR homodimerization (Pryor et al, 2013), our spatial stochastic
simulation method incorporates a Rule-Based approach that explicitly considers
important structural features that control erbB signaling. These features include the
stable upright configuration of the extracellular domain of erbB2 or ligand-bound erbB3,
rendering them dimerization competent throughout the simulation. In contrast, the
unstable flux of resting erbB3 from the bent state to a dimerization-capable state is
represented by a probability term; at each microsecond time step in the simulation only
1% of resting erbB3 receptors are upright and available to dimerize. The model also
assumes that the asymmetrical orientation of kinase domains in each dimer is a random
process, such that each monomer in the pair is assigned as a receiver or an activator
respectively. This simulation strategy sets up a scenario where individual receptor
monomers swap their status as a receiver or activator exclusively through a stochastic
process of dissociation and rebinding. During these encounters, the model tracks the
phosphorylation state of each receptor monomer, adding an experimentally estimated
multiplier for increased catalytic activity so long as the monomer remains
phosphorylated. The simulation is governed by experimentally-defined rate constants for
phosphorylation, dephosphorylation, and dimer dissociation. ErbB receptors cycle
through many encounters during these simulations, revealing properties that drive signal
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propagation and pointing to important influences such as the relative ratios of each
receptor species, density, and dwell times.
A novel addition to the model is the use of single particle tracking data to estimate the
size of membrane domains (“confinement zones”) (Simson et al, 1995) that transiently
trap erbB2 and erbB3, incorporating previously described overlap of these domains
(Hsieh et al, 2008) with their respective dwell times. These factors translate in the model
to probabilities for escape from confinement. Finally, we utilize the model to analyze
experimental data collected in cells expressing a novel gain-of-function mutation in
erbB3. Located within the C-lobe of the erbB3 kinase domain, the E933Q mutation was
initially discovered by us as a heterozygous mutation in the SKBR3 breast cancer cell
line. We show that erbB3E933Q expressed in CHO cells is more readily phosphorylated at
low ligand dose than wildtype erbB3 (erbB3WT), with accompanying higher catalytic
activity. Since SPT data showed that the gain-of-function status was not linked to longer
homodimer lifetimes for erbB3E933Q compared to erbB3WT and ligand binding was
unaltered, the model was utilized to provide an estimate of the mutant’s increased
catalytic activity. This work sets the stage for mechanistic profiling of the entire spectrum
of erbB3 oncogenic mutations (Jaiswal et al, 2013), which are distributed across both the
extracellular and kinase domains and may each have unique contributions to dimer
stability or kinase activity.
5.3
5.3.1

RESULTS
ErbB3 dephosphorylation shows a lag after acute inhibition of erbB2
catalytic activity
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Ligand-dependent erbB3 phosphorylation requires erbB2, since it can be abrogated
by pretreatment with pertuzumab or lapatinib (Steinkamp et al, 2014; Zhang et al, 2009).
However, it is not known whether erbB2 activity is also required to maintain erbB3
phosphorylation after stimulation has upregulated erbB3 activity. Figure 5.1AB shows
results obtained in CHO cells expressing HA-tagged erbB2 (erbBHA) and GFP-tagged
erbB3 (erbBGFP). Cells were serum starved and stimulated for short duration with 12 nM
heregulin β (HRG), followed by treatment with lapatinib to acutely inhibit erbB2 kinase
activity. Lysates were collected at defined time intervals after adding lapatinib and
western blots were probed with phospho-specific antibodies against erbB3 tyrosine 1280
(PY1289) or erbB2 tyrosine 1248 (PY1248) to measure receptor dephosphorylation over
time. Results show that HRG stimulation alone led to elevated levels of PY1289 on
erbB3, which were maintained for up to 30 minutes after stimulation (Figure 5.1A). The
plot in Figure 5.1B (blue line) shows that addition of 10 µM lapatinib caused rapid
dephosphorylation of erbB2 PY1248 with a half-life (t ½) of ~14 seconds, comparable to
reported values (Kleiman et al, 2011). The drop in erbB3 phosphorylation at PY1289
demonstrated a lag, with a half-life of ~3.5 minutes (orange line, Figure 5.1B).
A potential explanation for this lag is that erbB3 phosphorylation is sustained for
short periods after erbB2 shutdown through its own improved autophosphorylation
capacity. To evaluate this, we developed a Rule-based non-spatial model using
BioNetGen (Faeder et al, 2009), that incorporated erbB3/erbB2 heterodimer and
erbB3/erbB3 homodimer lifetimes determined by SPT (Steinkamp et al, 2014) and equal
expression levels of both receptors, with 50% ligand bound erbB3. These and other
parameters for our dimerization models are listed in Table 4, along with sources for each
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ErbB2. ErbB2. ErbB3. ErbB3EQ.
Species
ErbB2
ErbB3 ErbB3-EQ ErbB2 ErbB3 ErbB3 ErbB3EQ
Diffusion
Coefficient
[um^2/s]1,2
0.0272
0.0310
0.0621
0.0150 0.0150 0.0185
0.0139
Dimer On Rate
[um^3/s]3
0.0034 0.0034 0.0034
0.0034
No-Ligand Dimer
Off Rate [1/s]1,2
0.4360 0.4360 0.4360
0.436
Phosphorylation
0.0730 0.00008
Rate [1/s]4,5
Dephos. Rate
[1/s]1
0.0725
0.0725
0.0064
Phosphorylation
Multiplier
[Unitless]1
2
0.53
varied
Ligand Dimer
Off Multiplier
[Unitless]1
0.9358
0.3
0.30
Phos Diffusion
Multiplier
[Unitless]1
1
0.31
0.15
0.48
Table 4: Parameters for ErbB2/3 and erbB2/ErbB3E933Q simulations. 1 – Experimental data in this
paper, 2 – Steinkamp et al (2014), 3 – Shankaran et al. (2013), 4 – Kleiman et al (2011), 5 – Shi et al.
(2010)
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Figure 5.1: ErbB3 kinase activity and dephosphorylation (A) CHO cells expressing exogenous HAerbB2 and erbB3 were stimulated with 12 nM HRG for 2 minutes at 37oC and then treated with the
erbB2 kinase inhibitor, lapatinib. ErbB3 phosphorylated at Y1289 or erbB2 phosphorylated at
Y1248 were detected using phospho-specific antibodies. Levels of phospho-receptors were
normalized to the total receptor levels. (B) The normalized phosphorylation levels for erbB2 and
erbB3 were plotted over time. Phosphorylation levels of both receptors were set to 1 for the two
minute time point (maximum HRG stimulation). Points were fit to a one-phase exponential decay
curve to determine the dephosphorylation half-life (C) Western blot of immunoprecipitated erbB2 or
erbB3 from CHO cells expressing ErbB2-mYFP (left two lanes) or ErbB3-mCitrine (right two lanes).
The kinase activity of immunoprecipitated samples was then normalized to the levels of phosphoreceptor. Comparison of the relative kinase activity of erbB2 and erbB3 +/- HRG after
normalization. ErbB2 kinase levels were set to 1. Data shown is the average of two independent trials
+/- STDEV. (D) Phosphorylation reactions. Our model allows phosphorylation to occur between all
dimer types. The phosphorylation rate (or kinase activity) is varied based on the dimer type.
Unphosphorylated ErbB33 homodimers have an extremely low phosphorylation rate (Lemmon),
while phosphorylated ErbB22 homodimers have a high phosphorylation rate (Steinkamp). We
employ the phosphorylation shuffle mechanism used in Pryor et al. (2013). (E) Results from the
BioNetGen model predicting a similar erbB3 dephosphorylation curve when erbB3 kinase remains
active after lapatinib treatment.
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value. In the simulation, phosphatase activity against both erbB2 and erbB3 were
equivalent. Kinase activity for each monomer is governed by a set of rules, including
dimerization competency based on ligand occupancy (for erbB3). ErbB2 kinase activity
was based upon published estimates for the basal rate (Kleiman et al, 2011), adjusted by a
multiplier when phosphorylated (Shankaran et al, 2006). To estimate a corresponding
multiplier value for erbB3, we compared catalytic activity in erbB2 immune complexes
versus erbB3 immunoisolated from resting or HRG-stimulated cells (Figure 5.1C); results
were normalized for loading based upon immunolabeling with the commercial panreactive anti-phosphotyrosine antibody, PY20. In the simulation, lapatinib addition
converted erbB2 kinase activity immediately to zero. ErbB3 kinase activity is insensitive
to lapatinib (Shi et al, 2010). Therefore, in the simulation, erbB3 kinase activity is set at
its multiplier of 0.56 of the phosphorylated erbB2 receptor phosphorylation rate, as long
as erbB3 remains phosphorylated.
Figure 5.1D illustrates some of the possible dimer configurations that occur in the
simulation, to include homodimers of erbB2 (red-red), erbB3 (blue-blue) and erbB3erbB2 heterodimers (red-blue). During the simulation, there is a random assignment of
the orientation of their cytoplasmic tails such that only one monomer is upregulated
through contact of its N-lobe with the C-lobe of the activator. In this cartoon, ligand
bound to erbB3 is represented by orange ovals while phosphorylation is indicated by
colored features in the cytoplasmic tails. The arrows for each reaction depicted scale
according to the phosphorylation rate associated with the dimer state of the specific
reaction. Results of the simulation (Figure 5.1E) match well with the experimental
results: erbB2 phosphorylation drops off rapidly while erbB3 phosphorylation declines
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slower due to encounters between erbB3 monomers that have been phosphorylated
(primarily by erbB2) in a prior binding event.
5.3.2

Single particle tracking of erbB3 and erbB2 diffusion indicates that receptors
transiently reside in partially overlapping confinement zones

Our spatial stochastic model includes the capability to consider the impact of
membrane topography on diffusion-limited reactions between receptors. Our previous
models relied on “snap-shot” images of erbB receptor distributions on fixed cell
membranes, as observed by immuno-electron microscopy, to populate the 2D simulation
landscape with domains that transiently confined receptors. Our next goal was to expand
on this concept by using SPT data to estimate the area and shapes of confinement zones,
as well as to address the possibility that erbB3 and erbB2 receptors might exhibit
individual characteristics such as domain dwell time and distribution. For this portion of
the study, we used data sets acquired using 2-color quantum dot (QD) tracking on stably
transfected CHO cells, where erbB2HA was tracked with anti-HA-FAB-QD585 and erbB3
was tracked with HRG-conjugated QD655. An example of trajectories from a single
observation area is shown in Figure 5.2A, where three erbB2 and two erbB3 were tracked
simultaneously (defined by color coding in the legend to Figure 5.2A).
To analyze multiple datasets containing 2-color trajectories, we developed and
applied a Domain Reconstruction Algorithm (DRA). The DRA converts dynamic
trajectories to static spatial data that can be used to approximate the size and contours of
confinement zones occupied by erbB3 and erbB2 on the CHO cell membranes. The
algorithm is fully described in Chapter 2. In brief, SPT trajectory data is first sorted into
two groups that reflect either the confined or freely diffusing state. For each point, a
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Figure 5.2: (A) Sample of trajectories from SPT data showing overlap of ErbB2 and ErbB3
receptors. This is the initial data form before DRA analysis. (B) Compiled ranks for all the points
from the SPT data for ErbB2 and ErbB3. A bimodal distribution is apparent for both species. The
local minimum between the two modes was used to estimate the cutoff rank to group the points into
long and short points. Compilation of the ranks for SPT experiments where ErbB2 was tracked using
QD-585 and ErbB3 was tracked using QD-655. (C and D) Characteristic length study used to
determine the characteristic length for clustering. The average domain perimeter was calculated over
a range of characteristics lengths. The minimum of the average domain perimeter was used to
determine the optimal characteristic length. (C) is the characteristic length study for ErbB2 and (D)
is the characteristic length study for ErbB3. (E) Box plots of characteristic lengths calculated during
the characteristic length study for each SPT data file. ErbB2 characteristic length is compared to
ErbB3. Using the Kruskal-Wallis Nonparametric Test, the characteristic lengths for ErbB2 and
ErbB3 are statistically different, p value = 0.0000545. (F) Average total areas of domains and
explored membrane for ErbB2 and ErbB3. The explored membrane was calculated using the DRA
and setting the characteristic length to the localization error of the SPT experiments. While ErbB2
domains appear to be larger on average, ErbB3 receptors tend to explore more of the open
membrane. (G) Box plots of the ratio of domain area to explored membrane area for ErbB2 and
ErbB3. Using the Kruskal-Wallis Nonparametric Test to compare between ErbB2 and ErbB3, the
ratios are found to be statistically different, p value = 4.88e-10.
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ranking system is applied that compares the preceding and subsequent jump sizes in the
trajectories against one another. When these ranks are compiled and sorted into a
histogram, a bimodal distribution becomes apparent (Figure 5.2B). The local minimum of
the bimodal distribution is then used to determine a cutoff rank to separate the confined
points from the freely diffusing points. The analysis was applied to 25 SPT data sets to
generate the plots in Figure 5.2B. Results were comparable when applied to 13 SPT data
sets where the QD probes were reversed as an important control measure since there is a
slight difference in localization accuracy for the two classes of QDs (QD655 and QD585;
Figure A.6). Based upon these results, a cutoff score of 6.5 was utilized for further DRA
analyses.
An estimation of domain size was our next goal, incorporating a clustering algorithm
based on work by Espinoza et al. (2012) that assigns a reasonable length parameter as the
maximum distance between two points for them to be considered in the same cluster. The
average perimeter of all the clusters in a single file is computed over a range of clustering
characteristic lengths. This average perimeter is then compared across all the SPT
tracking files. Figure 5.2C and Figure 5.2D show the average perimeter of domains for
each characteristic length from the ErbB2 tracking data and ErbB3 tracking data,
respectively. We defined the average characteristic length of the clusters for each
receptor based on the local minimum in these plots. This local minimum corresponds to a
minimum of domain perimeters. “Inflating” the perimeter points in each cluster by onehalf the characteristic length creates the final confinement shape and area.
Based upon the DRA results, we are able to compare the membrane domain
characteristics for ErbB2 and for HRG-bound ErbB3. We used the Kruskal-Wallis
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nonparametric test, which does not assume any specific distribution type, only that the
data sets being compared come from the same distribution. We find that the characteristic
lengths for ErbB2 and ErbB3 domains are statistically different (p = 0.0000545). Box
plots of the two data sets are shown in Figure 5.2E, confirming that the characteristic
lengths for erbB2 and HRG-bound erbB3 clusters on CHO membranes are 57nm and
30nm, respectively. We note that cluster size and total domain area for these receptors
may vary in different cell types (Nagy et al, 2010; Yang et al, 2007).
The next important membrane characteristic to take into account is the density of
domains on the membrane. A hallmark of SPT experiments is the sparse labeling of
receptors to allow for single particle resolution. One method to compensate for this sparse
labeling is to estimate the total area of the membrane explored by labeled receptors from
a single SPT data file and compare it to the total domain area of the membrane from the
same SPT data file. To calculate the area of the membrane explored by a receptor, the
DRA was used to analyze the SPT data using a characteristic length equal to the average
localization error of the SPT experiment. Computing the ratio of Total Domain Area to
the Total Explored Membrane Area allows the sparse SPT domain reconstruction
information to be applied to the full cell membrane. As shown in Figure 5.2F,G, the ratio
of Total Domain Area to Total Explored Membrane Area can be computed for each SPT
data file for each receptor. This ratio can be compared between ErbB2 and ErbB3 to
determine whether both receptors explore the same membrane space. Using the KruskalWallis Nonparametric Test, we find that this ratio is also statistically different between
ErbB2 and ErbB3 (p = 4.88x10-10). The results of these two sets of tests suggest that
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motion of ErbB2 and ligand-bound ErbB3 is differentially constrained within the
membrane landscape.
5.3.3

The simulation landscape is studded with overlapping domains consistent
with experimental results.

Figure 5.3 shows the final simulation space created using the cumulative information
from the DRA analyses. The simulation space includes a defined number of ErbB2 and
ErbB3 receptors, as well the domain spaces in which they are transiently confined.
Density of receptors was determined by calculating the number of receptors per µm2 of
membrane surface in a CHO cell, reported to be 588 µm2 (Miyagi & Maruyama, 2010).
Given our estimates of ~500,000 of each receptor species in these stably transfected cells,
we derive a receptor density of ~850 copies of each receptor per 1 µm2 of membrane – or
a total of 1700 receptors/µm2. During the stochastic simulations, every receptor is
accounted for individually. This level of detail in simulations significantly increases the
computational costs when running simulations. To reduce the computing time, the
simulation space was converted to a total surface area of 0.1 µm2, equating to ~170 of
each type of receptor.
Note that while the domains are statistically different, analysis of the single particle
tracking data also revealed an overlap between the two types of domains. This result is
consistent with the findings from our prior immuno-electron microscopy study (Yang et
al, 2007). Next, the ratio of the Domain Area to Explored Membrane Area ratio was used
to determine the amount of domain cover for the desired surface area. The reconstruction
of these irregular domains is depicted by blue (erbB2) and orange (erbB3) contours in
Figure 5.3. During the simulations, receptor species exhibit no preference to enter their
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Figure 5.3: Reconstructed Simulation Space (A) Simulation Space Constructed based on the DRA
analysis. Domains from a SPT data file were used, and then domains from the same file were added
until the domain area to explored membrane area ratio was met. The receptor density was calculated
using the approximate number of receptors per cell and average surface area of a CHO cell, then
scaling to the simulation space area.
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respective domains but a penalty for escape is imposed such that at steady state receptors
occupy free and domain spaces according to the DRA cutoff score (65% in domains, 35%
unconstrained).
5.3.4

Receptors cycle repeatedly through heterodimer and homodimer reactions.

Results of spatial simulations are shown in Figure 5.4. In Figure 5.4A,B, the relative
ratios of erb2 and erbB3 were equal and 50% of the erbB3 were prebound to ligand at the
start for simplicity. By illustrating the dimer and phosphorylation events for a single
erbB2 monomer (Figure 5.4A) or HRG-bound erbB3 monomer (Figure 5.4B), the plots
illustrate the essential stochasticity of the system. The erbB2 in 4A spends time as a
monomer, as an erbB2-erbB2 homodimer and as an erbB2-erbB3 heterodimer, with the
phosphorylation state of each monomer in the pairs tracked throughout. Similarly, the
erbB3 receptor in 4B cycles through monomer, homodimer and heterodimer states. Due
to the more stable lifetime, erbB3 homodimers are a predominant feature.
Simulations were also performed varying the ratios of erbB2 to erbB3, as well as the
ligand dose. In Figure 5.4CD, a scenario of 20-fold excess erbB3 over erbB2 was
considered. Here, the representative plot of an erbB2 shows it to cycle predominantly
through heterodimer reactions, with short durations as an unphosphorylated monomer.
The plot of one of the erbB3 species in the simulation follows it through at least one
binding event with erbB2, leading to dual phosphorylation, followed by relatively stable
periods as a homodimer and short periods as a monomer. Finally, the plots in Figure
5.4E,F show results for the case of equal ratios of receptors but a lower ligand occupancy.

126

Figure 5.4: Receptor States over time. (A and B) State changes for ErbB2 and ligand bound ErbB3,
respectively, for simulations with equal amounts of ErbB2 and ErbB3, and 50% ligand bound ErbB3
present. (C and D) State changes for ErbB2 and unliganded ErbB3, respectively, for simulations with
1/20th the amount of ErbB2 to ErbB3, and 50% ligand bound ErbB3 present. (E and F) State changes
for ErbB2 and unliganded ErbB3, respectively, for simulations with equal amounts of ErbB2 and
ErbB3, and 15% ligand bound ErbB3 present.
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5.3.5

Steady state analysis of erbB phosphorylation reactions underscores the
dependency of erbB3 activation on erbB2 and a potentially significant role
for erbB3 kinase

Figure 5.5 presents summary data for a series of spatial stochastic simulations,
varying conditions such as receptor ratio and dose. The graphs report the total
phosphorylation state of each species and the kinase species responsible for the
transphosphorylation reactions. As shown in Figure 5.5A, when erbB3 is the only species
in the simulation (total 170), there is no phosphorylation. When the simulation
parameters are set to equal erbB3-erbB2 levels (total 340), measurable erbB3
phosphorylation results after encounters between erbB3 that “flux” to the upright position
and bind erbB2. The number of ErbB3 phosphorylation events at 15% and 50% ligand
occupancy are 40 and 45, respectively. At 100% ligand occupancy, the number of
phosphorylation events involving an ErbB3 receptor nearly doubles, to 77 events.
Results in Figure 5.5BC show the relative contributions of each receptor for
transphosphorylation of the same species (while in homodimers) or of the opposite
species (while in heterodimers) is a dose-dependent. For example, Figure 5.5B shows
erbB2 homointeractions drive most of the erbB2 and erbB3 phosphorylation events when
there are equal numbers of both receptors. By comparison, erbB3’s catalytic activity
mediates 10-24% of erbB2 phosphorylation events and less than 5% of the erbB3
phosphorylation events. Figure 5.5C reports results when erbB3 outnumber erbB2 20fold. Here erbB2 densities are low and erbB homodimerization/transphorylation events
are infrequent. However, erbB2’s phosphorylation of erbB3 is a critical step, since it
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governs the erbB3 activation step. ErbB3 receptors do not start phosphorylating other
receptors until they

Figure 5.5: Spatial Stochastic Simulation Results. (A) ErbB3 phosphorylation events. When ErbB2 is
not present, ErbB3 receptors fail to phosphorylate other ErbB3 receptors. As the amount of liganded
ErbB3 increases, the number of ErbB3 phosphorylation events also increases. (B and C)
Phosphorylation events by activator species for varying amounts of liganded ErbB3. (B) Equal
amounts of ErbB2 and ErbB3. Each bar in a group represents a ligand percentage for ErbB3, 0%,
15%, 50%, and 100% respectively. The majority of ErbB3 phosphorylation comes from ErbB2.
ErbB3 receptors only phosphorylate other receptors once phosphorylated themselves. (C) Low
amount of ErbB2 receptor (5%) compared to ErbB3 receptors. Each bar in a group represents a
ligand percentage for ErbB3, 0%, 50%, and 100% respectively. Majority of ErbB3 phosphorylation
still comes form ErbB2, however there is higher activity in ErbB3 homodimers.
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have been phosphorylated first. Activated erbB3 is responsible for the large majority of
phosphorylation events where there is 0 or 50% ligand occupancy. Note that, at 100%
ligand occupancy, erbB3-erbB3 transphosphorylation is not significant. This is explained
by the long lifetime – and the likelihood that repeated interactions of erbB3 pairs in
homodimers renders it less likely for a productive “activating” dimerization event with
erbB2.
Note that elevated basal levels of erbB2 phosphorylation were noted previously in
cultured cells overexpressing erbB2, along with a slight reduction upon stimulation with
HRG (Steinkamp et al., 2014; Yang et al., 2007). Thus the simulation results for erbB2
phosphorylation point to a high degree of erbB2 homodimerization and activation at high
surface density and are in good agreement with experimental results.
5.3.6

Computational approaches offer tractable methods to evaluate impact of
mutations on erbB3-mediated signaling.

We next extended out model to look into how mutations that impact erbB3 activation
would impact these dynamics. To replicate a mutation in erbB3 that causes the kinase
domain to become more active, we added another multiplier to the model. This multiplier
is applied on top of the experimentally determined multipliers for erbB2 and erbB3. In
the simulation, when a mutant erbB3 is chosen to be an activator, the multiplier is applied
to the phosphorylation rate. This simulates an increase in activity to the C-lobe of the
receptor.
In Figure 5.6AB, the impact of the multiplier on the percent phosphorylation of erbB2
and erbB3 over time is shown. These simulations used equal amounts of erbB2 and
erbB3, with a low amount of ligand-bound erbB3 present (15%). The simulated mutation
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Figure 5.6: Gain of Function Impact on Receptor Phosphorylation for Low Amounts of Ligand. (A
and B) Percent receptor phosphorylation over time for ErbB2 and ErbB3, respectively. (A) Initially
the GOF mutation has a negative impact on ErbB2 phosphorylation. Overall, the GOF mutation
does not show a large impact on the amount of ErbB2 phosphorylation. (B) ErbB3 phosphorylation
increases slightly with a modest increase in phosphorylation rate multiplier, and jumps drastically
with a multiplier of 10. (C) Phosphorylation events by activator species for increasing
phosphorylation rate multipliers. Each bar in a group is a specific multiplier, 1, 2, 10, and 100,
respectively. Each group indicates what species the receiver was and what species the activator was
for a specific phosphorylation event. When the multiplier reaches 10, ErbB33 homodimers begin to
be active without needing to interact with ErbB2 first.
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appears to have little impact on erbB2 phosphorylation, however erbB3 phosphorylation
is greatly impacted. Figure 5.6C shows the relative distribution of phosphorylation events
broken into groups based on which receptor was the activator and which receptor was the
receiver. Each bar in a group is for a multiplier of 1, 2, 10, and 100, respectively. Overall,
this figure shows that erbB phosphorylation events increase with the multiplier, as would
be expected. An interesting observation highlighted by this figure is that when the
multiplier reaches 10, erbB3 begins to overcome its reliance on erbB2 for activation, as
indicated by the unphosphorylated erbB3 contributing to the phosphorylation of other
erbB3 receptors.
5.3.7

Substitution at erbB3-E933Q is a gain-of-function mutation that amplifies
the PI3 kinase/AKTsignaling pathway.

We discovered a novel amino acid substitution mutation in one of the erbB3 alleles in
the widely-used SKBR3 breast cancer cell line (Figure A.7). To evaluate the possibility
that this was an activating mutation, CHO cells were transfected with vectors for
expression of mCitrine-fusion proteins bearing either erbB3WT or erbBE933Q. After
selection to ensure comparable surface expression of the two fluorescent erbB3-fusion
proteins, cells were challenged with a series of HRG doses, lysed, and subjected to SDSPAGE and western blotting to measure levels of erbB3 phosphorylation at PY1289.
Robust phosphorylation of mutant erbB3 was consistently detected at the lowest dose of
HRG, with 2 to 3 fold stronger phosphorylation than wild type erbB3 at suboptimal
ligand concentrations (Figure 5.7A).
We reasoned that the robust phosphorylation of ErbB3E933Q in response to low doses
of ligand might amplify downstream signaling by increased recruitment of Class I A
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Figure 5.7: The gain of function mutant erbB3 E933Q demonstrates increased sensitivity to ligand
and increased kinase activity when expressed in CHO cells. (A) CHO erbB3E933Q-mCitrine cells have
high levels of erbB3 phosphorylation even at the lowest dose of HRG (3 nM). (B)
Immunoprecipitated erbB3 E933Q co-immunoprecipitates more p85, a PI3kinase subunit, in the
presence of ligand. (C) Increased levels of phosphorylated Akt that lead downstream of PI3kinase
indicates an overall upregulation of the erbB3 signaling network in CHO erbB3E933Q-mCitrine cells.
(D) Immunoprecipitated erbB3E933Q has higher basal and ligand-dependent kinase activity in the in
vitro kinase assay compared to erbB3wt.
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phosphotidylinositol-3-kinase (PI3K). Cells expressing erbB3WT or erbB3E933Q were
stimulated over the same range of doses, followed by immunoprecipitation of erbB3 from
cell lysates and western blotting to measure co-precipitated p85 regulatory subunits of
PI3K. The amount of p85 recovered in ErbB3 immune complexes paralleled the degree
of phosphorylation of ErbB3 in the CHO transfectants, with more p85 recovery at low
ligand doses for ErbB3E933Q than for ErbB3WT (Figure 5.7B). Cells expressing ErbB3E933Q
also had a more robust activation of the downstream serine/threonine kinase, AKT, as
measured by phosphorylation of AKT S473 (Figure 5.7C). The phosphoAKT/total AKT
ratio was higher at times after HRG stimulation of CHO cells expressing ErbB3E933Q,
compared to cells expressing the wildtype receptor. Figure 5.7D reports results of in vitro
kinase assays for erbB3WT and erbB3E933Q immune complexes, isolated independently
from the cell lysates of the two transfected CHO cell lines after 2 min challenge with
12nM HRG. Greater activity is shown for mutant erbB3, despite modest differences in
phosphorylation at this dose. Together, these results indicate that the E933Q substitution
is an example of a class of gain-of-function mutations (Jaiswal et al, 2013) for which the
mathematical model might provide valuable insight.
As a prelude to simulations, we applied our existing experimental methods to
determine if the E933Q mutation might alter basic parameters in the model such as the
diffusion rate, homodimer lifetime or dephosphorylation kinetics. Results of these
experiments are shown in Figure 5.8A-D. Liganded erbB3 homodimers are slow <0.05
for all pairs composed of either WT or E933Q forms (Figure 5.7A). However, we
observed slightly faster monomer diffusion coefficients for erbB3E933A, whether co-
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Figure 5.8: Single particle tracking of HA-erbB3E933Q. (A) Diffusion by state comparing HA-erbB3
E933Q to HA-erbB3 wt. E933Q shows faster diffusion when separated or co-confined, but both
unliganded and liganded interacting pairs diffuse slower than interacting HA-erbB3 wt pairs. (B)
Unliganded dimer pairs are short lived as shown by the histogram of dimer lifetimes. Unliganded
receptor pairs have an off rate of 0.42 sec-1 that is comparable to the wild type value. (C) Liganded
HA-erbB3 E933Q receptor pairs are longer lived as seen with the wildtype receptor and have an off
rate of 0.19 sec-1 that is equivalent to the wild type value. (D) Normalized phosphorylation levels for
erbB3wt versus erbB3E933Q were plotted over time. As in Figure 5.4B, phosphorylation levels of both
receptors were set to 1 for the two minute time point (maximum HRG stimulation). Points were fit to
a one-phase exponential decay curve to determine the dephosphorylation half-life.
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confined in domains or widely separated (Figure 5.7A). The off-rate of 0.41/sec for
unliganded erbB3E933Q homodimers (Figure 5.7B) is comparable to previously measured
values for erbB3WT (Steinkamp et al, 2014), as is the 2-fold slower off-rate of 0.19/sec for
liganded pairs (Figure 5.7C). The plot in Figure 5.8D (derived from data shown in
Supplemental Figure 5.4) shows that dephosphorylation kinetics for WT and E933Q
forms of erbB3 are the same.
5.4

DISCUSSION
Here we have presented a combination of experimental and quantitative methods to

explore the relationship between erbB2 and erbB3, as well as set a framework for
evaluation of the growing list of erbB3 mutations. Starting from observations in the
experimental data about receptor dynamics and membrane landscape, we were able to
develop a new algorithm to deduce confinement zone shapes to be used in conjunction
with a spatial stochastic model. Our spatial stochastic model was then able to not only
reproduce the receptor dynamics observed in experiments, but also give further insight
into the complex interplay between erbB2 and erbB3.
Previous work in both the experimental and modeling fields have given great insights
to the erbB receptor family. Until recently it was believed that the kinase domain of
erbB3 was completely dead. Shi et al. (2010) reported weak kinase activity for erbB3
cytoplasmic tails tethered to liposomes. In conjunction with evaluating erbB2/3
interactions by single molecule methods, we made the novel observation that erbB3
kinase activity was significantly upregulated in an erbB2-dependent manner and linked to
its phosphorylation state (Steinkamp et al 2014). Although the putative phosphorylation
site that activates erbB3 has not yet been identified, the erbB2-mediated activation of
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erbB3 is a major assumption in our mathematical model. We use spatial stochastic
modeling to extend that erbB2/3 analysis one step further, quantifying the relative
contributions of erbB2 and erbB3 based upon their dependency upon asymmetric
orientation of their kinase domains and their relative phosphorylation states. Our model
incorporates the relative dimer lifetimes and diffusion rates for each species, showing that
the more transient nature of ErbB2-3 heterodimers is a critical factor in the signaling
process.
The results of our model indicate that erbB2 is critical to erbB3 activation. Dimer
lifetime was also highlighted as an important factor in phosphorylation. ErbB3
homodimers are extremely stable causing the homodimer to become a hindrance for
erbB3 receptor phosphorylation. Simulations showed that erbB3 receptors quickly
formed homodimers with one another before having the chance to interact with erbB2.
This caused a lack of phosphorylation capacity between erbB3 receptors, since there was
no activation by erbB2. The erbB3 receptors that were able to interact with erbB2
receptors tended to interact again with other erbB2 receptors because the other erbB3
receptors were tied up in unproductive homodimers.
Our simulation results are in good agreement with the experimental data, giving
confidence to broaden the model beyond wt ErbB3 interactions. As a preliminary
exploration, we implemented a gain of function mutation that caused an increase in
activity of the C-lobe of the mutant erbB3 receptor. Varying the intensity the mutation
has on the phosphorylation rate gave insight into how this mutation would impact erbB2
and erbB3 activation and reliance on one another. Our discovery of the E933Q erbB3
gain of function mutation gave us experimental data to relate our mutation simulation to
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real experimental data. Extending our model to look at the impact of erbB3 mutations is a
characteristic of the experimental-modeling handshake. We can now use our model to
make predications about how different mutations will affect the dynamics and kinetics
between erbB2 and erbB3 receptors, giving experimentalists a good idea of which
mutations may be advantageous to investigate further. Interesting mutation to study in
future work, related to receptor activation, could cause a change in receptor conformation
stability, longer or short dimer lifetimes, and/or different kinase domain activation levels.
5.5

MATERIALS & METHODS

5.5.1

Experimental

5.5.1.1 Determination of the dephosphorylation rates for erbB2 and erbB3
CHO cells stably transfected with a pcDNA3.1- HA-erbB2 construct were transiently
transfected with a pcDNA3.1-erbB3-GFP construct and seeded into six well dishes. Two
days after transfection, cells were serum starved for up to four hours, and then stimulated
for two minutes at 37oC with 12 nM (75 ng/ml) heregulin-β (US Biologicals). Cells were
then treated with 10 µM lapatinib (Santa Cruz) to inhibit erbB2 kinase activity and
harvested 1-30 minutes after HRG activation. Controls were harvested at time 0 (no HRG
stimulatiom), time 2 min. (HRG stimulation –lapatinib) and time 30 (HRG stimulation –
lapatinib). Cells were harvested in lysis buffer and total protein levels were determined
by BCA assay. 20 ug of total protein/sample was run on an acrylamide gel and
transferred to nitrocellulose membranes using the iBlot system (Invitrogen).
Phosphorylated erbB3 was detected using a PY1289-specific rabbit polyclonal antibody
(Cell Signaling) and total erbB3 protein was detected using an anti-erbB3 monoclonal
rabbit antibody (Cell Signaling). Phosphorylated erbB2 was detected using a PY1248138

specific rabbit polyclonal antibody (Cell Signaling) and total erbB2 was detected using an
anti-erbB2 monoclonal mouse antibody (Thermo Scientific). Secondary anti-rabbit and
anti-mouse-HRP were from Santa Cruz Biotech. Blots were revealed using the
SuperSignal West Pico Chemiluminescent Substrate (Pierce) and detected on a
ChemiDoc Gel Imager (BioRad). Bands were quantified using ImageLab quantification
software (BioRad). Data was plotted and fit to a one phase exponential decay curve using
GraphPad Prism5. The dephosphorylation half-life was calculated from this curve.
5.5.1.2 Immunoprecipitation
CHO cells expressing ErbB constructs were serum starved for up to 4 hours. CHO
ErbB3wt-mCitrine were stimulated with 12 nM HRG for 2 minutes. All cells were
washed with ice cold PBS on ice and lysed with cold NP-40 lysis buffer (Yang et al,
2007). Protein concentrations in cleared lysates were measured by BCA assay (Pierce,
Rockford, IL). Supernatants were precleared with Protein A-beads (Amersham GE
Healthcare, Chicago, IL) and normal rabbit IgG (Cell Signaling) followed by overnight
incubation at 4°C with primary antibodies against erbB2 (RB9040, Neomarkers) or
erbB3 (sc285, Santa Cruz). Proteins in washed immune complexes were either
resuspended in reaction buffer for the in vitro kinase assay or denatured and separated by
SDS-PAGE, transferred to nitrocellulose membranes, and probed with anti-PY20 (Sanat
Cruz) to detect all phosphorylated proteins in the IP or with primary antibodies against
erbB2 or erbB3 and HRP-conjugated secondary antibodies. Blots were revealed and
detected as above.
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5.5.1.3 Sequencing of erbB3 from SKBR3 cells
mRNA was extracted from SKBR3 cells using the RNeasy Mini Kit (QIAGEN,
Chartsworth, CA). Pairs of primers were designed to span the ErbB3 tyrosine kinase
domain: 5’-CTC TGG ACC CCA GTG AGA AG-3’ and 5’-GGG AGT ACA AAT TGC
CAA GG-3’; 5’-GGT CAG CCA CAC CAA AAT CT-3’ and 5’- CAG ATA CCG TGG
TGG GTC TC-3’. After amplification using a QIAGEN One-step RT-PCR kit, PCR
products were separated by agarose gel electrophoresis, extracted with the QIAquick gel
extraction kit, and sequenced using the above primer sets.
5.5.1.4 In vitro kinase assay
The in vitro kinase assay was performed as detailed in (Steinkamp et al, 2014).
Briefly, CHO cells expressing either erbB3wt-mCitrine or ErbB3E933Q-mCitrine were
serum starved then stimulated for 2 minutes with 12 nM HRG-β for maximal erbB3
activation. Lysates were immunoprecipitated with the anti-ErbB3 polyclonal rabbit
antibody, sc-285 (Santa Cruz Biotech).
5.5.1.5 Single particle tracking
The E933Q mutation was introduced into an expression vector pcDNA3.1-HA-erbB3
and stably transfected into CHO parental cells. CHO HA-erbB3E933Q cells were sorted
for high expression after labeling with an anti-HA-Alexa488 antibody (Cell Signaling).
Single particle tracking experiments were performed as in (Steinkamp et al, 2014).
Briefly, CHO HA-erbB3E933Q cells were plated in 8-well chambers (LabTek) the day
before imaging. Heregulin was biotinylated using NHS-ester chemistry with Biotin-XXSE (Invitrogen) and purified from free biotin on a G25 column by gravity flow.
Biotinylated HRG and biotinylated anti-HA Fab were conjugated to streptavidin QDots
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(Invitrogen) QD655 and QD585, in a 1:1 molar ratio in PBS + 0.1% BSA by rotating for
1 hour or more at 4oC. Cells were serum starved for 1 hour and then moved into imaging
medium, Tyrodes buffer supplemented with 1% BSA and 20 mM glucose. Cells were
labeled with 100 pM QD-anti-HA Fab for 15 min. or with 20 pM QD-HRG for 5 min
before washing and imaging at 20 frames/s on an Olympus IX71 inverted microscope
with a 60× 1.2 N.A. water objective. An objective heater (Bioptechs, Butler, PA) was
used to stabilize chamber temperature at 34-35 °C. A mercury lamp with a 436/10 nm BP
excitation filter provided wide-field excitation. Emission was collected by an electron
multiplying CCD camera (Andor iXon 887) using a DuoView image splitter (Optical
Insights) to image both the QD585 (585/20 BP) and QD655 (655/40 BP) probes. Image
processing was performed using Matlab (The MathWorks, Inc., Natick, MA) functions in
conjunction with the image processing software DIPImage (Delft Univ. of Technology).
Single molecule localization, trajectory elongation, and 2-channel image registration
were performed as previously described (Low-Nam et al, 2011; Smith et al, 2010;
Steinkamp et al, 2014).
5.5.1.6 State determination of receptor pairs
Receptor interactions were identified using a three-state Hidden Markov Model
(HHM) (Low-Nam et al, 2011). The separation between two color QD pairs (one QD585
and one QD 655) is determined and pairs that are less than 1 micron apart are considered
candidate pairs. Distribution of the displacements between the QDs is modeled by a zero
mean Gaussian distribution in each (x,y) dimension using σdimer and σdomain respectively.
The value σdimer for erbB3 was estimated by combining information from EGFR crystal
structure measurements, homology modeling, and the size of QDs (Steinkamp et al,
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2014). For the Separated state in the model, the probability density is calculated as a
function of the observed distance in the previous frame and a characteristic diffusion
constant. Rate constants are determined by maximizing the likelihood over all
interactions of two QDs for a specific condition. Standard errors for parameters are
calculated as (Hi,i-1)-0.5 where H is the Hessian matrix of the negative log-likelihood and
i denotes one of the estimated rate constants. The Viterbi algorithm (Forney, 1973) is
used to identify the most likely state within individual QD interactions. Diffusion by state
was calculated based on the mean square displacement of all tracks per condition.
5.5.2

Modeling

5.5.2.1 Modeling Biological Assumptions
Our model assumes that erbB3 dimerization occurs through conventional interactions
between dimerization arms of the extracellular domains (Yarden & Sliwkowski, 2001).
This premise is supported by evidence that blockade of the erbB2 dimerization arm with
2C4 antibodies ablates its transactivation of erbB3 (Steinkamp et al, 2014; Zhang et al,
2009), as well as homology models of erbB3 based upon the structure of EGFR (not
shown). We do not formally consider the possibility that erbB3 may engage in homointeractions through other interfaces (Zhang et al, 2012), due to the lack of available
kinetic parameters. We also do not consider the intriguing possibility for higher order
oligomers (Kani et al, 2005; Kozer et al, 2013), since the sparse labeling of SPT renders
it highly unlikely that such events can be captured and measured using our available
technologies.
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5.5.2.2 Non-spatial modeling of dephosphorylation kinetics
We used BioNetGen to create a non-spatial version of our model to investigate the
dephosphorylation kinetics. Dephosphorylation is a space independent reaction, therefore
we used a non-spatial model to allow us to look over a longer period of simulation time
to see the impact. The parameters and reaction network are the same as the parameters
used for the spatial stochastic model.
5.5.2.3 Spatial stochastic model for homo and heterodimerization.
Domain Reconstruction Algorithm. To score each point in each trajectory from a
single file and channel, the length of the jump is compared for varying step sizes.
Compiling and comparing these scores against one another reveals a bimodal distribution
in the scores. The local minimum of the modes is used as a cutoff score. This score
separates the trajectory points in to confined points and free points. This step takes the
dynamic SPT data and creates a subset of static data. The slow points are considered to
be representative of confined areas on the membrane. The slow points are then clustered
to determine confinement areas or domains. A characteristic length study is first done to
determine the characteristic length that best describes the distance between points in a
cluster. This length is varied from 0nm to 1000nm. Over this range the average perimeter
of the clusters is computed. The perimeter reaches a local minimum over this range. The
characteristic length where this minimum is reached is used as the characteristic length.
The characteristic length is then used to create the clusters. Each cluster is then used to
create a contour that will define the final confinement area. The contour is created by
“inflating” the cluster. The outside points of the cluster are extended outward by ½ the
characteristic length. This allows some give in the confinement area to consider that these
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points could have bounced off a structure and would not have sat directly next to the
confining structure. The extended points are then connected to create a contour. This is
the final domain structure.
Reaction Network Generation. Our reaction network definition begins with the
interaction model proposed by Steinkamp et al. (2014). In this model, ErbB2 receptors
dimerize with ErbB3, allowing ErbB2 to activate (Phosphorylate) ErbB3. These dimer
interactions appear to be transient, and quickly fall apart. The activated ErbB3 receptor is
then free to homo-dimerize with another ErbB3. The activated state of the ErbB3 allows
it to illicit kinase activity from the unphosphorylated ErbB3 causing activation and
therefore phosphorylation. We extend this model slightly by implementing the
asymmetric phosphorylation model used in our previous ErbB1 activation paper (Pryor et
al, 2013).
Receptor Diffusion and Reaction Kinetics. Receptors diffuse according to
Brownian motion through a combination of specific diffusion coefficients calculated
from SPT experiments and normally distributed random variables. Diffusion is
interrupted when a membrane domain is encountered in the receptors path. To account
for this obstacle two tolls are considered, entrance into the domain and exit from the
domain. The entrance and exit rates of the domains are converted to probabilities using
the simulation time-step. When a receptor attempts to enter or exit a domain, the relevant
probability is evaluated and the receptor is allowed to either leave the domain or the
receptor is reflected back into the domain.
Receptor reactions are treated differently depending on their reaction order. 1st order
reactions are treated similarly to the domain entrance/exit tolls. The reaction rate is
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converted to a probability using the time-step and evaluated. If the probability is met, the
reaction occurs, if it is not met, no reaction occurs. Second order reactions are a bit more
complicated. These reactions are diffusion limited, and therefore the spatial aspect of the
model must be taken into consideration. The solution to this problem, proposed by
Andrews and Bray (2004), is to use a binding radius and unbinding radius, if the reaction
is reversible (Andrews & Bray, 2004). The binding radius is a function of simulation
time-step, receptor diffusion coefficients, and receptor on rates. At the end of a receptors
diffusion step, the area around the receptor bounded by the binding radius is scanned for
other receptors. If an available receptor is found within the binding radius, a reaction
occurs. There is no probability associated with second order reactions; likelihood of
reaction is taken into consideration through the binding radius. If a reverse reaction is
possible, an unbinding radius is implemented. The length of the unbinding radius is
picked such that an unrealistic number of repeated interactions are minimized. Andrews
and Bray suggest the binding to unbinding radius ratio be 20% as a starting point.
5.6

NOTES
This work is currently being prepared for submission for peer review.

5.7

ACKNOWLEDGEMENTS
This work was supported by NIH-CA119232 (BSW), NSF MCB-0845062 (DSL) and

P50GM085273 (BSW), NIH grants R01 GM104973 (to JSE and AMH) K25 CA131558
(AMH). MMP was supported by the U.S. Department of Energy through the
LANL/LDRD Program for this work. Use of the UNM Cancer Center Microscopy
Facility, and NIH support for instruments and staff support, is gratefully acknowledged.

145

CHAPTER 6: DISCUSSION
6.1

SUMMARY
The focus of this dissertation was to integrate data from live cell imaging into a

spatial stochastic model to be used to study the kinetics and dynamics of the ErbB family
of tyrosine kinase receptors. We started by building a spatial stochastic model using an
EM image as our simulation space and parameters derived from SPT tracking of ErbB1
receptors. We were able to validate our model by replicating the SPT data. We used that
model to investigate how membrane landscape and receptor interactions impact receptor
state in ErbB1 receptors. We then moved on to analyze SPT even further to uncover
anomalous diffusion characteristics and how the membrane landscape related to those
dynamics. Taking the SPT analysis a step further, we developed an algorithm to
reconstruct confinement zones directly from the SPT data. Finally, we used the
reconstructed confinement zones from ErbB2 and ErbB3 tracking data to create a
simulation space for our stochastic model, while extending the spatial stochastic model to
a heterogeneous population to study ErbB2 and ErbB3 interaction dynamics.
6.2

SIGNIFICANCE
Our spatial stochastic model agrees well with existing experimental data, and enabled

us to look deeper into the mechanisms behind erbB receptor signaling beyond current
experimental capabilities. Through each of our modeling studies we were able to
highlight the importance of the cellular membrane landscape and how it impacts receptor
activation for signaling. We also characterized the distribution of confinement zones on
the membrane landscape and the size and shape of the confining areas present, gaining

146

important insight as to what to type of structures could contribute to the confinement
zones.
6.2.1

Spatial Stochastic Model

Our spatial stochastic model directly used SPT experimental data without the need to
do any parameter fitting, giving our model a very strong connection to the biology it was
built to simulate. Our model is extremely useful for studying how different protein
dynamics, typically studied without the ability to consider the impact of one another,
come together. This view allows us to get a more comprehensive look at how all the
factors impact receptor signal initiation. Our model nicely lends itself to be built upon
further in the future to either study erbB receptors more in-depth or branch out to a
different transmembrane protein system.
6.2.2

ErbB1 Receptor State Dependence on Membrane Landscape

Through our ErbB1 study, we showed that spatial aspects of the cellular membrane
are a critical element to take into consideration when investigating membrane receptor
dynamics. These findings are very important for the membrane and erbB receptor
research communities, as this is a source of debate. We show that confinement zones on
the membrane create small zones of high-density receptors, causing an increase in
receptor interactions. These interactions lead to higher dimer phosphorylation and
activation, impacting the extent of down stream signaling in cells.
6.2.3

Anomalous Diffusion, Membrane Landscape, and Domain Reconstruction

Building off the conclusion of the ErbB1 study, we decided to delve deeper into the
cellular membrane landscape. Analysis of SPT tracking data of FcεRI receptors revealed
non-Brownian motion features. We found that these diffusion characteristics could be
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contributed to a membrane landscape consisting of attractive domains, but not for a
landscape made up of corrals. Insight into the size and distribution of these confinement
zones is useful for future work determining the actual structure or structures that cause
these diffusion anomalies in cell membranes.
6.2.4

ErbB2 – ErbB3 Interactions and ErbB3 Gain of Function Mutation

In our ErbB2/3 study, we employed a combination of experimental and modeling
methods. We were first able to use our SPT analysis to show that erbB2 and erbB3
receptors have significantly different diffusion characteristics. Building from the previous
ErbB3 kinase activity study by Steinkamp et al. (2014), we showed that erbB3 can
sustain activation after being activated by erbB2, indicating erbB3 receptors have kinase
activity, and were able to relate erbB2 phosphorylation to erbB3 phosphorylation to
calculate a phosphorylation rate multiplier for erbB3. These results alone have an
enormous impact on the current understanding of erbB3 activation and signaling.
Applying this information to our spatial stochastic model, we were able to confirm the
dependence of erbB3 activation on erB2 interactions. We also concluded that the stability
of erbB3 homodimers is actually an obstruction to erbB3 activation.
Agreement between the erbB2/3 experimental results and our model provide a high
level of confidence in our model predictions. We decided to extend the model beyond wt
interactions, and investigate how a gain of function mutation in the kinase tail of erbB3
would alter erbB2 and erbB3 phosphorylation. We found that, while erbB2
phosphorylation was not drastically impacted, erbB3 phosphorylation showed a strong
dependence on the kinase domain activity. We were also able quantify how strong the
gain of function would have to be to eliminate erbB3 dependence on erbB2 activation.

148

We discovered an E933Q amino acid swap gain of function mutation in erbB3, which
allowed us to study the kinetics and dynamics of the mutated receptor. We show that this
mutation does not impact erbB3 homodimer lifetimes; we therefore conclude that this
mutation may cause an uptick in kinase activity, allowing us to compare out experimental
results with our model predictions. The ability of the model to predict outcomes of
mutations provides great insight in to what types of mutations could be advantageous to
study more in-depth.
6.3

FUTURE DIRECTIONS
Our spatial stochastic model can continue to be used and extended for deeper research

into erbB receptor dynamics, or can be modified to study an entirely different membrane
protein system. The Domain Reconstruction Algorithm can also be used to study and
characterize other proteins whose diffusion can be tracked individually, in real time. Here
we discuss a few possibilities for the future use of our model.
6.3.1

Current Path Forward: ErbB3 Mutation Study

In our erbB2/3 study, we used our model to investigate a mutation in the kinase
domain of erbB3. We propose, and are currently in the process of, using the model to
look into other gain of function mutations for erbB3. Jaiswal et al. (2013) compiled a list
of known erb3 mutation, we add our E933Q gain of function mutation to this list. We can
then use our model to investigate mutations that have yet to be discovered. The model
will give insight into the type of gain of function mutation that will have the greatest
impact on erbB3 activation. These mutations can then be replicated in real erbB3
receptors and studied for different therapeutic uses.
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Examples of possible high impact mutations that would change receptor activation
include alterations in receptor conformation flux, dimer lifetimes, and/or receptor kinase
activity. Altering the stability of unliganded erbB3 receptors through receptor
conformation decreases erbB3’s dependence on ligand. A more stable unliganded
receptor would allow higher dimerization rates with other erbB2 and erbB3 receptors in
the absence of ligand. Changing the lifetime of erbB3 homo and hetero-dimers would
impact the ability of erbB3 receptors to become phosphorylated. In our wt erbB2-3
model, we showed that the long dimer lifetimes of erbB3 dimers negatively impacts
erbB3’s ability to become activated. Varying the dimer lifetimes of hetero and homodimers would allow for a balance to be struck to either up-regulate or down-regulate
receptor phosphorylation. Finally, a mutation in the kinase domain, similar to the E933Q
mutation we found, would directly alter receptor activity. We believe our E933Q
mutation causes an uptick in activity in the C-lob of the erbB3 receptor, making it a
stronger activator in receptor phosphorylation. The mutation we propose here to study
would be located in the N-lobe of the kinase domain, making the erbB3 receptor a strong
receiver.
6.3.2

For Future Investigators

We originally built the Domain Reconstruction Algorithm with characterizing erbB2
and erbB3 domains in mind, however it is easy to see that this algorithm can be used for
any type of trajectory data. The analysis can be used to characterize confinement zones
for other transmembrane proteins, such as MET, FcεRI, or Toll-like Receptors. A useful
project for the DRA would be to characterize the confinement zone characteristics for a
specific protein for various cell lines. This would give insight into how much the cellular
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membrane landscape varies between cells, and also how the membrane landscapes vary
between “normal” cells and cancerous cells. It can also be extended to characterize
confinement of other types of proteins that can be tracked individually. This algorithm
can even be extended beyond biological systems, to characterize diffusion characteristics
of particles or diffusion-limited chemical species.
Beyond using the spatial stochastic model to investigate different erbB3 mutation
scenarios, the model can quickly be altered to investigate the interaction dynamics of
another diffusion dependent protein family that forms dimers. No change to the actual
code would be necessary, only the input parameters dictating diffusion and receptor
reactions would need to be updated to match the protein system.
To extend the model further, protein families that form higher order oligomers could
be studied by altering the dimerization rule in the model. This would be an interesting
next step for the model, as oligomerization of erbB receptors has been a popular research
focus (Kani et al, 2005; Kozer et al, 2013). This rule change for the model would also
allow the model to be used to study other proteins known to form oligomers, such as
FcεRI.
A more drastic change to the model would be to add a 3D component to represent the
cytoplasm. This addition would allow for investigation deeper into the proteins involved
in the signaling cascade initiated through membrane receptor activation. Members of our
group previously explored this type of model using a lattice-based spatial stochastic
model (Costa et al, 2009b). Since this work was published, experimental methods have
improved, giving more precise parameters for model building.
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6.4

PERSPECTIVES

During this dissertation we worked hard to directly integrate experimental data with our
modeling methods. In each study we used experimental data to create our model, then
extended the model beyond current experimental capabilities. This extension shows the
usefulness of modeling for scientific research. Models give us deeper insight and greater
flexibility when studying the intricate relationships and mechanisms of physical
processes. Integration of experiments and modeling is a crucial step for the future of
scientific research. Creating a continuous cycle of experiments and modeling will allow
us to expedite scientific discoveries by using models to predict interesting and relevant
mechanisms to study leading to novel experiment development.
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APPENDICES
APPENDIX A: Simulation Space Program Scripts
SIMULATION IMAGE IMPORTER
%% EM Image Importer m-file
% Final Version by Meghan McCabe Pryor April 16th, 2014
%% Fresh Start
clear all; close all; clc
%% Input information
% Name of save file
datafilename='EMFileName';
% Name of image to be used for particle positions
photoname='5-10957Large_ScaleBar.jpg';
% Unit conversion for scale bar on image
scalebar=0.1; % Enter in units of um
%% Check File Name Existance
% To avoid overwritting past data files
if exist(strcat(datafilename,'.mat'),'file') == 2
% Check before overwritting savefilename
choice1 = questdlg('Data Filename already used, are you sure you want to overwrite
the file?', ...
'Save Name Check', ...
'Yes','No','No');
switch choice1
case 'Yes'
case 'No'
disp('Please rename the save file name and re-start the simulation.')
return
end
end
%% Data Import
choice2 = questdlg('Do you want to include domains?', ...
'Domain Check', ...
'Yes','No','No');
switch choice2
case 'Yes'
%%
% Import image and show
EM = imread(photoname);
imshow(EM)
hold on
%%
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% How many domains?
prompt = {'How many domains are there?'};
dlg_title = '# of Domains';
num_lines = 1;
answer = inputdlg(prompt,dlg_title,num_lines);
numdomain=str2double(answer{1});
%%
% Measure scale bar distance
h1=msgbox('Scale Bar Length (2 Clicks)');
uiwait(h1)
[d1 d2] = ginput(2);
%%
% Measure x axis and y axis
h2=msgbox('x-axis Length (2 Clicks)');
uiwait(h2)
[px nay] = ginput(2);
h3=msgbox('y-axis Length (2 Clicks)');
uiwait(h3)
[nax py] = ginput(2);
%%
% Measure x axis and y axis
r=zeros(1,3);
for i = 1:numdomain
h5=msgbox(sprintf('x-axis Length of Domain %.0f (2 Clicks)',i));
uiwait(h5)
[idpx nay] = ginput(2);
dpx(i,:)=idpx';
h6=msgbox(sprintf('y-axis Length of Domain %.0f (2 Clicks)',i));
uiwait(h6)
[nax idpy] = ginput(2);
dpy(i,:)=idpy';
dxmin=idpx(1);
dymin=idpy(2);
dxmax=idpx(2);
dymax=idpy(1);
plot([dxmin dxmax dxmax dxmin dxmin], [dymax dymax dymin dymin
dymax],'b')
%%
% Measure distance ***Press Return when finished clicking***
h4=msgbox(sprintf('Particle Placement in Domain %.0f (Right Click when
finished)',i));
uiwait(h4)
iXp=[];
iYp=[];
%key = '';
key = 1;
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while key == 1%strcmp(key,'')
[Xp Yp key] = ginput(1);
iXp=[iXp Xp];
iYp=[iYp Yp];
plot(iXp,iYp,'r.')
%key = get(gcf,'CurrentKey');
end
%key=set(gcf,'CurrentKey','');
key = 1;
[m n] = size(r);
r(m+1:m+length(iXp),:)=[iXp' iYp' i*ones(length(iXp),1)];
end
r(1,:)=[];
%%
% Measure distance ***Press Return when finished clicking***
h4=msgbox(sprintf('Free Particle Placement (Right Click when finished)'));
uiwait(h4)
key=1;
iXpfree=[];
iYpfree=[];
while key == 1; %strcmp(key,'')
[Xpfree Ypfree key] = ginput(1);
iXpfree=[iXpfree Xpfree];
iYpfree=[iYpfree Ypfree];
plot(iXpfree,iYpfree,'r.')
%key = get(gcf,'CurrentKey');
end
key=1;
%%
% Scale Units
unit=abs(d1(2)-d1(1))/scalebar; % Converts bewteen pixels and um [=] # pixels/um
xlimmax=px(2)/unit; % x limit in um
ylimmax=py(1)/unit; % y limit in um
xlimmin=px(1)/unit; % x limit in um
ylimmin=py(2)/unit; % y limit in um
% Domain limits
dxmin=dpx(:,1)/unit;
dymin=dpy(:,2)/unit;
dxmax=dpx(:,2)/unit;
dymax=dpy(:,1)/unit;
%%
% Add free data points to domain data points
rcombine(:,1) = [r(:,1)' iXpfree]';
rcombine(:,2) = [r(:,2)' iYpfree]';
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r(length(r(:,1))+1:length(rcombine),:)=[rcombine(length(r(:,1))+1:length(rcombine),:)
zeros(length(rcombine)-length(r(:,1)),1)];
%%
% Scale collected data
iX=rcombine(:,1)./unit;
iY=rcombine(:,2)./unit;
close all
%%
% Plot initial data compared to image
figure
subplot(1,2,1);
plot(iX,iY,'.', [dxmin dxmax dxmax dxmin dxmin]', [dymax dymax dymin dymin
dymax]')
xlim([xlimmin xlimmax])
ylim([ylimmin ylimmax])
set(subplot(1,2,1),'YDir','reverse')
subplot(1,2,2)
imshow(EM)
hold on
plot(rcombine(:,1),rcombine(:,2),'.')
hold off
case 'No'
%%
% Import image and show
EM = imread(photoname);
imshow(EM)
%%
% Measure scale bar distance
h1=msgbox('Scale Bar Length (2 Clicks)');
uiwait(h1)
[d1 d2] = ginput(2);
%%
% Measure x axis and y axis
h2=msgbox('x-axis Length (2 Clicks)');
uiwait(h2)
[px nay] = ginput(2);
h3=msgbox('y-axis Length (2 Clicks)');
uiwait(h3)
[nax py] = ginput(2);
%%
% Measure distance ***Press Return when finished clicking***
h4=msgbox('Particle Placement (Hit Enter when finished)');
uiwait(h4)
[iXp iYp] = ginput;
%%
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% Scale Units
unit=abs(d1(2)-d1(1))/scalebar; % Converts bewteen pixels and um [=] # pixels/um
xlimmax=px(2)/unit; % x limit in um
ylimmin=py(2)/unit; % y limit in um
xlimmin=px(1)/unit; % x limit in um
ylimmax=py(1)/unit; % y limit in um
%%
% Scale collected data
iX=iXp./unit;
iY=iYp./unit;
close all
%%
% Plot initial data compared to image
figure
subplot(1,2,1);
plot(iX,iY,'.')
xlim([xlimmin xlimmax])
ylim([ylimmin ylimmax])
set(subplot(1,2,1),'YDir','reverse')
subplot(1,2,2)
imshow(EM)
hold on
plot(iXp,iYp,'.')
hold off
end
NP=length(iX);
%% Save Imported Data
save(datafilename)
DOMAIN RECONSTRUCTION ALGORITHM
The scripts presented in this appendix are still a work in progress. The script posted here
are up-to-date as of the writing of this document.
Domains_V006.m
% Labels points based on step size distributions %
%
% V001 - can make histograms or not, labels points based on a percentage
% cutoff
%
% V002 - file and folder name separate, can use rankings
%
% V003 - added combination scoring
%
% V003a - cleaning up
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%
- multi zoom saves
%
% V004 - multi-file processing
%
- analyze a set of files defined by a string token
%
- output two-channel results in a single proecessed data file
%
- build a cumulative step distribution from all files (by channel)
%
- for each file and channel, do the scoring and short points
%
- cluster the short points
%
- put out detailed clustering data for one length (MyLength)
%
% V005
% - add domain diameter to geometric measures of domains
% - length study option for short points
% - two different MyLength values for the two channels (V005a)
%
% V006
% TODO:
% - area calculation for all (short and other) points -- done
% - put out detailed clustering data for selected lengths
% - use this to pick a common cutoff (one for each channel) - do this by hand?
%
% Beyond this:
% - look at overlap of trajectories and domains
% - overlay plots with trajectories, domains from 1 or 2 channels
% - estimate fraction of area covered by domains
% - something else..?
%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%
*** EDIT THIS AS NEEDED ***
%
% folder for source files
FolderPath = 'CHO/CHO_HA-ErbB2_ErbB3_ErbB3/';
%FolderPath = 'CHO/CHO_HA-ErbB2-ErbB3_ERBB2/';
% String pattern to help pick out a group of files %
%
make it blank ('') to process all the files
SpecialString = '';%'2013-3-29';%'2013-3-29-10-42';%'2012-12-19';%'';%
% extensions for source files (two channels)
Ext={'.HMMData_ch1_StDis2.mat','.HMMData_ch2_StDis2.mat'};
% length parameters used to define clusters and contours
%MyLength={0.0305,0.0570}; %{0.0570,0.0305}; % %0.070;%0.035;
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MyLength={0.1,0.1};
% for the length study option
% (substring to be found in the file names, set it to 'zumm'
% to turn off length study, set it equal to SpecialString to
% make it default
LS_SpecialString = 'zumm';%;'-3-29';
% folder for output files
% OutputFolder = 'Scratch/SampleRunsForPlots_ErbB32/';
OutputFolder = 'Scratch/Run005a/';
% extension+tag for processed files
OutputExt = {...
sprintf('_DomRec_L%dnm.mat',floor(1000*MyLength{1})),
sprintf('_DomRec_L%dnm.mat',floor(1000*MyLength{2}))};
% ** Processing / Analysis Parameters **
% step count values we expect in the input files
SelectStepVals=[1 2 5 10 20 50 100 200];
% Step Count Values (1,2,5,10,20,50,100,200)
% that will be used in building the score, for example:
% [3] means we only use the 5 step values
% [3 4 4 5] means 5 steps, 10 with double weight, and 20
%ScorePattern=[4 5 6];
ScorePattern=[1 2 3 3 4 4 5 5 5 6 6 7 7 8 8];% a combo score I liked
% cutoff used to define the short points (score below means short - max is 1)
CutFactor = 1.01;%0.65;
% ** Optional Figures and Data Outputs ** %
MakePlot1001 = false; % cumulative step distribution plot
MakePlot404 = false; % individual histogram of scores (one per file)
MakePlot405 = false; % cumulative histogram of scores (one for the entire group)
MakePlot2001 = false; % length study plot
FILEOUTPUT = false; % text file outputs of contours and points etc
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%
% get a file list
DirOut = dir([FolderPath '*' SpecialString '*' Ext{1}]);
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FileCount = size(DirOut,1);
FileTrajectoryCount = zeros(FileCount,2); % counts the points in each channel of each
file
FilePointCount = zeros(FileCount,2); % counts the points in each channel of each file
ShortFileNames = cell(FileCount,1);
%% Global step size statistics %%
% Initialize the global step statistics object
% NOTE: make sure there is enough space
StepCounts=zeros(2,8); % keeps track of the number of values in the statistic
StepStats = cell(2,8);% holds the values of the step sizes

% best guesses for the size of the statistics
SSizes=[450000, 250000, 110000, 65000, 35000, 15000, 7000, 3000];
for ich=1:2,
for isz=1:8,
StepStats{ich,isz} = zeros(SSizes(isz),1);
end;
end;
tic
% Collect metadata for the step statistics
for ifile=1:FileCount % initial loop through files (defined by the short name)
% short file name from the dir() output
%q=strsplit(DirOut1(ifile).name,'.');% works only in v2013 or later
q=strread(DirOut(ifile).name,'%s','delimiter','.');% may be obsolete, use the above
ShortFileNames{ifile} = q{1};
fprintf('%s\n',ShortFileNames{ifile});
for ich=1:2 % loop through channels
File = [FolderPath ShortFileNames{ifile} Ext{ich}];
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if ~exist(File,'file'), % get trajectory, point and step info from the file
fprintf('File %3d ch%d: %s not found\n',ifile, ich, File);
else
fprintf('ch%d: ',ich);
load(File);
FileTrajectoryCount(ifile,ich)=size(Trajectories,1);
for TrNo = 1:FileTrajectoryCount(ifile,ich); %loop over trajectories and count the
points in them
FilePointCount(ifile,ich) = FilePointCount(ifile,ich)+Trajectories{TrNo,2};
end;
fprintf('TrCt:%3d
',FileTrajectoryCount(ifile,ich),FilePointCount(ifile,ich));
% error check: the pixel size should come with the data
if ~exist('PixelSize','var'), fprintf('
Domains **error**
found!\n'); return; end;

PtCt:%4d

No PixelSize

L2ConversionFactor=PixelSize^2;
% add the step values to the global statistics
for ist=1:8;
StValueCount = StepDistributions{ist,2};
StValueDist = L2ConversionFactor * StepDistributions{ist,3}(:,1); % step
values
%fprintf('%5d ',StepDistributions{is,1});
fprintf('%6d ',StValueCount);
fprintf('%7.3f ',max(StValueDist));
MinInd=StepCounts(ich,ist)+1;
MaxInd=StepCounts(ich,ist)+StValueCount;
StepStats{ich,ist}(MinInd:MaxInd) = StValueDist;
StepCounts(ich,ist)=StepCounts(ich,ist)+StValueCount;
%MaxStepValues(ich,is)=max(MaxStepValues(ich,is),max(StValueDist));
end; % loop over select step counts
fprintf('\n');
end; % if file was found
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end % loop over channels
end % loop over file [names]
% Build cumulative step distributions and histograms
StepRange = cell(2,8); % bin definitions
StepHist = cell(2,8); % histograms
if MakePlot1001, figure(1001); clf; end;% optional global step distribution plot
for ich=1:2 % double loop for step statistics
for ist=1:8
% clip off the unused pieces of StepStats
StepStats{ich,ist}=StepStats{ich,ist}(1:StepCounts(ich,ist));
% define the value range
MaxV = 20*mean(StepStats{ich,ist}); % upper end
DV = MaxV/1000;
% bin size
StepRange{ich,ist} = 0:DV:MaxV; % range
Missed=length(find(StepStats{ich,ist}>MaxV)); % values left out
% do the histogram
W = histc(StepStats{ich,ist},StepRange{ich,ist}); % histogram
StepHist{ich,ist} = cumsum(W)/StepCounts(ich,ist);% cumulative fractions
if MakePlot1001, % optional cumulative step statistics plot
figure(1001)
subplot(2,4,ist)
if ich==2, hold on; end;
%stairs(StepRange{is,ich},log(W/DV)/log(10),'Color',[ich-1,0,2-ich]);
%semilogy(StepRange{is,ich},W/DV,'Color',[ich-1,0,2-ich]);
semilogx(StepRange{ich,ist},StepHist{ich,ist},'Color',[ich-1,0,2-ich]);
if ich==2, % format and embellish
xstring='Sq.dis (\mum)';
tstring='CDF';
nstring=sprintf('%d steps',SelectStepVals(ist));
if SelectStepVals(ist)==1, nstring='1 step'; end;
xf=0.0001; yf=0.925;
ylim([0 1.2]);
nmin=floor(log(DV)/log(10));
nmax=ceil(log(MaxV)/log(10));
xlim([10^nmin 10^nmax]);
set(gca,'XTick',[10.^(nmin:nmax)]);
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legend(sprintf('Ch1:%d',StepCounts(1,ist)),sprintf('Ch2:%d',StepCounts(2,ist)));
legend('Location','SouthEast');
FormatThisFigure;
end
end
end
end
if MakePlot1001, FigureName=[OutputFolder 'CumulativeStepStats_' SpecialString];
SaveThisFigure; end;
%return % optional stop before building the individual scores
% done collecting step statistiscs
%% Analysis of trajectory files
% Variables for point scoring
OverallPointCount = sum(FilePointCount,1);
OverallShortPoints
=
{zeros(OverallPointCount(1),1),zeros(OverallPointCount(2),1)};%cell(2,1);
OverallBiRanks
=
{zeros(OverallPointCount(1),3),zeros(OverallPointCount(2),3)};
%cell(2,1);
BiRankCount = zeros(2,1);
for ifile=1:FileCount % main analysis loop over trajectory files..
SPC = cell(2,2);
for ich=1:2

% ..and over channels

File= [FolderPath ShortFileNames{ifile} Ext{ich}];
% Length study is done for a subset of the files
LENGTHSTUDY=false;
if ~isempty(strfind(File,LS_SpecialString)), LENGTHSTUDY=true; end;
fprintf('File:%3d ch.%1d : ',ifile,ich);
load(File);
fprintf('.');
NTr = size(Trajectories,1);
TrajectoryRanks = cell(NTr,1);
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if ~exist('PixelSize','var'), % the pixel size should come with the data
fprintf(' Domains **error** No PixelSize found!\n File: %s',File);
return;
end;
L2ConversionFactor=PixelSize^2; % convert into physical units
% this will hold the output set of points
AllShortPoints = zeros(FilePointCount(ifile,ich),3);
ShortPointCount = 0;
AllPoints = zeros(FilePointCount(ifile,ich),3);
% collect the ranks for all points in this file/channel combination
CumulativeBiRanks = zeros(FilePointCount(ifile,ich),1);
PointCount = 0;
for TrNo = 1:NTr; % loop over trajectories
ThisTrace = Trajectories{TrNo,3};
ThisTrace(:,1:2) = PixelSize * ThisTrace(:,1:2);%convert the xy coordinates into
\mum
TraceLength = size(ThisTrace,1);% length of this trace
%% find the forward and reverse step sizes for the trajectory %
% these will hold the ranks for each number of steps
FwRanks = zeros(length(SelectStepVals),TraceLength);
BkRanks = zeros(length(SelectStepVals),TraceLength);
for ist=1:length(SelectStepVals) % loop over the 8 step numbers
FBSqDist
displacements

=

zeros(TraceLength,2);%

forward

and

backward

StCount=SelectStepVals(ist); % step count for this step number
for ip=1:TraceLength % loop over all entries in the trajectory
% point StCount after the current frame
IFw = find(ThisTrace(:,3)==ThisTrace(ip,3) + StCount,1);
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square

if ~isempty(IFw),
ThisTrace(IFw,1:2)).^2); end;

FBSqDist(ip,1)

=

sum(

(ThisTrace(ip,1:2)

% point StCount before the current frame
IBk = find(ThisTrace(:,3)==ThisTrace(ip,3) - StCount,1);
if ~isempty(IBk), FBSqDist(ip,2) = sum( (ThisTrace(ip,1:2)
ThisTrace(IBk,1:2)).^2); end;

-

-

end
% convert the recorded distances into bins in Range
FBRanks = min(ceil(FBSqDist/StepRange{ich,ist}(2)),...
length(StepRange{ich,ist}));
% convert the (nonzero) bin indices into percentages using AllRanks
FBRanks(FBRanks(:,1)~=0,1)
StepHist{ich,ist}(FBRanks(FBRanks(:,1)~=0,1));
FBRanks(FBRanks(:,2)~=0,2)
StepHist{ich,ist}(FBRanks(FBRanks(:,2)~=0,2));

=
=

% put the info into the multi-step size rank structures
FwRanks(ist,:) = FBRanks(:,1);
BkRanks(ist,:) = FBRanks(:,2);
end
%% build a unique score for each point
BothPresent=FwRanks>0 & BkRanks>0;
BiRank=zeros(size(FwRanks));
BiRank(BothPresent) = (FwRanks(BothPresent)+BkRanks(BothPresent))/2.0;
WeightedRank
=
sum(BiRank(ScorePattern,:),1)
./
sum(BiRank(ScorePattern,:)~=0,1);
%StDBiRank = sqrt( sum(BiRank.*BiRank,1) ./ sum(BiRank~=0,1) MeanBiRank .* MeanBiRank );
TrajectoryRanks{TrNo} = WeightedRank';
%TrajectoryRanks{TrNo,2} = StDBiRank;
%% identify the points associated with shorter step sizes
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ShortPoints = find(WeightedRank>0 & WeightedRank < CutFactor)';
AllShortPoints(ShortPointCount+(1:size(ShortPoints,1)),:) =...
[ThisTrace(ShortPoints,1:2) TrNo*ones(size(ShortPoints,1),1)];
ShortPointCount = ShortPointCount + size(ShortPoints,1);
AllPoints(PointCount+(1:TraceLength),:) =...
[ThisTrace(:,1:2) TrNo*ones(size(ThisTrace,1),1)];

CumulativeBiRanks(PointCount+(1:TraceLength)) = TrajectoryRanks{TrNo};
PointCount = PointCount + TraceLength;
end
fprintf('.');
AllShortPoints=AllShortPoints(1:ShortPointCount,:);
AllPoints=AllPoints(1:PointCount,:);
if CutFactor>1, AllShortPoints=AllPoints; end;
% keep this for channel to channel comparisons
SPC{ich,1}=AllShortPoints;
if MakePlot404, % individual histogram of scores
figure(404)
if ich==1, clf; else hold on; end;
hr=0:0.01:1;
w=hist(CumulativeBiRanks,hr);
if ich==1, stairs(hr,w,'b'); else stairs(hr,w,'r'); end;
if ich==1,
ystring='Frequency';
xstring='Score';
title(sprintf('Scores %s',ShortFileNames{ifile}),'interpreter','none');
FormatThisFigure;
end
if ich==2,
legend('ch 1','ch 2');
FormatThisFigure;
FigureName=[OutputFolder
sprintf('%d',ScorePattern)];

ShortFileNames{ifile}
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'_Scores_both_Pt'

SaveThisFigure;
end
end
CleanBiRanks=CumulativeBiRanks(~isnan(CumulativeBiRanks));
MinInd=BiRankCount(ich)+1;
MaxInd=BiRankCount(ich)+length(CleanBiRanks);
OverallBiRanks{ich}(MinInd:MaxInd)=CleanBiRanks;
BiRankCount(ich)=MaxInd;
OutFileName=[OutputFolder
ShortFileNames{ifile}
sprintf('.ch%d',ich)
OutputExt{ich}];
save(OutFileName, 'ShortFileNames', 'Trajectories', 'PixelSize', 'StepRange',
'StepHist', 'WeightedRank', 'AllShortPoints');
%save(OutFileName);
%% Clustering (still inside the loop over files + channels)
fprintf('.');
%
RootFileName = [OutputFolder ShortFileNames{ifile} sprintf('.ch%d',ich)];
% list of distances to look at for clusters
DVecLong = 0.001:0.001:1;
% Clustering
MyZ = linkage(AllShortPoints(:,1:2));
T = cluster(MyZ,'cutoff',DVecLong,'criterion','distance');
fprintf('.');
% pull out the cluster arrangement with the chosen length scale
BestInd=find(DVecLong>=MyLength{ich},1);
BestLength=DVecLong(BestInd);
Clusters=T(:,BestInd);
% keep this for channel to channel comparisons
SPC{ich,2}=Clusters;
fprintf('.');
% cell array to collect the cluster info
% {<number of points>, <Nx2 array of points>}
% for: (1) actual points, (2) tight contour, (3) fat contour
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ClustersAndContours=cell(max(Clusters), 6);
% count the points in each cluster
CC=zeros(max(Clusters),1); % holds cluster sizes, should be replaced eventually
for IC=1:max(Clusters)
CC(IC)=sum(Clusters==IC);
end
% This will collect area and perimeter info
% inside A / P, est. padding A /P , padded polyline A / P
ClusterAP = zeros(max(Clusters), 8);
%% Contour building loop over clusters %%
for ISCC=1:max(Clusters);
%% Tight contour
% Pick out a cluster
Chozen = find(Clusters==ISCC);
MyPoints = AllShortPoints(Chozen,1:2);
% record the points of this cluster
ClustersAndContours{ISCC,1}=CC(ISCC);
ClustersAndContours{ISCC,2}=MyPoints(:,1:2);
% Build the tight contour
BestLength2=BestLength*1.01;
[Contour, Diam] = TightContour(MyPoints, BestLength2);
% record the tight contour - no repeat of the first point
ClustersAndContours{ISCC,3}= size(Contour,1);
ClustersAndContours{ISCC,4}= MyPoints(Contour,1:2);
%% Build the fat contour
MinAngle = pi / 6; % for spokes in circles added around corners
FatContour = FatContourBuild(MyPoints(Contour,1:2), BestLength2, MinAngle);
% record the fat contour - skip the repeat of the first point
ClustersAndContours{ISCC,5}=size(FatContour,1)-1;
ClustersAndContours{ISCC,6}=FatContour(1:end-1,:);
%% Geometry - areas and perimeters
% area inside the tight contour - assumed closed
ClusterAP(ISCC,1) = polyarea(MyPoints(Contour,1), MyPoints(Contour,2));
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% length of inner perimeter
ClusterAP(ISCC,2) = sum(sqrt(sum((MyPoints(Contour([2:end
MyPoints(Contour,:)).^2,2)));

1]),:)

-

% estimation of padding area (add rectangles + a circle)
ClusterAP(ISCC,3) = ClusterAP(ISCC,1) + ClusterAP(ISCC,2) * BestLength2/2
+ pi*(BestLength2/2)^2;
% estimation of padded contour length (innner perimeter + circle
ClusterAP(ISCC,4) = ClusterAP(ISCC,2) + pi * BestLength2;
% area of fat contour
ClusterAP(ISCC,5) = polyarea(FatContour(:,1),FatContour(:,2));
% perimeter of fat contour
ClusterAP(ISCC,6) = sum(sqrt(sum((FatContour(2:end,:)-FatContour(1:end1,:)).^2,2)));
% cluster diameter (no padding)
ClusterAP(ISCC,7) = Diam;
% cluster diameter (with padding)
ClusterAP(ISCC,8) = Diam + BestLength;
end
fprintf('.');
OutFileName=[OutputFolder
ShortFileNames{ifile}
sprintf('.ch%d',ich)
OutputExt{ich}];
save(OutFileName, 'T', 'MyLength', 'BestLength', 'Clusters', 'ClustersAndContours',
'ClusterAP', '-append');
fprintf('.');
if FILEOUTPUT ,
% metadata output
% point count, perimeter, area, etc.
fout
=
sprintf('_%dnm_meta.txt',floor(1000*BestLength))],'w');

fopen([RootFileName

for ISC=1:max(Clusters)
%if DEMO && ISC>12, break; end; % loop limited to the 12
fprintf(fout,'%3d ', ISC); % cluster index
fprintf(fout,'%4d ',ClustersAndContours{ISC,1});% original (slow) point count

169

fprintf(fout,'%4d ',ClustersAndContours{ISC,3});% point count on tight
contour
fprintf(fout,'%4d ',ClustersAndContours{ISC,5});% point count on padded
contour
fprintf(fout,'%6.4f %6.4f %10.8f %6.4f %6.4f %6.4f %6.4f %6.4f\n',
ClusterAP(ISC,[1 3 5 2 4 6 7 8]));
end
fclose(fout);
% contour output
% polylines for each contour
fout=fopen([RootFileName
sprintf('_%dnm_contours.txt',floor(1000*BestLength))],'w');
% number of clusters on a separate line
fprintf(fout,'%4d\n',max(Clusters));
% write out the fat contours only
for ISC=1:max(Clusters)
% if DEMO && ISC>12, break; end; % loop limited to the 12
% point counts from all contours on a single line
fprintf(fout,'%4d', ClustersAndContours{ISC,5});
end
fprintf(fout,'\n');
for ISC=1:max(Clusters)
% if DEMO && ISC>12, break; end; % loop limited to the 12
% pull out the contour data
FatContourOut = ClustersAndContours{ISC,6};
% x coordinates on a single line
fprintf(fout,'%8.5f ',FatContourOut(:,1));
fprintf(fout,'\n');
% y cordinates on a single line
fprintf(fout,'%8.5f ',FatContourOut(:,2));
fprintf(fout,'\n');
end
fclose(fout);
end;
fprintf('.\n');
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if LENGTHSTUDY,
tic
% loop over characteristic lengths
APtot=zeros(length(DVecLong),8);
for Ind=1:length(DVecLong)
Clusters=T(:,Ind);
APtot(Ind,5)=max(Clusters);
DiamVals = zeros(max(Clusters),1);
for ICl=1:max(Clusters)
BestLength=DVecLong(Ind);
MyPoints=AllShortPoints(Clusters==ICl,1:2);
[Contour, DiamVals(ICl)] = TightContour(MyPoints, 1.01*BestLength);
% area inside the tight contour - assumed closed
AreaIn = polyarea(MyPoints(Contour,1), MyPoints(Contour,2));% area
inside the tight contour - assumed closed
% length of inner perimeter
PerimIn
=
sum(sqrt(sum((MyPoints(Contour([2:end
1]),:)
MyPoints(Contour,:)).^2,2)));
% estimation of padding area (add rectangles + a circle)
AreaTot = AreaIn + PerimIn * BestLength/2 + pi*(BestLength/2)^2;
% estimation of padded contour length (innner perimeter + circle
PerimTot = PerimIn + pi * BestLength;
APtot(Ind,1:4)=APtot(Ind,1:4)+[AreaIn, AreaTot, PerimIn, PerimTot];
end
APtot(Ind,6:8)=[mean(DiamVals),median(DiamVals),max(DiamVals)];
fprintf('L=%3dnm NCl=%3d Ain=%6.3f Atot=%6.3f Pin=%5.3f Ptot=%5.3f
AvDiam=%5.3f\n',...
floor(DVecLong(Ind)*1000), max(Clusters), APtot(Ind,1:4), APtot(Ind,6));
end
toc
save(OutFileName, 'APtot','-append');
if MakePlot2001, % length study plot
figure(2001); clf;
subplot(2,2,1) %
plot(DVecLong,APtot(:,2));
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tstring='Aggregate Domain Area';
xstring='L (\mum)'; ystring='\mum^2';
FormatThisFigure;
subplot(2,2,2) %
plot(DVecLong,APtot(:,4));
tstring='Aggregate Perimeter';
xstring='L (\mum)'; ystring='\mum';
FormatThisFigure;
subplot(2,2,3) %
plot(DVecLong,APtot(:,5));
xlim([0 0.2]);
tstring='Number of clusters';
xstring='L (\mum)'; ystring='Count';
FormatThisFigure;
subplot(2,2,4) %
plot(DVecLong,APtot(:,6),'b-');hold on;
plot(DVecLong,APtot(:,7),'r-');
legend('mean','median');
tstring='Diameter';
xstring='L (\mum)'; ystring='\mum';
FormatThisFigure;
FigureName=[OutputFolder
sprintf('_ch%d_LengthStudy',ich)];
SaveThisFigure;
end

ShortFileNames{ifile}

%return
end % LENGTHSTUDY
end % end loop over channels
% channel comparisons here
Overlap_V001;
% fout = fopen([OutputFolder ShortFileName...
%
sprintf('_Overlaps_%dnm_%dnm.txt',floor(1000*MyLength{1}),floor(1000*MyLength{
2}))]...
%
,'w');
%
% save overlap info in both channel files
for ich=1:2
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OutFileName=[OutputFolder
ShortFileNames{ifile}
OutputExt{ich}];
save(OutFileName,'TotalOverlap', 'OvlAreas', '-append');

sprintf('.ch%d',ich)

end
end % end loop over files
if MakePlot405, % two channel summary histogram of global scores
for ich=1:2
OverallBiRanks{ich}=OverallBiRanks{ich}(1:BiRankCount(ich));
figure(405)
if ich==1, clf; else hold on; end;
hr = 0:0.01:1;
w=hist(OverallBiRanks{ich},hr);
if ich==1, stairs(hr,w,'b'); else stairs(hr,w,'r'); end;
xstring='Score';
ystring='Counts';
if ich==2,
tstring='HA HRG Pattern: ';
tstring = [tstring sprintf('%d',ScorePattern)];
legend('ch1','ch2');
FormatThisFigure;
FigureName=sprintf('HA_HRG_%s_both_Pt',SpecialString);
FigureName=[OutputFolder FigureName sprintf('%d',ScorePattern)];
SaveThisFigure;
end
end
end
toc
return
ContourV004.m
%% Cluster calls and contour finding for 'short' points from an SPTData file %%
%% Development history / features
% ** Version 1 **
% * loads the result of the first two sets of processing steps performed
% on a single movie file
% * requires a set of points, organized in a distance based cluster
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% structure, and a length parameter value
% * makes a plot of the points, colored by the cluster assignment
% * performs the contour finding for a set of selected clusters
% * plots the clusters andthe contours un a multi-plot
% * Contour finding algorithm:
% - starts from the rightmost point
% (could be any point on the convex hull)
% - uses a reference direction
% + initially the RD is the positive x
% - Update steps:
% + subsequently, RD is 60 degrees to the left of the direction
%
pointing from the current to the previous point
% + identify all points within L of the current point
% + calculates their angle w.r.to RD
% + next point is the one with the smallest such angle
% - Stopping criteria
% + The initial point is hit
%
TODO: change this to crossing the initial segment in the same direction
% + Number of steps exceeds nuber of points
%
% ** Version 2 **
% Contour algorithm
% * make sure it works for small clusters
% * change stopping criterion to segment
% * add expanded footprint (rectangles and circles)
% * build polyline contour of expanded footprint
%
% ** Version 3 **
%
% Contour algorithms
% * more options for initial point, direction? -- later
% * connect to convex hull somehow? - not necessary
% * add universal self intersection check (uses polyxpoly() ) -- done
% * convert to function -- done
% * calculate area, perimeter, density, etc. -- done
%
%
%% Switches for behavior and output control %%
if ~exist('TOP12PLOTS','var'), TOP12PLOTS=true; end;% plots the top 12 clusters
Fig.5002
if ~exist('CLUSTERCONTOURPLOTS','var'), CLUSTERCONTOURPLOTS=true;
end;% Fig 5003
if ~exist('OVERLAYPLOTS','var'), OVERLAYPLOTS=false; end;% if true, used hold
on; if false uses clf
if ~exist('FILEOUTPUT','var'), FILEOUTPUT=true; end; % outputs cluster info
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if ~exist('LENGTHSTUDY','var'), LENGTHSTUDY=false; end; % loops over length
values and stops
%RootFileName='ClusterDemoFile_Ch2';
%RootFileName=['Scratch/' ShortFileName];
RootFileName = 'Scratch/TestFile';
RootFileName = ShortFileName;
MyLength=0.035;%
ContourColor=[0 0 0];
% list of distances to look at for clusters
DVecLong = 0.001:0.001:1;
tic
% Clustering
MyZ = linkage(AllShortPoints(:,1:2));
MyT = cluster(MyZ,'cutoff',DVecLong,'criterion','distance');
T=MyT;
toc
if LENGTHSTUDY,
tic
% loop over characteristic lengths
APtot=zeros(length(DVecLong),5);
for Ind=1:length(DVecLong)
Clusters=T(:,Ind);
APtot(Ind,5)=max(Clusters);
for ICl=1:max(Clusters)
BestLength=DVecLong(Ind);
MyPoints=AllShortPoints(Clusters==ICl,1:2);
Contour = TightContour(MyPoints, 1.01*BestLength);
% area inside the tight contour - assumed closed
AreaIn = polyarea(MyPoints(Contour,1), MyPoints(Contour,2));% area inside the
tight contour - assumed closed
% length of inner perimeter
PerimIn
=
sum(sqrt(sum((MyPoints(Contour([2:end
1]),:)
MyPoints(Contour,:)).^2,2)));
% estimation of padding area (add rectangles + a circle)
AreaTot = AreaIn + PerimIn * BestLength/2 + pi*(BestLength/2)^2;
% estimation of padded contour length (innner perimeter + circle
PerimTot = PerimIn + pi * BestLength;
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APtot(Ind,1:4)=APtot(Ind,1:4)+[AreaIn, AreaTot, PerimIn, PerimTot];
end
fprintf('L=%3dnm NCl=%3d Ain=%6.3f Atot=%6.3f Pin=%5.3f Ptot=%5.3f\n',...
floor(DVecLong(Ind)*1000), max(Clusters), APtot(Ind,1:4));

end
toc
figure(2001)
FileName=[ShortFileName sprintf('_ch%d_LengthStudy',Channel)];
save(FileName);
return
end
% pull out the cluster arrangement with the chosen length scale
if exist('MyLength','var'),
BestInd=find(DVecLong>=MyLength,1);
BestLength=DVecLong(BestInd);
Clusters=T(:,BestInd);
end

%% Preliminaries
% cell array to collect the cluster info
% {<number of points>, <Nx2 array of points>}
% for: (1) actual points, (2) tight contour, (3) fat contour
ClustersAndContours=cell(max(Clusters), 6);
% count the points in each cluster
CC=zeros(max(Clusters),1); % holds cluster sizes, should be replaced eventually
for IC=1:max(Clusters)
CC(IC)=sum(Clusters==IC);
end
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% find the top 12 clusters by size
Q = [[1:max(Clusters)]',CC];
Q = sortrows(Q,-2);
SpecialClusters = Q(1:12,1);
% This will collect area and perimeter info
% inside A / P, est. padding A /P , padded polyline A / P
ClusterAP = zeros(max(Clusters), 6);
if CLUSTERCONTOURPLOTS,
figure(5003);
if OVERLAYPLOTS, hold on; else clf; end;
plot(AllShortPoints(:,1),AllShortPoints(:,2),'ro','MarkerSize',1);
end
%% Contour building loop over clusters %%
for ISCC=1:max(Clusters);
%% Pick out a cluster %%
Chozen = find(Clusters==ISCC);
% this is nonempty if this cluster is on the list
ISC=find(SpecialClusters==ISCC,1);
MyPoints = AllShortPoints(Chozen,1:2);
% record the points of this cluster
ClustersAndContours{ISCC,1}=CC(ISCC);
ClustersAndContours{ISCC,2}=MyPoints(:,1:2);
% Build the tight contour
BestLength2=BestLength*1.01;
Contour = TightContour(MyPoints, BestLength2);
% record the tight contour - no repeat of the first point
ClustersAndContours{ISCC,3}= size(Contour,1);
ClustersAndContours{ISCC,4}=MyPoints(Contour,1:2);
% Build the fat contour
MinAngle = pi / 6; % for spokes in circles added around corners
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FatContour = FatContourBuild(MyPoints(Contour,1:2), BestLength2, MinAngle);
if TOP12PLOTS && ~isempty(ISC), % make a plot for this cluster
figure(5002);
subplot(4,3,ISC,'replace')
% plot the points in the cluster
plot(MyPoints(:,1),MyPoints(:,2),...
'ro','MarkerSize',2,'MarkerFaceColor',[0.9 0.9 0],'LineWidth',0.5);
hold on
% plot the tight contour (close it)
Inds=Contour([1:end,1]);% normal
%StopInd=min(size(Contour,1),30);Inds=Contour(1:StopInd);%debug
plot(MyPoints(Inds,1),MyPoints(Inds,2),...
'bo-','MarkerSize',2,'LineWidth',0.5);
% plot the fat contour (it is closed already)
plot(FatContour(:,1),FatContour(:,2),'k-');
% format and embellish
axis equal
tstring=sprintf('#%d (%d pts.)', ISCC, CC(ISCC));
title(tstring);
FormatThisFigure;% makes the output nicer
end;
% record the fat contour - skip the repeat of the first point
ClustersAndContours{ISCC,5}=size(FatContour,1)-1;
ClustersAndContours{ISCC,6}=FatContour(1:end-1,:);
%% geometry - areas and perimeters
% area inside the tight contour - assumed closed
ClusterAP(ISCC,1) = polyarea(MyPoints(Contour,1), MyPoints(Contour,2));
% length of inner perimeter
ClusterAP(ISCC,2)
=
MyPoints(Contour,:)).^2,2)));

sum(sqrt(sum((MyPoints(Contour([2:end

1]),:)

-

% estimation of padding area (add rectangles + a circle)
ClusterAP(ISCC,3) = ClusterAP(ISCC,1) + ClusterAP(ISCC,2) * BestLength2/2 +
pi*(BestLength2/2)^2;
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% estimation of padded contour length (innner perimeter + circle
ClusterAP(ISCC,4) = ClusterAP(ISCC,2) + pi * BestLength2;
% area of fat contour
ClusterAP(ISCC,5) = polyarea(FatContour(:,1),FatContour(:,2));
% perimeter of fat contour
ClusterAP(ISCC,6)
=
1,:)).^2,2)));

sum(sqrt(sum((FatContour(2:end,:)-FatContour(1:end-

if CLUSTERCONTOURPLOTS,
figure(5003)
hold on
if ClustersAndContours{ISCC,1}
','Color',ContourColor); end;
figure(1003)
hold on
if ClustersAndContours{ISCC,1}
','Color',ContourColor); end;
end

>

0,

plot(FatContour(:,1),FatContour(:,2),'-

>

0,

plot(FatContour(:,1),FatContour(:,2),'-

end

if TOP12PLOTS,
figure(5002);
FigureName=[RootFileName sprintf('_%dnm_TopClusters',floor(1000*BestLength))];
SaveThisFigure;
end;
if CLUSTERCONTOURPLOTS,
figure(5003)
%axis([22 23 15.5 16.5])
FormatThisFigure;
FigureName=[RootFileName '_AllContours'];
%savefig(FigureName);
SaveThisFigure;
end
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if FILEOUTPUT ,
% metadata output
% point count, perimeter, area, etc.
fout = fopen([RootFileName sprintf('_%dnm_meta.txt',floor(1000*BestLength))],'w');
for ISC=1:max(Clusters)
%if DEMO && ISC>12, break; end; % loop limited to the 12
fprintf(fout,'%3d ', ISC); % cluster index
fprintf(fout,'%4d ',ClustersAndContours{ISC,1});% original (slow) point count
fprintf(fout,'%4d ',ClustersAndContours{ISC,3});% point count on tight contour
fprintf(fout,'%4d ',ClustersAndContours{ISC,5});% point count on padded contour
fprintf(fout,'%6.4f %6.4f %6.4f %6.4f %6.4f %6.4f\n', ClusterAP(ISC,[1 3 5 2 4
6]));
end
fclose(fout);
% contour output
% polylines for each contour
fout=fopen([RootFileName
sprintf('_%dnm_contours.txt',floor(1000*BestLength))],'w');
% number of clusters on a separate line
fprintf(fout,'%4d\n',max(Clusters));
% write out the fat contours only
for ISC=1:max(Clusters)
% if DEMO && ISC>12, break; end; % loop limited to the 12
% point counts from all contours on a single line
fprintf(fout,'%4d', ClustersAndContours{ISC,5});
end
fprintf(fout,'\n');
for ISC=1:max(Clusters)
% if DEMO && ISC>12, break; end; % loop limited to the 12
% pull out the contour data
FatContourOut=ClustersAndContours{ISC,6};
% x coordinates on a single line
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fprintf(fout,'%8.5f ',FatContourOut(:,1));
fprintf(fout,'\n');
% y cordinates on a single line
fprintf(fout,'%8.5f ',FatContourOut(:,2));
fprintf(fout,'\n');
end
fclose(fout);
end;
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APPENDIX B: Spatial Stochastic Model Program Script
ReceptorInfo Module
MODULE ReceptorInfo
! General Constants
DOUBLE PRECISION, PARAMETER :: Pi = 3.14159265
! Species
!
!
(1) ErbB2
!
(2) ErbB3
!
(3) ErbB2.ErbB3
!
(4) ErbB3.ErbB3
!
(5) ErbB2.ErbB2
! Species Info
INTEGER :: NumBaseSpecies
INTEGER :: NumPhosStates
INTEGER :: NumLigandStates
INTEGER :: NumMonomerSpecies
! Species during simulation
INTEGER, POINTER :: SpeciesCount(:)
! Species matrix f(monomer species, monomer species)
INTEGER, POINTER :: SpeciesMatrix(:,:) ! 2,2
! Dimer Allowed to form f(species,ligandcount)
LOGICAL, POINTER :: DimerForm(:,:) ! 5,3
! Diffusion Coefficients [=] um^2/s, f(species, phosphorylation)
! *** Parameters from Mara, lumped Monomer/Dimer together***
!
Unphosphorylated Species
DOUBLE PRECISION, POINTER :: DiffCoeff(:,:) ! 5,3
! Phosphorylation Rate [=] 1/s, f(species, phosphorylation)
! *** Parameters from Shankaran et al (2006) BiophysJ ***
! No Phosphorylation
DOUBLE PRECISION, POINTER :: PhosRate(:,:) ! 5,3
! Dephosphorylation Rate [=] 1/s, f(species,phosphorylation)
! *** Parameters from Shankaran et al (2006) BiophysJ ***
DOUBLE PRECISION, POINTER :: DePhosRate(:,:) ! 5,3
! Dimer Off Rate [=] 1/s, f(species,ligand)
! *** Parameters from Mara, unless noted ***
! No Ligand
DOUBLE PRECISION, POINTER :: DimOffRate(:,:) ! 5,3
! Dimer Binding Radius [=] um, f(proposed species type, phosphorylation)
! Dimers forming with No Phos
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DOUBLE PRECISION, POINTER :: BindRadius(:,:) ! 5,3
! Dimer UnBinding Radius [=] um, f(proposed species type, proposed ligand
count)
! Dimers forming with No Ligand
DOUBLE PRECISION, POINTER :: UnBindRadius(:,:) ! 5,3
! Domain Escape Rate [=] 1/Frame, f(species)
! *** Shalini Data for now ***
DOUBLE PRECISION, POINTER :: EscapeRate(:) ! 5
! Receptor Flux Probability
DOUBLE PRECISION, POINTER :: RecFlip(:) ! 2
! Phosphorylation Multiplier
DOUBLE PRECISION, POINTER :: PhosMulti(:,:) ! 2,3
! Dephosphorylation Multiplier
DOUBLE PRECISION, POINTER :: DephosMulti(:,:) ! 2,3
Type Molecule
! Species [1-5]
INTEGER :: OriginalSpecies
INTEGER :: Species
! Ligand State [0 1]
INTEGER :: Ligand
! Phos State [0 1]
INTEGER :: Phosphate
! Position(2)
DOUBLE PRECISION :: Position(2)
! Initial Position(2)
DOUBLE PRECISION :: InitialPosition(2)
! Bound Partner
INTEGER :: BoundBuddy
! Domain
INTEGER :: Domain
! Active Receptor Receptor in dimer that is in active conformation
INTEGER :: ActiveTail
END TYPE Molecule
TYPE MoleculeData
! Dimer Lifetime
DOUBLE PRECISION :: DimerStart
! Phosphorylation Lifetime
DOUBLE PRECISION :: PhosStart
! Last Jump Size [=] um
DOUBLE PRECISION :: JumpSize(3)
! Tail has been phosphorylated in this dimer lifetime
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INTEGER :: PhosSuccess
END TYPE MoleculeData
!TYPE DomainLimits
!
!
!
!
!
!
!
!
!
!
!
!
!
!

DOUBLE PRECISION, POINTER :: xmin
DOUBLE PRECISION, POINTER :: xmax
DOUBLE PRECISION, POINTER :: ymin
DOUBLE PRECISION, POINTER :: ymax
END TYPE DomainLimits
TYPE DomainVertices
DOUBLE PRECISION, POINTER :: XCoord(:) => null()
DOUBLE PRECISION, POINTER :: YCoord(:) => null()
END TYPE DomainVertices
TYPE DomainInfo
DOUBLE PRECISION, POINTER :: xmin
DOUBLE PRECISION, POINTER :: xmax
DOUBLE PRECISION, POINTER :: ymin
DOUBLE PRECISION, POINTER :: ymax
DOUBLE PRECISION, POINTER :: XCoord(:) => null()
DOUBLE PRECISION, POINTER :: YCoord(:) => null()
END TYPE DomainInfo
TYPE MembraneLimits
DOUBLE PRECISION :: xlimmin
DOUBLE PRECISION :: xlimmax
DOUBLE PRECISION :: ylimmin
DOUBLE PRECISION :: ylimmax
END TYPE MembraneLimits
TYPE SimulationData
DOUBLE PRECISION :: Length ! Seconds
DOUBLE PRECISION :: TimeStep ! Seconds
DOUBLE PRECISION :: RTimeStep ! TimeStep per Receptor
DOUBLE PRECISION :: CurrentTimeStep
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DOUBLE PRECISION :: FrameRate ! Frames per Second
INTEGER :: NumberReceptors
INTEGER, POINTER :: NumberDomains(:) ! => null()
CHARACTER(80) :: OutputDirectory
INTEGER, POINTER :: NumberVertices(:,:) ! => null()
END TYPE SimulationData
TYPE SpeciesData
INTEGER :: Liganded(3)
INTEGER :: Phosphorylated(3)
END TYPE SpeciesData
TYPE(Molecule), POINTER :: Receptor(:)
TYPE(MoleculeData), POINTER :: ReceptorData(:)
TYPE(DomainInfo), POINTER :: Domain(:,:)
!TYPE(DomainLimits), POINTER :: Domain(:)
!TYPE(DomainVertices), POINTER :: Vertex(:)
TYPE(SpeciesData), POINTER :: Species(:)
TYPE(MembraneLimits) :: Membrane
TYPE(SimulationData) :: Simulation
END MODULE ReceptorInfo
BoundaryCondition Module
MODULE BCCheck
CONTAINS
SUBROUTINE PeriodicBC(i,xjump,yjump)
USE ReceptorInfo
IMPLICIT NONE
DOUBLE PRECISION, INTENT(IN) :: xjump, yjump! Proposed x jump,
Proposed y jump
INTEGER, INTENT(IN) :: i ! current receptor
DOUBLE PRECISION :: x, y ! proposed new position
! Calculate new receptor position
x = xjump + Receptor(i)%Position(1)
y = yjump + Receptor(i)%Position(2)
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!! Periodic Boundary Conditions
! Check & Apply Periodic Boundary Condition
! Check x move
IF (x < Membrane%xlimmin) THEN ! Add width of box
! Define X New Coordinate
Receptor(i)%Position(1)=x+(Membrane%xlimmaxMembrane%xlimmin)
ELSE IF (x > Membrane%xlimmax) THEN ! Subtract width of box
! Define X New Coordinate
Receptor(i)%Position(1)=x-(Membrane%xlimmaxMembrane%xlimmin)
ELSE ! remains unchanged
! Define X New Coordinate
Receptor(i)%Position(1)=x
END IF
! Check y move
IF (y < Membrane%ylimmin) THEN ! Add length of box
! Define Y New Coordinate
Receptor(i)%Position(2)=y+(Membrane%ylimmaxMembrane%ylimmin)
ELSE IF (y > Membrane%ylimmax) THEN ! Subtract length of box
! Define Y New Coordinate
Receptor(i)%Position(2)=y-(Membrane%ylimmaxMembrane%ylimmin)
ELSE ! remains unchanged
! Define Y New Coordinate
Receptor(i)%Position(2)=y
END IF
! No periodic condition applied to allow for free diffusion
END SUBROUTINE PeriodicBC
SUBROUTINE ReflectiveBC(i,xjump,yjump)
! Condition: Only for receptors in domains, does not work for free
receptors
USE ReceptorInfo
IMPLICIT NONE
DOUBLE PRECISION, INTENT(IN) :: xjump, yjump
INTEGER, INTENT(IN) :: i ! Current receptor
DOUBLE PRECISION :: x, y ! Proposed move
IF (Receptor(i)%Domain == 0) THEN
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WRITE(*,*) 'ERROR : FREE RECEPTOR PASSED TO
ReflectiveBC Subroutine'
END IF
! Check & Apply Reflective Boundary Condition
x=Receptor(i)%Position(1)+xjump
y=Receptor(i)%Position(2)+yjump
!WRITE(*,*) 'x = ', x, 'y = ', y
! Check x move
IF
(x
Domain(Receptor(i)%Domain,Receptor(i)%OriginalSpecies)%xmin) THEN
! Define X New Coordinate

<

Receptor(i)%Position(1)=2*Domain(Receptor(i)%Domain,Receptor(i)%Original
Species)%xmin&
&-xjump-Receptor(i)%Position(1)
ELSE
IF
(x
>
Domain(Receptor(i)%Domain,Receptor(i)%OriginalSpecies)%xmax) THEN
! Define X New Coordinate
Receptor(i)%Position(1)=2*Domain(Receptor(i)%Domain,Receptor(i)%Original
Species)%xmax&
&-xjump-Receptor(i)%Position(1)
END IF
! Check y move
IF
(y
Domain(Receptor(i)%Domain,Receptor(i)%OriginalSpecies)%ymin) THEN
! Define Y New Coordinate

<

Receptor(i)%Position(2)=2*Domain(Receptor(i)%Domain,Receptor(i)%Original
Species)%ymin&
&-yjump-Receptor(i)%Position(2)
ELSE
IF
(y
>
Domain(Receptor(i)%Domain,Receptor(i)%OriginalSpecies)%ymax) THEN
! Define Y New Coordinate
Receptor(i)%Position(2)=2*Domain(Receptor(i)%Domain,Receptor(i)%Original
Species)%ymax&
&-yjump-Receptor(i)%Position(2)
END IF
END SUBROUTINE ReflectiveBC
SUBROUTINE DomainCheck(i,xjump,yjump,domainnum,DomainChange)
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USE ReceptorInfo
IMPLICIT NONE
INTEGER, INTENT(IN) :: i ! Current receptor
INTEGER, INTENT(OUT) :: domainnum ! domain where proposed coordinates
fall, if 0 not in a domain
DOUBLE PRECISION, INTENT(IN) :: yjump, xjump
INTEGER :: k, numdomains, j, kk, nverts, ReceptorDomain, c, jjj ! Counter
DOUBLE PRECISION :: x, y ! proposed new location
LOGICAL, INTENT(OUT) :: DomainChange
LOGICAL
::
xmincheck(Simulation%NumberDomains(Receptor(i)%OriginalSpecies))
LOGICAL
::
ymincheck(Simulation%NumberDomains(Receptor(i)%OriginalSpecies))
LOGICAL
::
xmaxcheck(Simulation%NumberDomains(Receptor(i)%OriginalSpecies))
LOGICAL
::
ymaxcheck(Simulation%NumberDomains(Receptor(i)%OriginalSpecies))
x=Receptor(i)%Position(1) + xjump
y=Receptor(i)%Position(2) + yjump
DomainChange = .FALSE.
ReceptorDomain = Receptor(i)%Domain
numdomains = Simulation%NumberDomains(Receptor(i)%OriginalSpecies)
!ALLOCATE(xmincheck(Simulation%NumberDomains),
xmaxcheck(Simulation%NumberDomains))
!ALLOCATE(ymincheck(Simulation%NumberDomains),
ymaxcheck(Simulation%NumberDomains))
! Check where the new coordinate falls in the simulation space
domainnum = 0 !Receptor(i)%Domain
IF (numdomains /= 0) THEN
!WRITE(*,*) 'Check if Receptor is in a Domain. Receptor Species
Receptor(i)%OriginalSpecies, 'numdomains =', numdomains
! Create boolean vectors for each domain edge
DO jjj = 1, numdomains
xmincheck
=
x
Domain(jjj,Receptor(i)%OriginalSpecies)%xmin
xmaxcheck
=
x
Domain(jjj,Receptor(i)%OriginalSpecies)%xmax
ymincheck
=
y
Domain(jjj,Receptor(i)%OriginalSpecies)%ymin
ymaxcheck
=
y
Domain(jjj,Receptor(i)%OriginalSpecies)%ymax
END DO
!WRITE(*,*) x, y
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=',

>=
<=
>=
<=

!WRITE(*,*) xmincheck, xmaxcheck, ymincheck, ymaxcheck
DO k = 1,numdomains
IF (xmincheck(k) .AND. xmaxcheck(k) .AND. ymincheck(k)
.AND. ymaxcheck(k)) THEN
!WRITE(*,*) 'Receptor MAY be in a domain'
domainnum = k
! Check if receptor is actually in polygon
nverts
=
Simulation%NumberVertices(k,Receptor(i)%OriginalSpecies)
kk = nverts - 1
j=1
c=0
DO WHILE (j < nverts)
! ,Receptor(i)%OriginalSpecies
!IF (((Vertex(k)%YCoord(j) >
(Vertex(k)%YCoord(kk)>y)) .AND. &
!
(x<(Vertex(k)%XCoord(kk)Vertex(k)%XCoord(j))*(y-Vertex(k)%YCoord(j))&
!
/(Vertex(k)%YCoord(kk)Vertex(k)%YCoord(j))+Vertex(k)%XCoord(j))) THEN
IF
(((Domain(k,Receptor(i)%OriginalSpecies)%YCoord(j) > y) .NEQV. &

y)

&(Domain(k,Receptor(i)%OriginalSpecies)%YCoord(kk)>y)) .AND. &
(x<(Domain(k,Receptor(i)%OriginalSpecies)%XCoord(kk)-&
&Domain(k,Receptor(i)%OriginalSpecies)%XCoord(j))*&
&(yDomain(k,Receptor(i)%OriginalSpecies)%YCoord(j))&
/(Domain(k,Receptor(i)%OriginalSpecies)%YCoord(kk)-&
&Domain(k,Receptor(i)%OriginalSpecies)%YCoord(j))+&
&Domain(k,Receptor(i)%OriginalSpecies)%XCoord(j))) THEN
c=c+1
END IF
kk = j
j=j+1
END DO
IF (MOD(c,2) /= 0) THEN
!WRITE(*,*) 'Receptor IS in a domain'
IF (domainnum /= ReceptorDomain) THEN
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.NEQV.

DomainChange = .True.
END IF
ELSE
!WRITE(*,*) 'Receptor IS NOT in a domain'
domainnum = 0
END IF
END IF
END DO
END IF
IF (domainnum == 0 .AND. domainnum /= ReceptorDomain) THEN
DomainChange = .True.
END IF
!WRITE(*,*) 'Domain Change?', DomainChange, 'New Domain', domainnum,
'Old Domain', Receptor(i)%Domain
END SUBROUTINE DomainCheck
SUBROUTINE DomainEscape(EscapeProb,i,xjump,yjump,domainnum)
! Condition: Only for receptors in domains, does not work for free
receptors
USE ReceptorInfo
USE mtmod
IMPLICIT NONE
DOUBLE PRECISION, INTENT(IN) :: EscapeProb, xjump, yjump
INTEGER, INTENT(IN) :: i, domainnum ! Current receptor, anticipated
domain
INTEGER :: domainnum2
LOGICAL :: DomainChange2
DomainChange2 = .False.
IF (Receptor(i)%Domain == 0 .AND. EscapeProb < 1) THEN
WRITE(*,*) 'ERROR : FREE RECEPTOR PASSED TO
DomainEscape Subroutine'
END IF
!IF (Receptor(i)%Species == 3) THEN
!
IF
(Receptor(i)%Domain
>
0
.AND.
Receptor(Receptor(i)%BoundBuddy)%Domain > 0) THEN
!
WRITE(*,*) 'Dimer with Receptors in their own domains',
Receptor(i)%OriginalSpecies,&
!
& Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies
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!
!

END IF
END IF
IF (EscapeProb >= grnd()) THEN ! Escape!
IF (EscapeProb /= 1) THEN
!WRITE(*,*) 'ESCAPE! Successful Domain Change'
END IF
IF (domainnum == 0) THEN ! Moving to free membrane, check

periodic BC
!WRITE(*,*) 'Periodic Check'
CALL PeriodicBC(i,xjump,yjump)
ELSE ! Moving to another domain
!WRITE(*,*) 'Auto Assign'
Receptor(i)%Position(1)=Receptor(i)%Position(1)+xjump
Receptor(i)%Position(2)=Receptor(i)%Position(2)+yjump
Receptor(i)%Domain=domainnum
END IF
ELSE ! Reflect back into domain
!WRITE(*,*) 'Reflective Check'
CALL ReflectiveBC(i,xjump,yjump)
END IF
IF (Receptor(i)%Species == 3) THEN ! Heterodimer
! Check of opposite species leaves its own domain
CALL
DomainCheck(Receptor(i)%BoundBuddy,xjump,yjump,domainnum2,DomainChange2)
! Update bound receptors position
Receptor(Receptor(i)%BoundBuddy)%Position(1)=Receptor(i)%Position(1)+xju
mp
Receptor(Receptor(i)%BoundBuddy)%Position(2)=Receptor(i)%Position(2)+yju
mp
! Update bound buddy domain information
IF (DomainChange2) THEN
!WRITE(*,*) 'Dimer with Receptors in their own
domains', Receptor(i)%OriginalSpecies,&
!&
Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies
!WRITE(*,*)
'New
Domain
1',
Receptor(i)%Domain, 'Domain 2', Receptor(Receptor(i)%BoundBuddy)%Domain
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Receptor(Receptor(i)%BoundBuddy)%Domain=domainnum2
!WRITE(*,*) '-----------------------------^^^^^^^-----------------'
!WRITE(*,*) 'Domain Change for BoundBuddy?',
DomainChange2
!WRITE(*,*)

'domainnum

=',

domainnum,

'domainnum2 =', domainnum2
!WRITE(*,*)
'New
Domain
1',
Receptor(i)%Domain, 'New Domain 2', Receptor(Receptor(i)%BoundBuddy)%Domain
!WRITE(*,*) '-----------------------------------------------------'
END IF
END IF
END SUBROUTINE DomainEscape
END MODULE BCCheck
ReceptorReactions Module
MODULE ReceptorReactions
CONTAINS
! Diffusion (Dimerization Possible)
SUBROUTINE ReceptorDiffuse(i,Reaction)
USE ReceptorInfo
USE mtmod
USE BCCheck
IMPLICIT NONE
INTEGER, INTENT(IN) :: i
DOUBLE PRECISION :: r1, r2, w1, w2, xjump, yjump, DiffSTD,
EscapeProb
INTEGER :: LigandCount, PhosphateCount, domainnum, domainnum2
LOGICAL :: DomainChange, DomainChange2, Dimer, Reaction
! Calculate Ligand count and phosphate count of current receptor and its
partner (if applicable)
Reaction = .False.
Dimer = .False.
DomainChange2 = .False.
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IF (Receptor(i)%BoundBuddy > 0) THEN ! Dimer
Dimer = .True.
LigandCount
=
Receptor(i)%Ligand
Receptor(Receptor(i)%BoundBuddy)%Ligand + 1
PhosphateCount
=
Receptor(i)%Phosphate
Receptor(Receptor(i)%BoundBuddy)%Phosphate + 1
ELSE ! Monomer
LigandCount = Receptor(i)%Ligand + 1
PhosphateCount = Receptor(i)%Phosphate + 1
END IF
! Calculate Escape Probability
EscapeProb
EscapeRate(Receptor(i)%Species)*Simulation%FrameRate*Simulation%TimeStep

+
+

=

! Calculate Diffusion Deviation, DiffCoeff(Species,Phosphate)
! ***increase phosphate count by 1 due to array indexing starting at 1 not
0***
DiffSTD=sqrt(2*DiffCoeff(Receptor(i)%Species,PhosphateCount)*Simulation%
TimeStep)
!!! randomly make a trajectory for particles using mtmod.f90 for random
numbers !!!
!! Generate random number & Normally distribute random number !
http://www.taygeta.com/random/gaussian.html
!* Generate x move
r1=2*grnd()-1
r2=2*grnd()-1
! Check unit circle, if not in reject and try again
w1=r1*r1+r2*r2
DO WHILE (w1 > 1)
! Generate random number again
r1=2*grnd()-1
r2=2*grnd()-1
! Unit circle check
w1=r1*r1+r2*r2
END DO
w2=sqrt((-2*log(w1))/w1)
! Normally distributed random # for distance
xjump=r1*w2
! Generate y move
r1=2*grnd()-1
r2=2*grnd()-1
! Check unit circle, if not in reject and try again
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w1=r1*r1+r2*r2
DO WHILE (w1 > 1)
! Generate random number again
r1=2*grnd()-1
r2=2*grnd()-1
! Unit circle check
w1=r1*r1+r2*r2
END DO
w2=sqrt((-2*log(w1))/w1)
yjump=r2*w2
! Account for diffusion coefficient based on species type
yjump=yjump*DiffSTD
xjump=xjump*DiffSTD
!! Add new normaly distributed distance to previous distance
! Define Move Distance
ReceptorData(i)%JumpSize(1)=xjump ! dx(j,i)=xjump
ReceptorData(i)%JumpSize(2)=yjump ! dy(j,i)=yjump
! Overall Distance Interval Calculation
ReceptorData(i)%JumpSize(3)=sqrt(yjump**2+xjump**2)
d(j,i)=sqrt(yjump**2+xjump**2)
! Assign move distances to bound receptor if necessary
IF (Dimer) THEN

!

ReceptorData(Receptor(i)%BoundBuddy)%JumpSize(:)=ReceptorData(i)%Jump
Size(:)
END IF
! Determine if the particle leaves the domain or stays in the domain
CALL DomainCheck(i,xjump,yjump,domainnum,DomainChange)
IF (DomainChange) THEN ! Changing domains
! Check if leaving or entering domain
IF (Receptor(i)%Domain > 0) THEN ! Leaving domain
! Check if receptor escapes, if yes move to new domain
CALL
DomainEscape(EscapeProb,i,xjump,yjump,domainnum)
ELSE ! Free receptor moving to domain, always allowed
! execute with escape prob = 1
CALL DomainEscape(1.0d0,i,xjump,yjump,domainnum)
END IF
ELSE ! Not Changing domains
! execute with escape prob = 1 just updates position or calls
periodic if needed
CALL DomainEscape(1.0d0,i,xjump,yjump,domainnum)
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END IF
IF (.NOT. Dimer) THEN ! Monomer, Check for dimerization
CALL BindReaction(i,Dimer)
Reaction = Dimer
END IF
IF (Dimer .AND. Receptor(i)%Species > 3) THEN ! Homodimers
IF (Receptor(i)%BoundBuddy == 0) THEN
WRITE(*,*) 'ERROR : Monomer being treated as Dimer in
ReceptorDiffuse Subroutine'
END IF
! Update boundbuddy info
Receptor(Receptor(i)%BoundBuddy)%Position(1)=Receptor(i)%Position(1)
Receptor(Receptor(i)%BoundBuddy)%Position(2)=Receptor(i)%Position(2)
Receptor(Receptor(i)%BoundBuddy)%Domain=Receptor(i)%Domain
END IF
END SUBROUTINE ReceptorDiffuse
! Dimerization Reaction
SUBROUTINE BindReaction(i,Reaction)
! CONDITION: Can only be called for monomer species!!!
USE ReceptorInfo
USE mtmod
IMPLICIT NONE
INTEGER, INTENT(IN) :: i ! current particle
LOGICAL, INTENT(OUT) :: Reaction
LOGICAL :: monomercheck(Simulation%NumberReceptors), DimerPoss,
PhosCheck
INTEGER :: PickedSpecies, Phosphate(Simulation%NumberReceptors),
LigandCount(Simulation%NumberReceptors)
INTEGER :: NewSpecies, k
DOUBLE
PRECISION
::
x_POI,
y_POI,
distsq(Simulation%NumberReceptors), rannum
Reaction = .FALSE.
PhosCheck = .TRUE.
! Error check
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IF (Receptor(i)%BoundBuddy > 0) THEN
WRITE(*,*) 'ERROR : DIMER SPECIES PASSED TO
BindReaction Subroutine'
END IF
x_POI=Receptor(i)%Position(1)
y_POI=Receptor(i)%Position(2)
PickedSpecies = Receptor(i)%Species ! Always a monomer
! Calculate distance between picked receptor and other receptors
distsq=sqrt((Receptor%Position(1)-x_POI)**2+(Receptor%Position(2)y_POI)**2)
! Determine monomers
monomercheck = Receptor%Species <= SIZE(SpeciesMatrix,1)
! Calculate proposed phosphate & species, Add 1 for index counting
starting at 1, 0 phosphates accessed by variable(1)
Phosphate = Receptor(i)%Phosphate+Receptor%Phosphate + 1
LigandCount = Receptor(i)%Ligand+Receptor%Ligand + 1
DO k = 1,Simulation%NumberReceptors
IF (monomercheck(k)) THEN
NewSpecies
=
SpeciesMatrix(PickedSpecies,Receptor(k)%Species)
DimerPoss = DimerForm(NewSpecies,LigandCount(k))
IF
(DimerPoss
.AND.
BindRadius(NewSpecies,Phosphate(k)) .AND. k/=i) THEN

distsq(k)

<=

rannum = 0
IF (LigandCount(k) < 3) THEN
rannum = grnd()
END IF
IF (rannum <= RecFlip(PickedSpecies)) THEN !
Check conformation of first monomer
rannum = 0
IF (LigandCount(k) == 1) THEN
rannum = grnd()
END IF
IF
(rannum
RecFlip(Receptor(k)%Species)) THEN ! Check conformation of second monomer
Reaction = .True.
SpeciesCount(PickedSpecies)=SpeciesCount(PickedSpecies)-1
SpeciesCount(Receptor(k)%Species)=SpeciesCount(Receptor(k)%Species)-1
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<=

! Record Dimer Start Time
Receptor(i)%Species = NewSpecies
Receptor(k)%Species = NewSpecies
ReceptorData(i)%DimerStart
=
Simulation%CurrentTimeStep
ReceptorData(k)%DimerStart
Simulation%CurrentTimeStep
Receptor(i)%BoundBuddy=k
Receptor(k)%BoundBuddy=i
SpeciesCount(PickedSpecies)=SpeciesCount(PickedSpecies)+1
! Pick active receptor of dimer
rannum = grnd()
IF (rannum <= .5) THEN
Receptor(i)%ActiveTail=i
Receptor(k)%ActiveTail=i
ELSE
Receptor(i)%ActiveTail=k
Receptor(k)%ActiveTail=k
END IF
END IF
END IF
RETURN
END IF
END IF
END DO
END SUBROUTINE BindReaction
! Dimer dissociation Reaction
SUBROUTINE DissociationReaction(i)
USE ReceptorInfo
USE mtmod
USE BCCheck
IMPLICIT NONE
INTEGER, INTENT(IN) :: i
DOUBLE PRECISION :: placeangle, xjump, yjump, EscapeProb
INTEGER :: LigandCount, PhosphateCount, domainnum, k
LOGICAL :: DomainChange
! We know dissociation will occur, need to sort out data information
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=

SpeciesCount(Receptor(i)%Species)=SpeciesCount(Receptor(i)%Species)-1
! Calculate new postion for moving (unbinding) receptor
! Randomly pick position to place chosen part
placeangle=2*Pi*grnd() ! Pick a number between 0 and 2*Pi
! Calculate LigandCount
LigandCount
=
Receptor(i)%Ligand
+
Receptor(Receptor(i)%BoundBuddy)%Ligand + 1
PhosphateCount
=
Receptor(i)%Phosphate
+
Receptor(Receptor(i)%BoundBuddy)%Phosphate + 1
! Separate Receptors
xjump
=
cos(placeangle)*UnBindRadius(Receptor(i)%Species,LigandCount)
yjump
=
sin(placeangle)*UnBindRadius(Receptor(i)%Species,LigandCount)
IF (xjump == 0) THEN
WRITE(*,*) 'ERROR in DissociationReaction'
END IF
! Check if moving receptor changes domains and update position
accordingly
IF (Receptor(Receptor(i)%BoundBuddy)%Domain > 0) THEN ! Check if
moves from domain
CALL
DomainCheck(Receptor(i)%BoundBuddy,xjump,yjump,domainnum,DomainChange)
IF (DomainChange) THEN
! Calculate Escape Probability
EscapeProb
=
EscapeRate(Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies)*Simulation%Frame
Rate*Simulation%TimeStep
CALL
DomainEscape(EscapeProb,Receptor(i)%BoundBuddy,xjump,yjump,domainnum)
ELSE
CALL
DomainEscape(1.0d0,Receptor(i)%BoundBuddy,xjump,yjump,domainnum)
END IF
END IF
! Record Dimer lifetime
! Receptor 1 receptor 2 Dimer Start, Dimer End, Difference
WRITE(4,*)
i,Receptor(i)%BoundBuddy,Receptor(i)%Species,LigandCount,PhosphateCount,Recepto
rData(i)%DimerStart, &
&Simulation%CurrentTimeStep,Simulation%CurrentTimeStepReceptorData(i)%DimerStart
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! Update both receptors info back to monomer status
SpeciesCount(Receptor(i)%OriginalSpecies)=SpeciesCount(Receptor(i)%Origina
lSpecies)+1
SpeciesCount(Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies)=SpeciesC
ount(Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies)+1
Receptor(Receptor(i)%BoundBuddy)%Species
=
Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies
Receptor(Receptor(i)%BoundBuddy)%BoundBuddy = 0
ReceptorData(Receptor(i)%BoundBuddy)%DimerStart = 0
ReceptorData(Receptor(i)%BoundBuddy)%PhosSuccess = 0
ReceptorData(i)%PhosSuccess = 0
Receptor(i)%ActiveTail = 0
Receptor(Receptor(i)%BoundBuddy)%ActiveTail = 0
Receptor(i)%Species = Receptor(i)%OriginalSpecies
Receptor(i)%BoundBuddy = 0
ReceptorData(i)%DimerStart = 0
END SUBROUTINE DissociationReaction
! Phosphorylation
SUBROUTINE Phosphorylate(i)
USE ReceptorInfo
USE mtmod
IMPLICIT NONE
INTEGER, INTENT(IN) :: i ! Particle number,
IF (Receptor(i)%Species <= SIZE(SpeciesMatrix,1)) THEN
WRITE(*,*) 'ERROR : in Phosphorylate subroutine, monomer
species'
END IF
!! Symmetric Model !!
! update phosphate
!Receptor(i)%Phosphate = 1
!Receptor(Receptor(i)%BoundBuddy)%Phosphate = 1
!IF (Receptor(i)%Species == 4) THEN
WRITE(*,*) 'In Function: PHOSPHORYLATE! Species: ',
Receptor(i)%Species!, 'Ligand Count: ', LigandCount, 'Phos Count: ', PhosphateCount
!WRITE(*,*) 'Species = ', Receptor(i)%Species,'UnbindProb =',
UnbindProb, 'PhosProb =', PhosProb, 'DephosProb =', DephosProb
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WRITE(*,*)
'Ligand
Count
(+1
for
indexing)=',
Receptor(i)%Ligand + Receptor(Receptor(i)%BoundBuddy)%Ligand + 1
WRITE(*,*)
'PhosState
of
ActiveTail
=',
Receptor(Receptor(i)%ActiveTail)%Phosphate
!END IF
!! Asymmetric Model
Receptor(Receptor(i)%ActiveTail)%Phosphate = 1
! update phos start
ReceptorData(Receptor(i)%ActiveTail)%PhosStart
=
Simulation%CurrentTimeStep
ReceptorData(Receptor(i)%ActiveTail)%PhosSuccess = 1
!ReceptorData(Receptor(i)%BoundBuddy)%PhosStart
=
Simulation%CurrentTimeStep
! Record phosphorylation reaction information
! Active Receptor (one phosphorylated), Active Receptor Original
Species, Receiver Receptor, Receiver Phos state, timestamp
WRITE(8,*)
Receptor(i)%ActiveTail,
Receptor(Receptor(i)%ActiveTail)%OriginalSpecies,&
&Receptor(Receptor(i)%ActiveTail)%BoundBuddy,Receptor(Receptor(Receptor(
i)%ActiveTail)%BoundBuddy)%OriginalSpecies,&
&Receptor(Receptor(Receptor(i)%ActiveTail)%BoundBuddy)%Phosphate,
Simulation%CurrentTimeStep
END SUBROUTINE Phosphorylate
! Dephosphorylation
SUBROUTINE DePhosphorylate(i)
! Dephosphorylation Subroutine. Only dephosphorylates the picked receptor. If
the
! receptor is bound to another receptor, the bound receptor is left alone.
USE ReceptorInfo
USE mtmod
IMPLICIT NONE
INTEGER, INTENT(IN) :: i
Receptor(i)%Phosphate = 0
! Record Phos lifetime
! Receptor 1 receptor 2 Phos Start, Phos End, Difference
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WRITE(9,*)
i,Receptor(i)%BoundBuddy,Receptor(i)%Species,ReceptorData(i)%PhosStart, &
&Simulation%CurrentTimeStep,Simulation%CurrentTimeStepReceptorData(i)%PhosStart
ReceptorData(i)%PhosStart = 0
END SUBROUTINE DePhosphorylate
END MODULE ReceptorReactions
Main Spatial Stochastic Simulation Module
PROGRAM ErbB23_Sim
! Use mtmod to generate random number
USE mtmod
USE ReceptorInfo
USE BCCheck
USE ReceptorReactions
IMPLICIT NONE
INTEGER :: i, k, seed, LigandCount, PhosphateCount, datacutcount, datacut
INTEGER :: framecount, frames, DomainLimitsFile(2), DomainVertFile(2)
LOGICAL :: Reaction
INTEGER*8 :: NMoves, RMoves, j
CHARACTER*200 fnstring, fnstring2, fnstring3, fnstring4, fnstring5, fnstring6,
fnstring7 ! Filename string
DOUBLE PRECISION :: UnbindProb, PhosProb, DephosProb, randnum
WRITE(*,*) 'Importing Parameter Data'
OPEN(4,file='ParameterInput')
READ(4,*)
NumBaseSpecies,
NumMonomerSpecies

NumPhosStates,

NumLigandStates,

ALLOCATE(SpeciesMatrix(NumMonomerSpecies,NumMonomerSpecies),Dime
rForm(NumBaseSpecies,NumLigandStates))
ALLOCATE(DiffCoeff(NumBaseSpecies,NumPhosStates),PhosRate(NumBaseS
pecies,NumPhosStates))
ALLOCATE(DePhosRate(NumBaseSpecies,NumPhosStates),DimOffRate(Num
BaseSpecies,NumLigandStates))
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ALLOCATE(BindRadius(NumBaseSpecies,NumPhosStates),UnBindRadius(Nu
mBaseSpecies,NumLigandStates))
ALLOCATE(EscapeRate(NumBaseSpecies),RecFlip(NumMonomerSpecies),Spe
ciesCount(NumBaseSpecies))
ALLOCATE(PhosMulti(NumMonomerSpecies,NumPhosStates),
DephosMulti(NumMonomerSpecies,NumPhosStates))

!
!
!
!
!
!
!

SpeciesCount(:) = 0
! Assign input values to parameters
DO k = 1,NumPhosStates
READ(4,*) DiffCoeff(:,k)
END DO
DO k = 1,NumPhosStates
READ(4,*) PhosRate(:,k)
END DO
DO k = 1,NumPhosStates
READ(4,*) DePhosRate(:,k)
END DO
DO k = 1,NumLigandStates
READ(4,*) DimOffRate(:,k)
END DO
DO k = 1,NumPhosStates
READ(4,*) BindRadius(:,k)
END DO
DO k = 1,NumLigandStates
READ(4,*) UnBindRadius(:,k)
END DO
READ(4,*) EscapeRate(:)
READ(4,*) RecFlip(:)
DO k = 1,NumMonomerSpecies
Read(4,*) SpeciesMatrix(:,k)
END DO
DO k = 1,NumLigandStates
READ(4,*) DimerForm(:,k)
!WRITE(*,*) DimerForm(:,k)
END DO
DO k = 1,NumPhosStates
READ(4,*) PhosMulti(:,k)
WRITE(*,*) 'Phos:',PhosMulti(:,k)
END DO
DO k = 1,NumPhosStates
READ(4,*) DephosMulti(:,k)
END DO
CLOSE(4)
! Read in Simulation input, initial receptor locations, & domain locations
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OPEN (1,file='BMIP')
OPEN (2,file='InitialParticleLoc')
OPEN (7,file='DomainVertices_1')
OPEN (3,file='DomainLimits_1')
OPEN (8,file='DomainVertices_2')
OPEN (4,file='DomainLimits_2')
DomainLimitsFile(1) = 3
DomainLimitsFile(2) = 4
DomainVertFile(1) = 7
DomainVertFile(2) = 8
ALLOCATE (Simulation%NumberDomains(NumMonomerSpecies))
WRITE(*,*) 'Importing Input Data'
! Read in values from input file
READ(1,107) Simulation%OutputDirectory ! HPC Path info
READ(1,100) Simulation%NumberReceptors ! # of particles
READ(1,101) Simulation%TimeStep ! Time step [s]
READ(1,102)
Membrane%xlimmax,Membrane%ylimmax,Membrane%xlimmin,Membrane%ylimmin !
simulation boundaries
READ(1,*) Simulation%FrameRate ! data print frequency
READ(1,106) Simulation%Length
READ(1,109) Simulation%NumberDomains(:) ! simulation length [s], # of
domains [ErbB2 ErbB3]
ALLOCATE
(Receptor(Simulation%NumberReceptors),ReceptorData(Simulation%NumberReceptors
))
ALLOCATE (Species(NumBaseSpecies))
ALLOCATE
(Simulation%NumberVertices(Simulation%NumberDomains(2),NumMonomerSpecies))
DO k = 1,NumBaseSpecies
Species(k)%Liganded(:)=0
Species(k)%Phosphorylated(:)=0
END DO
WRITE(*,*) 'Importing Individual Receptor Data'
! Read intial position of Receptor
DO k = 1,Simulation%NumberReceptors
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READ(2,103)
Receptor(k)%InitialPosition(1),Receptor(k)%InitialPosition(2), &
&Receptor(k)%Domain,
Receptor(k)%OriginalSpecies, Receptor(k)%Ligand, &
&Receptor(k)%BoundBuddy
103 FORMAT(F18.16,F18.16,I3,I2,I2,I4)
SpeciesCount(Receptor(k)%OriginalSpecies)=SpeciesCount(Receptor(k)%Origin
alSpecies)+1
Species(Receptor(k)%OriginalSpecies)%Liganded(Receptor(k)%Ligand+1)= &
&Species(Receptor(k)%OriginalSpecies)%Liganded(Receptor(k)%Ligand+1)+1
END DO
CLOSE(2)
!WRITE(*,*) Receptor(:)%Domain
Receptor(:)%Species = Receptor(:)%OriginalSpecies
Receptor(:)%Position(1) = Receptor(:)%InitialPosition(1)
Receptor(:)%Position(2) = Receptor(:)%InitialPosition(2)
100 FORMAT(I10)
101 FORMAT(F10.7)
102 FORMAT(F7.4,F7.4,F7.4,F7.4)
105 FORMAT(I10)
106 FORMAT(F6.2)
107 FORMAT(a)
109 FORMAT(I3,I3)
CLOSE(1)
WRITE(*,*) 'Importing Domain Data'
ALLOCATE (Domain(Simulation%NumberDomains(2),NumMonomerSpecies))
ALLOCATE
(Domain(Simulation%NumberDomains(2),NumMonomerSpecies)%xmin)
ALLOCATE
(Domain(Simulation%NumberDomains(2),NumMonomerSpecies)%xmax)
ALLOCATE
(Domain(Simulation%NumberDomains(2),NumMonomerSpecies)%ymin)
ALLOCATE
(Domain(Simulation%NumberDomains(2),NumMonomerSpecies)%ymax)
! Read in number of vertices for each dom
READ(DomainVertFile(1),*)
Simulation%NumberVertices(1:Simulation%NumberDomains(1),1)
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READ(DomainVertFile(2),*) Simulation%NumberVertices(:,2)
DO i = 1,2
DO j = 1,Simulation%NumberDomains(i)
! Import Domain mins and maxes
ALLOCATE (Domain(j,i)%xmin)
ALLOCATE (Domain(j,i)%xmax)
ALLOCATE (Domain(j,i)%ymin)
ALLOCATE (Domain(j,i)%ymax)
READ(DomainLimitsFile(i),*)
Domain(j,i)%xmax, Domain(j,i)%ymin, Domain(j,i)%ymax

Domain(j,i)%xmin,

! Import Domain Vertices
ALLOCATE
(Domain(j,i)%XCoord(Simulation%NumberVertices(j,i)))
ALLOCATE
(Domain(j,i)%YCoord(Simulation%NumberVertices(j,i)))
READ(DomainVertFile(i),*) Domain(j,i)%XCoord
READ(DomainVertFile(i),*) Domain(j,i)%YCoord
END DO
END DO
CLOSE(3)
CLOSE(4)
CLOSE(7)
CLOSE(8)
WRITE(*,*) 'Initializing Files'
! Create output files
WRITE(fnstring3,9000) TRIM(Simulation%OutputDirectory)
WRITE(fnstring4,9001) TRIM(Simulation%OutputDirectory)
WRITE(fnstring5,9002) TRIM(Simulation%OutputDirectory)
WRITE(fnstring6,9003) TRIM(Simulation%OutputDirectory)
WRITE(fnstring7,9004) TRIM(Simulation%OutputDirectory)
9000 FORMAT(a,'/TrueDimerLifetimes')
9001 FORMAT(a,'/MSDData')
9002 FORMAT(a,'/PhosReactions')
9003 FORMAT(a,'/PhosLifetimes')
9004 FORMAT(a,'/DomainExitInfo')
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OPEN(4,file=fnstring3) ! dimer lifetimes from the actual simulation, not the
frame rate
OPEN(7,file=fnstring4) ! MSD info written to according to frame rate, calculated
each dt
OPEN(8,file=fnstring5) ! time to phosphorylation for each dimer
OPEN(9,file=fnstring6) ! Phosphorylation time
OPEN(10,file=fnstring7) ! Exit rate info for Adam
! Initialize variables
Simulation%CurrentTimeStep = 0
Receptor(:)%Phosphate = 0
ReceptorData(:)%DimerStart = 0
ReceptorData(:)%PhosStart = 0
ReceptorData(:)%JumpSize(1) = 0
ReceptorData(:)%JumpSize(2) = 0
ReceptorData(:)%JumpSize(3) = 0
Receptor(:)%ActiveTail = 0
ReceptorData(:)%PhosSuccess = 0
! Account for double picking of a dimer on rates **Need to make general**
DimOffRate((NumMonomerSpecies+1):NumBaseSpecies,:)=DimOffRate((Num
MonomerSpecies+1):NumBaseSpecies,:)/2
PhosRate((NumMonomerSpecies+1):NumBaseSpecies,:)=PhosRate((NumMono
merSpecies+1):NumBaseSpecies,:)/2
DePhosRate((NumMonomerSpecies+1):NumBaseSpecies,:)=DePhosRate((Num
MonomerSpecies+1):NumBaseSpecies,:)/2
! Initialize Random Seed and Seed Random Number Generator
CALL SYSTEM_CLOCK(COUNT=seed)
! Seed grnd()
CALL sgrnd(seed)
! Calculate number of moves
NMoves = Simulation%Length/Simulation%TimeStep
! Divid number of moves among all receptors
RMoves = NMoves*Simulation%NumberReceptors
! Calculate time step per Receptor
Simulation%RTimeStep=Simulation%TimeStep/Simulation%NumberReceptors
! Calculate datacut frequency
frames = INT(Simulation%FrameRate*Simulation%Length)
datacut = INT((RMoves)/(Simulation%FrameRate*Simulation%Length))
framecount = 0
datacutcount=0
WRITE(*,*) 'Main Loop Started'
! MAIN SIMULATION LOOP
DO j = 1,RMoves
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! Update time
Simulation%CurrentTimeStep=Simulation%CurrentTimeStep
Simulation%RTimeStep
! Pick current receptor
i=1+INT((Simulation%NumberReceptors-1)*grnd())
! initialize probabilites
PhosProb = 0
UnbindProb = 0
DephosProb = 0
! Move receptor
CALL ReceptorDiffuse(i,Reaction)

+

IF (.NOT. Reaction) THEN ! Check for other possible Reactions
(Dissociation, Phosphorylation, Dephosphorylation)
!WRITE(*,*) 'Check for other reaction'
IF (Receptor(i)%BoundBuddy > 0) THEN ! Dimer
LigandCount
=
Receptor(i)%Ligand
+
Receptor(Receptor(i)%BoundBuddy)%Ligand + 1
PhosphateCount
=
Receptor(i)%Phosphate
+
Receptor(Receptor(i)%BoundBuddy)%Phosphate + 1
ELSE ! Monomer
LigandCount = Receptor(i)%Ligand + 1
PhosphateCount = Receptor(i)%Phosphate + 1
END IF
! Calculate Unbinding Probability f(species, ligand)
UnbindProb
=
DimOffRate(Receptor(i)%Species,LigandCount)*Simulation%TimeStep
!WRITE(*,*) 'Current Species =', Receptor(i)%Species, 'Original
Species =', Receptor(i)%OriginalSpecies
!WRITE(*,*) 'LigandCount =', LigandCount, 'PhosphateCount',
PhosphateCount
!WRITE(*,*) 'Active Tail =', Receptor(i)%ActiveTail
! Calculate Phosphorylation Probability f(species, receiver
phosphorylation state)
IF (Receptor(i)%ActiveTail > 0) THEN ! Dimer, ActiveTail is the
receptor in the dimer that is active (to be phosphorylated)
!WRITE(*,*)
'Active
Tail
Species
=',
Receptor(Receptor(i)%ActiveTail)%OriginalSpecies
!WRITE(*,*) 'Receiver Phosphorylation State =',
(Receptor(Receptor(Receptor(i)%ActiveTail)%BoundBuddy)%Phosphate + 1)
!PhosProb
=
PhosMulti(Receptor(Receptor(i)%ActiveTail)%OriginalSpecies,PhosphateCount) &
!
&*PhosRate(Receptor(i)%Species,PhosphateCount)*Simulation%TimeStep

207

PhosProb=PhosRate(Receptor(Receptor(Receptor(i)%ActiveTail)%BoundBuddy)
%OriginalSpecies,&
&(Receptor(Receptor(Receptor(i)%ActiveTail)%BoundBuddy)%Phosphate
1))*Simulation%TimeStep
ELSE
!
PhosProb
PhosMulti(Receptor(i)%OriginalSpecies,PhosphateCount) &
!
&*PhosRate(Receptor(i)%Species,PhosphateCount)*Simulation%TimeStep

+
=

!PhosProb=PhosRate(Receptor(Receptor(i)%BoundBuddy)%OriginalSpecies,&
!
&(Receptor(Receptor(i)%BoundBuddy)%Phosphate + 1))*Simulation%TimeStep
PhosProb = 0
END IF
! Avoid double phosphorylation in a single lifetime
IF (ReceptorData(i)%PhosSuccess == 1) THEN
PhosProb = 0
END IF
! Calculate Dephosphorylation Probability f(species)
!DephosProb
=
DephosMulti(Receptor(i)%OriginalSpecies,PhosphateCount) &
!
&*DePhosRate(Receptor(i)%Species,PhosphateCount)*Simulation%TimeStep
IF (Receptor(i)%Phosphate == 1) THEN
DephosProb=DePhosRate(Receptor(i)%OriginalSpecies,PhosphateCount)*Simul
ation%TimeStep
END IF
!IF (Receptor(i)%Species == 4) THEN
!
WRITE(*,*)
'Species
=
',
Receptor(i)%Species,'UnbindProb =', UnbindProb, 'PhosProb =', PhosProb, 'DephosProb
=', DephosProb
!
WRITE(*,*) 'Ligand Count =', LigandCount
!
WRITE(*,*)
'PhosState
of
ActiveTail
=',
Receptor(Receptor(i)%ActiveTail)%Phosphate
!
END IF
! Calculate total probability
!ProbTot=UnbindProb+PhosProb+DephosProb
! Normalize probabilities
!UnbindProbNorm=UnbindProb/ProbTot
!PhosProbNorm=PhosProb/ProbTot
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!DesphosProbNorm=DephosProb/ProbTot
! Find reaction based on probability
!WRITE(*,*)
'Ceiling:
',
CEILING(UnbindProb+PhosProb+DephosProb),
'Sum:
',
UnbindProb+PhosProb+DephosProb
IF (CEILING(UnbindProb+PhosProb+DephosProb)>0) THEN
! Generate random number
randnum=grnd()
IF (randnum > 0 .AND.randnum <= PhosProb) THEN
! Phosphorylate
!IF (Receptor(i)%Species == 4) THEN
!
WRITE(*,*)
'Out
of
Function:
PHOSPHORYLATE! Species: ', Receptor(i)%Species!, 'Ligand Count: ', LigandCount,
'Phos Count: ', PhosphateCount
!
!WRITE(*,*)
'Species
=
',
Receptor(i)%Species,'UnbindProb =', UnbindProb, 'PhosProb =', PhosProb, 'DephosProb
=', DephosProb
!
WRITE(*,*) 'Ligand Count (+1 for
indexing)=', Receptor(i)%Ligand + Receptor(Receptor(i)%BoundBuddy)%Ligand + 1
!
WRITE(*,*) 'PhosState of ActiveTail =',
Receptor(Receptor(i)%ActiveTail)%Phosphate
!
END IF
!Write(*,*) 'Min Prob: 0, Max Prob: ', PhosProb
!WRITE(*,*) 'Unbind: ', UnbindProb, '**Phos: ',
PhosProb, 'Dephos: ', DephosProb, 'Rand #: ', randnum
IF (Receptor(Receptor(i)%ActiveTail)%Phosphate
== 0) THEN
CALL Phosphorylate(i)
END IF
ELSEIF (randnum > PhosProb .AND.randnum <=
UnbindProb+PhosProb) THEN
! Unbind
!WRITE(*,*)
'UNBIND!
Species:
',
Receptor(i)%Species, 'Ligand Count: ', LigandCount, 'Phos Count: ', PhosphateCount
!Write(*,*) 'Min Prob: ', PhosProb, ' Max Prob:
',UnbindProb+PhosProb
!WRITE(*,*) '**Unbind: ', UnbindProb, 'Phos: ',
PhosProb, 'Dephos: ', DephosProb, 'Rand #: ', randnum
CALL DissociationReaction(i)
ELSEIF
(randnum
>
UnbindProb+PhosProb
.AND.randnum <= UnbindProb+PhosProb+DephosProb) THEN
! Dephosphorylate
!WRITE(*,*) 'DEPHOSPHORYLATE! Species: ',
Receptor(i)%Species, 'Ligand Count: ', LigandCount, 'Phos Count: ', PhosphateCount
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!Write(*,*) 'Min Prob: ', UnbindProb+PhosProb, '
Max Prob: ', UnbindProb+PhosProb+DephosProb
!WRITE(*,*) 'Unbind: ', UnbindProb, 'Phos: ',
PhosProb, '**Dephos: ', DephosProb, 'Rand #: ', randnum
CALL Dephosphorylate(i)
END IF
END IF
END IF
! Record keeping code
datacutcount=datacutcount+1
!WRITE(*,*) 'DataCut:', datacutcount, '/', datacut
!WRITE(*,*) 'FrameCount:', framecount
!!!!!
! Check if the data should be written to a file
IF (datacutcount == datacut) THEN
framecount=framecount+1
! generate filename for data storage
IF (framecount < 10) THEN
WRITE(fnstring,
TRIM(Simulation%OutputDirectory), framecount

7001)

ELSE IF (framecount < 100) THEN
WRITE(fnstring,
TRIM(Simulation%OutputDirectory), framecount

7002)

ELSE IF (framecount < 1000) THEN
WRITE(fnstring,
TRIM(Simulation%OutputDirectory), framecount

7003)

ELSE IF (framecount < 10000) THEN
WRITE(fnstring,
TRIM(Simulation%OutputDirectory), framecount

7004)

ELSE IF (framecount < 100000) THEN
WRITE(fnstring,
TRIM(Simulation%OutputDirectory), framecount

7005)

ELSE
WRITE(fnstring,
TRIM(Simulation%OutputDirectory), framecount
END IF
OPEN(77,file=fnstring)
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7006)

!WRITE(*,*) 'New Data File'
WRITE(77,*) 'Rows: Receptor Columns: Receptor #, x, y, dx, dy,
d, monomer/dimer, &
&ligand, Bound Particle #, Domain, Phosphorylation state'
! Write data to file
DO i = 1,Simulation%NumberReceptors
IF (Receptor(i)%Species <= NumMonomerSpecies) THEN
WRITE(77,*)
i,
Receptor(i)%Position(1),
Receptor(i)%Position(2), ReceptorData(i)%JumpSize(1), &
&ReceptorData(i)%JumpSize(2),
ReceptorData(i)%JumpSize(3), 1, Receptor(i)%Ligand, &
&Receptor(i)%BoundBuddy,
Receptor(i)%Domain, Receptor(i)%Phosphate
ELSE
WRITE(77,*)
i,
Receptor(i)%Position(1),
Receptor(i)%Position(2), ReceptorData(i)%JumpSize(1), &
&ReceptorData(i)%JumpSize(2),
ReceptorData(i)%JumpSize(3), 2, Receptor(i)%Ligand, &
&Receptor(i)%BoundBuddy,
Receptor(i)%Domain, Receptor(i)%Phosphate
END IF
END DO
CLOSE(77)
datacutcount=0
!WRITE(*,*) 'Species Count: ', SpeciesCount(:)
END IF
7001
7002
7003
7004
7005
7006

FORMAT(a,'/Data_Files/ParticleData.',I1);
FORMAT(a,'/Data_Files/ParticleData.',I2);
FORMAT(a,'/Data_Files/ParticleData.',I3);
FORMAT(a,'/Data_Files/ParticleData.',I4);
FORMAT(a,'/Data_Files/ParticleData.',I5);
FORMAT(a,'/Data_Files/ParticleData.',I6);
END DO
CLOSE(4)
CLOSE(8)
CLOSE(9)
WRITE(*,*) 'Simulation Completed'

END PROGRAM ErbB23_Sim
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APPENDIX C: Chapter 3 Supplement
The foundation of this model is a Brownian motion simulator with three separate
modules (Figure A.1A). The first module performs initial data processing in Matlab
using graphical user interface (GUI, Figure A.1B). This function facilitates design of the
membrane simulation space based upon an EM image, providing the number of receptors,
their distribution on the membrane, the estimated area and position of confinement zones.
Module 2 is executed in FORTRAN for Brownian motion simulation, dimerization and
phosphorylation; the reactions are governed by modified Smoluchowski kinetics. Module
3 performs post data processing in Matlab.
Particle Diffusion. Particle diffusion is based on Brownian motion.

Brownian

motion is represented in a simulation by picking a random number from a normal
distribution and applying that value to the root mean square (RMS) step length, creating
the stochastic nature of diffusion (Andrews & Bray, 2004; Kusumi et al, 1993; Popov &
Agmon, 2001).

where x and y are the particle’s Cartesian coordinates, RMS is the root mean square
step, Dt is the time step, and ξx and ξy are the normally distributed random numbers.
Periodic boundary conditions are used for the boundaries of the simulation space.
Confinement zones, as imported from the EM image, create a hurdle for the diffusing
particles during the simulation. Particles are free to diffuse into confinement zones,
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Figure A.1: Model workflow and user interface. (A) Model workflow from user initiation through
final output. Initialization of the simulation occurs through a graphical user interface (GUI)
allowing the user to vary different simulation conditions. Input data collected through the GUI is
then passed through to the main simulator, which executes the desired simulation. Finally, the
simulation output is passed to post processing scripts to run relevant analysis and generate plots. (B)
Graphical user interface used to pass through variable model inputs to control simulation conditions.
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however receptors must pay a “toll” to escape the confinement zone. A probability is
calculated using escape rates calculated from the Single Particle Tracking (SPT)
experiments and the time step, similar to the previous version of the model by Hsieh et al.
(Hsieh et al, 2008):

However, this probability has been simplified further to:

due to the small time step. If a confined particle is set to diffuse out of a confinement
zone, and this escape probability is not met, the confinement zone assumes a reflective
boundary condition, trapping the particle inside.
Kinetics. Modified Smoluchowski kinetics are used to simulate particle kinetics (see
Andrews and Bray (Andrews & Bray, 2004)). During simulation, rules for dimerization
and phosphorylation determine the course of the receptor in question. The simulator
focuses on one receptor at a time, picking every receptor once over a fixed time step.
Receptors are picked randomly, allowing the order the receptors are moved or reacted to
be different for each time step. Once a receptor is picked, a series of reactions are
considered before the fate of the receptor is implemented. There are four possible
reactions that can take place, dimerization, dimer dissociation, phosphorylation, and
dephosphorylation. Dimerization is treated as a second-order reaction, while dimer
dissociation, phosphorylation, and dephosphorylation are all treated as first-order
reactions.
Dimerization
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A receptor’s likelihood to dimerize with another receptor is based on a distance
termed the binding radius. The binding radius takes into account the dimer on rate,
diffusion coefficient of the receptors that will comprise the dimer, and the simulation
time step (Andrews & Bray, 2004). While the binding radius is not a physical radius, the
use of this radius allows the simulation to be closer to the physical situation than previous
methods using probabilities (Andrews & Bray, 2004; Erban & Chapman, 2009; Gillespie,
1977; Hsieh et al, 2008; Popov & Agmon, 2001). When the chosen receptor is moved,
the final position is scanned for other receptors that are within the binding radius. If a
receptor is within this distance, then the receptors will form a dimer. Determination of
the binding radius is discussed in model parameters below.
Dimer Dissociation, Phosphorylation, & Dephosphorylation
Dimer dissociation and dephosphorylation are first order reactions.

Dimer

phosphorylation may be considered second-order due to the dimer and phosphate
reacting, however here phosphate is assumed to be in excess, therefore the reaction can
be approximated as first-order.

First-order reactions are implemented through a

probability calculated using the reaction rate and simulation time step:

This probability has been simplified further, as in Hsieh et al (Hsieh et al, 2008) and
Andrews and Bray (Andrews & Bray, 2004):
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When dimer dissociation occurs, an unbinding radius is used to set the dissociating
receptors apart.

The unbinding radius is calculated such that the occurrence of an

unrealistic amount of repeated interactions is minimized:

where σb is the binding radius and σu is the unbinding radius. The default ratio of binding
radius to unbinding radius is 0.2.
Model Parameters. The majority of parameters needed for the model are directly
measured using SPT experiments (Low-Nam et al, 2011). These parameters include
dimer off rates, diffusion coefficients, and confinement zone escape rates.
Phosphorylation and dephosphorylation rates were measured by Kleiman et al (Kleiman
et al, 2011). The most elusive model parameter is the dimer on rate, which cannot
currently be accurately measured through SPT. Martin-Fernandez (Martin-Fernandez et
al, 2002) found 14% of receptors on a membrane participate in preformed dimers at
steady state. Using this information, a binding radius is calculated by iterating the
binding radius over a large range until the percent of preformed dimers converged to
approximately 14% during 4 minute simulations. This binding radius is then used to
back calculate the dimer on rate using SMOLDYN (Andrews & Bray, 2004).
Model Validation. Parameters were validated by comparison to experimental data.
This is shown in Figure 3.1EF, where simulated diffusion coefficients and off rates match
well with the experimental values in Low-Nam et al. (Low-Nam et al, 2011). Plots in
Figure A.2A show good comparison of phosphorylation kinetics in the model versus
experimentally measured values in MCF7 cells (Verveer et al, 2000). In addition,
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Figure A.2: ErbB1 Receptor Phosphorylation (A) Average phosphorylation population over a 60
second simulation as compared to experimental data from Verveer et al. (Verveer et al, 2000) (B)
Average phosphorylation population for a 10% LR simulation and 100% LR simulation. (C)
Comparison of the simulated phosphorylation lifetime in simulation against experimental values
reported by Kleiman et al. (8). (D) Percent of total monomers relative to ligand occupancy, over a 4
minute simulation with 50% LR.
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Figure A.2C below reports model validation for phosphorylation lifetimes, as
compared to experimental values reported for dephosphorylation of EGFR after acute
exposure to the kinase inhibitor Gefitinib (Kleiman et al, 2011). Figure A.2D shows a
shift in available monomer equilibrium for a 50% LR simulation. Initially the simulation
has equal amounts of unliganded monomer (R) and liganded monomer (LR) available. As
reactions occur and receptors transition to different states, the equilibrium of available
monomer transitions from equal amounts, to an excess of R monomers. LRLR dimers
form whenever two LR monomers are within the binding radius. LRR dimers have a
0.1% chance of forming within the binding radius, compared to a 0.01% chance for RR
dimer, due to the conformational flux of R monomers.
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Figure A.6: Compiled ranks for all the points from SPT data for ErbB2 and ErbB3. A biomodal
distribution is apparent for both speices. This is a compilation for tracking erbB2 with QD-655 and
erbB3 with QD-585.

Figure A.7: Amino acid substitution mutation in one of the erbB3 alleles in the widely-used SKBR3
breast cancer cell line.
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Figure A.8: ErbB3 E933Q Dephosphorylation. An activation/inhibition assay shows high levels of
phosphorylated erbB3 up to the 5 minute time point.
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